0001262463-12-000355.txt : 20120919 0001262463-12-000355.hdr.sgml : 20120919 20120919162817 ACCESSION NUMBER: 0001262463-12-000355 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20120731 FILED AS OF DATE: 20120919 DATE AS OF CHANGE: 20120919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NUVILEX, INC. CENTRAL INDEX KEY: 0001157075 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 621772151 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-68008 FILM NUMBER: 121100087 BUSINESS ADDRESS: STREET 1: 12510 PROSPERITY DRIVE, SUITE #310 CITY: SILVER SPRING STATE: MD ZIP: 20904 BUSINESS PHONE: (240) OWN-NVLX MAIL ADDRESS: STREET 1: 12510 PROSPERITY DRIVE, SUITE #310 CITY: SILVER SPRING STATE: MD ZIP: 20904 FORMER COMPANY: FORMER CONFORMED NAME: EFOODSAFETY COM INC DATE OF NAME CHANGE: 20010808 10-Q 1 nuvilex10q73112.htm FORM 10-Q Form 10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q


(Mark One)

x           QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended July 31, 2012

or


¨        

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________


Commission file number 333-68008


NUVILEX, INC.

(Exact name of registrant as specified in its charter)


Nevada

62-1772151

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)


12510 Prosperity Drive, Suite #310, Silver Spring, MD 20904

(Address of principal executive offices)


(240) 696-6859
(Registrant’s telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  x   No  ¨



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.


Large accelerated filer          ¨    

Accelerated filer                    ¨     

Non-accelerated filer            ¨     

Smaller reporting company    x

(Do not check if a smaller reporting company)





Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No x


As of September 10, 2012, the registrant had 423,950,851 outstanding shares of Common Stock.



 

 

 

 


 

2




Forward-Looking Statements


 

This report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “1933 Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact are “forward-looking statements” for purposes of this Quarterly Report on Form 10-Q, including any projections of earnings, revenue or other financial items, any statements regarding the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or performance, any statements regarding expected benefits from any transactions and any statements of assumptions underlying any of the foregoing. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “estimates,” “potential” or “continue,” or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct and actual results could differ materially from those projected or assumed in the forward-looking statements. Thus, investors should refer to and carefully review information in future documents Nuvilex, Inc. files with the Securities and Exchange Commission. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risk and uncertainties, including, but not limited to, the risk factors set forth in “Part II, Item 1A – Risk Factors” below and for the reasons described elsewhere in this Quarterly Report on Form 10-Q. All forward looking statements and reasons why results may differ included in this report are made as of the date hereof and we do not intend to update any forward-looking statements accept as required by law or applicable regulations. Except where the context otherwise requires, in this Quarterly Report on Form 10-Q, the “Company,” “Nuvilex,” “we,” “us” and “our” refer to Nuvilex, Inc., a Nevada corporation, and, where appropriate, its subsidiaries.


 


 











3




PART 1 – FINANCIAL INFORMATION

ITEM  1.  FINANCIAL STATEMENTS

The unaudited financial statements included herein have been prepared by Nuvilex, Inc. (the “Company”). In the opinion of management, the interim financial statements reflect all adjustments of a normal recurring nature necessary for a fair statement of the results for interim periods. It is recommended these financial statements and notes to the financial statements should be read in conjunction with financial statements included in the Company’s Annual Form 10-K Report for the fiscal year ended April 30, 2012.

 

 

 

 

 

 

 

 

 

 

 



 

4




 


NUVILEX, INC.

C O N T E N T S




Consolidated Balance Sheets as of July 31, 2012 (Unaudited) and April 30, 2012

6


Consolidated Statements of Operations for the Three Months Ended

July 31, 2012 and 2011 (Unaudited)  

7


Consolidated Statement of Stockholders’ Equity (Deficit)

as of July 31, 2012 (Unaudited)

8


Consolidated Statements of Cash Flows for the Three Months Ended

July 31, 2012 and 2011 (Unaudited)

9


Notes to Consolidated Financial Statements (Unaudited)

10

 

 

 

 

 

 

 










5




 

 

 

 

 

 

 

 

 

 

 

 

 

NUVILEX, INC.

CONSOLIDATED BALANCE SHEETS

 

 

 

 

 

 

 

 

July 31,

2012

 

 

April 30,

2012

ASSETS

 

(unaudited)

 

 

 

   Cash

$

24,342

 

$

15,723

   Accounts receivable - net

 

-

 

 

2,581

   Inventory

 

9,620

 

 

6,846

   Prepaid on acquisition

 

1,069,980

 

 

874,230

   Prepaid and other assets

 

101,716

 

 

159,350

         Total Current Assets

 

1,205,658

 

 

1,058,730

 

 

 

 

 

 

Property, plant and equipment - net

 

-

 

 

-

Settlement Obligation Asset

 

1,028,778

 

 

1,028,778

          Total Assets

$

2,234,436

 

$

2,087,508

 

 

 

 

 

 

LIABILITIES AND STOCKHOLERS' EQUITY (DEFICIT)

 

 

 

 

 

Current Liabilities

 

 

 

 

 

   Accounts payable

$

424,181

 

$

730,068

   Accrued expenses

 

41,103

 

 

407,463

   Accrued interest, related party

 

20,702

 

 

11,461

   Due to related parties

 

382,958

 

 

360,108

   Due to an officer

 

202,769

 

 

185,862

   Settlement Obligation Liabilities

 

2,225,313

 

 

-

   Loans  payable

 

730,000

 

 

2,092,396

          Total Current Liabilities

 

4,027,026

 

 

3,787,358

 

 

 

 

 

 

Long-term Liabilities

 

 

 

 

 

    Long-term debt, related party

 

-

 

 

-

          Total Liabilities

 

4,027,026

 

 

3,787,358

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

   Preferred stock, authorized 10,000,000 shares,

 

 

 

 

 

   $0.0001 par value, 8,500 and 8,500 shares issued

 

 

 

 

 

   and outstanding, respectively

 

580,000

 

 

580,000

 

 

 

 

 

 

Stockholders' Equity (Deficit)

 

 

 

 

 

   Common Stock, authorized 1,490,000,000 shares,

 

 

 

 

 

   $0.0001 par value, 423,420,851 and 416,293,195

 

 

 

 

 

   shares issued and outstanding, respectively

 

42,345

 

 

41,631

   Additional paid in capital

 

37,943,587

 

 

37,526,524

   Accumulated deficit

 

(40,358,522)

 

 

(39,848,005)

          Total Stockholders' Equity (Deficit)

 

(2,372,590)

 

 

(2,279,850)

          Total Liabilities and Stockholders' Equity (Deficit)

$

2,234,436

 

$

2,087,508

 

 

 

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 



6





NUVILEX, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

 

 

 

 

For the Three Months Ended July 31,

 

 

2012

 

2011

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

Product sales

$

6,626

 

$

19,762

Total revenue

 

6,626

 

 

19,762

Cost of revenues

 

-

 

 

15,675

Gross profit

 

6,626

 

 

4,087

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

Sales and marketing

 

81,982

 

 

125,130

 

Compensation expense

 

181,181

 

 

305,564

 

Legal & professional fees

 

52,243

 

 

59,954

 

General and administrative

 

230,006

 

 

166,039

 

      Total operating expenses

 

545,412

 

 

656,687

Net loss from operations

 

(538,786)

 

 

(652,600)

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

Gain on forgiveness of debt

 

71,742

 

 

-

 

Other income

 

2,590

 

 

-

 

Interest expense

 

(46,063)

 

 

(33,420)

 

      Total other income (expense)

 

28,269

 

 

(33,420)

Net loss

$

(510,517)

 

$

(686,020)

 

 

 

 

 

 

 

Basic loss per share

$

(0.00)

 

$

(0.00)

 

 

 

 

 

 

 

Weighted average shares outstanding

 

419,566,403

 

 

367,294,646

 

 

 

 

 

 

 



The accompanying notes are an integral part of these consolidated financial statements.






 

7





NUVILEX, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

Common

 

 

 

 

 

Common Stock

 

Paid

 

Stock Not

 

Accumulated

 

 

 

Shares

 

Amount

 

In Capital

 

Yet  Issued

 

Deficit

 

Total

Balance April 30, 2011

  357,137,581

 $

  35,714

 $

  34,415,655

 $

    768,031

 $

  (37,948,693)

 $

  (2,729,293)

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for cash

500,000

 

50

 

20,950

 

              -   

 

                   -   

 

21,000

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for compensation

23,575,000

 

2,358

 

1,196,272

 

(37,750)   

 

                   -   

 

1,160,880

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for services

8,550,000

 

855

 

408,545

 

-

 

                   -   

 

409,400

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued on stock payable

14,605,614

 

1,461

 

728,820

 

(730, 281)

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for repayment of cash advances

9,250,000

 

925

 

599,075

 

-

 

-

 

600,000

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for incentive for cash advances

1,650,000

 

165

 

101,585

 

-

 

-

 

101,750

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for settlement of debt

1,025,000

 

103

 

55,622

 

-

 

-

 

55,725

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the year ended April 30, 2012

                   -   

 

          -   

 

                 -   

 

-

 

(1,899,312)

 

(1,899,312)

 Balance, April 30, 2012

416,293,195

 

41,631

 

37,526,524

 

-

 

  (39,848,005)

 

  (2,279,850)

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for compensation (unaudited)

2,885,000

 

290

 

171,891

 

-

 

-

 

172,181

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for services (unaudited)

2,400,000

 

240

 

146,760

 

-

 

-

 

147,000

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for settlement of debt (unaudited)

1,842,656

 

184

 

98,412

 

-

 

-

 

98,596

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the period ended July 31, 2012 (unaudited)

-

 

-

 

-

 

-

 

(510,517)

 

(510,517)

 

 

 

 

 

 

 

 

 

 

 

 

Balance, July 31, 2012 (unaudited)

423,420,851

$

42,345

$

37,943,587

$

-

$

(40,358,522)

$

(2,372,590)


The accompanying notes are an integral part of these consolidated financial statements.





 

8





 

NUVILEX, INC.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended

July 31,

 

 

 

 

2012

 

 

2011

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(510,517)

 

$

(686,020)

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

     Stock issued for services

 

 

319,181

 

 

536,213

 

     Gain on forgiveness of debt

 

 

71,742

 

 

-

 

     Depreciation and amortization

 

 

-

 

 

8,523

 

     Net amortization of discount/premium

 

 

(5,695)

 

 

(2,699)

 

     Change in assets and liabilities:

 

 

 

 

 

 

 

           (Increase) / decrease in accounts receivable

 

 

2,581

 

 

(6,291)

 

           (Increase)  / decrease in inventory

 

 

(2,774)

 

 

11,089

 

           (Increase)  / decrease in prepaid expenses

 

 

88,821

 

 

(3,355)

 

           Increase (decrease)  in accounts payable

 

 

(124,935)

 

 

(13,207)

 

           Increase in accrued interest, related party

 

 

9,241

 

 

-

 

           Increase in accrued expenses

 

 

66,967

 

 

36,120

 

                  Net cash used in operating activities

 

 

(85,388)

 

 

(119,627)

Cash flows from investing activities:

 

 

 

 

 

 

 

    Payments towards acquisition

 

 

(195,750

 

 

(320,000)

 

                 Net cash used by investing activities

 

 

(195,750)

 

 

(320,000)

Cash flows from financing activities:

 

 

 

 

 

 

 

    Proceeds from the sale of common stock

 

 

-

 

 

473,000

 

    Proceeds from notes payable

 

 

250,000

 

 

-

 

    Proceeds from borrowings, related party

 

 

39,757

 

 

1,500

 

    Repayment of debt, related party

 

 

-

 

 

(9,000)

 

                 Net cash provided by financing activities

 

 

289,757

 

 

465,500

 

Net increase in cash

 

8,619

 

 

25,873

 

Cash at beginning of period

 

 

15,723

 

 

57,201

 

Cash at end of period

 

$

24,342

 

$

83,074

 

Supplementary non-cash disclosures:

 

 

 

 

 

 

 

   Cash paid for interest

 

$

-

 

$

-

 

   Franchise and income taxes

 

$

-

 

$

-

 

   Common stock issued for debt

 

$

98,596

 

$

-

 

 

 

 

 

 

 

 



The accompanying notes are an integral part of these consolidated financial statements.




 

9





NUVILEX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY, 2012

 (UNAUDITED)


NOTE 1 – BACKGROUND, ACQUISITION AND LIQUIDITY

This summary of accounting policies for Nuvilex, Inc. and Subsidiaries is presented to assist in understanding the Company's consolidated financial statements. The accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the consolidated financial statements.

History of the Company

The Company was founded as DJH International, Inc., a Nevada corporation, on October 28, 1996, changing its name to eFoodSafety.com, Inc. following the October 16, 2000 acquisition of Global Procurement Systems, Inc. The Company acquired Ozone Safe Food, Inc. for Common Stock on October 29, 2003. The Company’s early mission provided methods and products to ensure safety of marketed fruits and vegetables worldwide. On February 4, 2004, the Company registered shares with the Securities and Exchange Commission and its Common Stock began publicly trading on the OTC Bulletin Board under the trading symbol EFSF. The Company did not issue shares of Common Stock pursuant to an initial public offering. With less than projected demand for its produce sterilization methods and software tracking products, the Company changed its strategy and acquired Knock-Out Technologies, Ltd. and MedElite, Inc. in May 2004 and August 2005, respectively, of which Knock-Out Technologies, Ltd. was a developer of products using organic, non-toxic, food based substances and MedElite, Inc. was the exclusive U.S. distributor of TalsynTM-CI Scar Cream (“Talsyn”), a topical scar- reducing cream. The Company’s strategy was to bring to market scientifically derived products. The Company sold its Ozone Safe Food, Inc. operations in August 2005. In November 2006, the Company formed Cinnergen, Inc., a wholly-owned subsidiary, to manufacture and market a non-prescription liquid nutritional supplement designed to promote healthy glucose metabolism, and purEffect, Inc., another wholly-owned subsidiary, to manufacture and market purEffectTM, a four-step non-prescription acne treatment. On March 10, 2006, the Company licensed the marketing rights for purEffectTM to Charlston Kentrist 41 Direct, Inc. (“CK41”). In July 2007, I-Boost, Inc., a wholly-owned subsidiary was formed to market products to support the immune system. In March 2008, Cinnechol, Inc. became a wholly-owned subsidiary to promote cardiovascular health. In February 2009, the Company sold the rights to the purEffectTM product to CK41 for an equity position in CK41 and future royalty compensation. In March 2009, Freedom2 Holdings, Inc. was acquired to manufacture and market products including Infinitink®, a permanent tattoo ink designed to be removed more easily using conventional laser light. The Company changed its name to Nuvilex, Inc. on March 18, 2009 as part of the process.

NOTE 2 - Going Concern and Management’s Plans

The Company's financial statements are prepared using accounting principles generally accepted in the United States of America (GAAP) applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenue sufficient to cover its operating costs and allow it to continue as a going concern. In addition, as of July 31, 2012, the Company had an accumulated deficit of $40,358,522, had incurred a net loss for the period ended July 31, 2012 of $510,517 and had negative working capital of $2,821,368. Funding has been provided by the Company’s CEO, Dr. Robert Ryan as well as old and new investors committed to make it possible to maintain, expand, and ensure the advancement of Nuvilex and help the Company see its vision through to providing a pancreatic cancer treatment in the future. Lastly, although the Company’s current business plan includes funding requirements beyond the anticipated cash flows from operations, we continue to acquire such funds as the Company moves forward toward its pancreatic cancer treatment and the numerous other opportunities being advanced at this point. Therefore, doubt exists as to the Company's ability to continue as a going concern.  All of us at Nuvilex are nonetheless actively undertaking the necessary steps and are committed to working with the myriad of personnel and interested investors to ensure our success.

Strategy

The Company has been in existence for more than a decade.  During this time products were brought into the Company with the intention to work toward seeing them become household names and products.  Several have become well used, but the challenge with all products is to make them well recognized, useful, important, and valuable enough that everyday consumers use them consistantly.  As a result, the overall Company structure of Nuvilex has changed in many ways over the years.  On a daily basis, the Company receives different inquiries for our products, indicating they still retain value.  From those humble beginnings we are now pushing to move this Company forward into a modern one with clarity and vision.  



10




Thus, since June 2011, we have been working with the Chief Executives of Austrianova Singapore Private Limited (“Austrianova Singapore” or ASPL), previously assets of SG Austria Private Limited or “SG Austria,” across a wide swath of areas.  Much of the effort has been on establishing plans for our future.  Therefore, and in conjunction with maintenance of the company, funding has been provided to ASPL and its personnel in order to ensure ASPL’s functionality and maintain its ability to accomplish numerous goals over the year.  This first vision has been noted as one of the most valuable advances for this company, enabling the creation of a biotechnology/life technology company.  Unlike most companies of this type and entirely due to the Company’s extensive array of products already in-house, Nuvilex exists as a Biotech Company with a broad company base, much like that of larger biotechnology or pharmaceutical companies after years of advances and purchasing of products from the outside.  Thus, with an overall goal of long-term growth, the Company is poised to be thrust into a very different position, particularly as a result of the stabilizing of its financial condition that has been occurring over the past year.

Management believes its vision to become an important industry-leading Biotechnology company, with a multi-part strategy like those of larger pharmaceutical companies will strengthen the Company’s position in both the short and long term.  Notwithstanding and as the financial experts accurately point out, Nuvilex may seek to raise capital to fund growth opportunities and provide for its working capital needs as the vision of the company is executed.  The Company’s efforts to achieve financial stability and enable carrying out the strategy of the company include several primary components:

1. Continued elimination of prior operation-associated debt from the Parent Company and all subsidiaries;

2. Advance and develop the biotechnology through ongoing research;

3. Acquisition of new contracts utilizing the biotechnology;

 4. Expand and Market products and their uses

NOTE 3 – Significant Accounting Policies

Unaudited Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), for interim financial information and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X. While these statements reflect all normal recurring adjustments which are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The unaudited interim financial statements should be read in conjunction with the Company’s annual report on Form 10-K, which contains the audited financial statements and notes thereto, together with Management’s Discussion and Analysis, for the fiscal year ended April 30, 2012.  The interim results for the three months ended July 31, 2012 are not necessarily indicative of the results for the full fiscal year.

Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company's system of internal accounting control is designed to assure, among other items, that 1) recorded transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented.

Principles of Consolidation

The consolidated financial statements include the accounts of Nuvilex, Inc. and its subsidiaries, Knock-Out Technologies, Ltd., MedElite, Inc., Cinnergen, Inc., I-Boost, Inc., Cinnechol Inc., Nuvilex GmbH, Berlin, Freedom-2 Creditor Partners, Freedom-2 Holdings, Inc, Freedom-2, Inc., Exceptional Equipment and Ink Supply Company, Inc. With respect to the latter three subsidiaries the financials include the profit and loss activity from the date of purchase March 2, 2009 to July 31, 2012 as the acquisition was accounted for under the purchase method of accounting.

All significant intercompany balances and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes. There were no cash equivalents as of July 31, 2012 or April 30, 2012.



11




Inventories

Inventories are stated at the lower of cost or market. Cost is computed on a weighted-average basis, which approximates the first-in, first-out method; market is based upon estimated replacement costs.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Property and Equipment

Property and equipment are recorded at cost. Expenditures that increase the useful lives or capacities of the plant and equipment are capitalized. Expenditures for repairs and maintenance are charged to income as incurred. Depreciation is provided using the straight-line method over the estimated useful lives as follows:

Computer equipment/software - 3 years

Furniture and fixtures - 7 years

Machinery and equipment - 7 years

Building improvements - 15 years

Building - 40 years


Goodwill and other indefinite-lived intangibles

The Company records the excess of purchase price over the fair value of the identifiable net assets acquired as goodwill and other indefinite-lived intangibles. The FASB standard on goodwill and other intangible assets, prescribes a two-step process for impairment testing of goodwill and indefinite-lived intangibles, which is performed annually, as well as when an event triggering impairment may have occurred. The first step tests for impairment, while the second step, if necessary, measures the impairment. The Company has elected to perform its annual analysis at the end of its reporting year.

Valuation of long-lived assets

The Company accounts for the valuation of long-lived assets under the FASB standard for accounting for the impairment or disposal of Long-Lived Assets. The FASB standard requires that long-lived assets and certain identifiable intangible assets be reviewed for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the long-lived assets is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less cost to sell.  

Basic and Diluted Earnings (Loss) per Share

Basic and diluted earnings per share is calculated using the weighted-average number of common shares outstanding during the period without consideration of the dilutive effect of stock warrants, convertible notes and convertible preferred shares.

Fair value of financial instruments

For certain of the Company’s non-derivative financial instruments, including cash and cash equivalents, receivables, accounts payable, and other accrued liabilities, the carrying amount approximates fair value due to the short-term maturities of these instruments. The estimated fair value of long-term debt is based primarily on borrowing rates currently available to the Company for similar debt issues. The fair value approximates the carrying value of long-term debt.

ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, “Financial Instruments,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:



12




 

 

 

  

·

Level 1. Observable inputs such as quoted prices in active markets;

  

·

Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

  

·

Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The following presents the gross value of assets and liabilities that were measured and recognized at fair value as of July 31, 2012 and April 30, 2012.

 

 

 

  

·

Level 1: none

  

·

Level 2: none

  

·

Level 3: none

Effective October 1, 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures ("ASC 820-10") and Accounting Standards Codification subtopic 825-10, Financial Instruments ("ASC 825-10"), which permits entities to choose to measure many financial instruments and certain other items at fair value. Neither of these statements had an impact on the Company's financial position, results of operations or cash flows. The carrying value of cash, accounts payable and accrued expenses, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments.

As of July 31, 2012 and April 30, 2012 the Company has recorded several of its assets and liabilities at fair value. The building or “Settlement Obligation Asset” (Note 11) was written down in the last quarter of fiscal 2010 to its fair value based upon a pending sale agreement. Although the agreement was not finalized it established the current market value for the property.  In Jan-March 2009, through the acquisition of another company the Company acquired certain debt. As part of the acquisition, these were evaluated by a third party and valued at fair value at the time they were recorded. As a result of this the Company is amortizing the associated discount and premium for two of the liabilities.

Recent accounting pronouncements

In September 2011 the Accounting Standards Update No. 2011-08, Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for impairment. This ASU's objective is to simplify the process of performing impairment testing for Goodwill. With this update a company is allowed to asses qualitative factors, first, to determine if it is more likely than not (greater than 50%) that the FV is less than the carrying amount. This would be done, prior to performing the two-step goodwill impairment testing, as prescribed by Topic 350.  Prior to this ASU, all entities were required to test, annually, their good will for impairment by Step 1 - comparing the FV to the carrying amount, and if impaired, then step 2 - calculate and recognize the impairment. Therefore, the fair value measurement is not required, until the "more likely than not" reasonableness test is concluded. Effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011.

In May 2011, FASB issued Accounting Standards Update No. 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.    This ASU clarifies the board's intent of current guidance, modifies and changes certain guidance and principles, and adds additional disclosure requirements concerning the 3 levels of fair value measurements. Specific amendments are applied to FASB ASC 820-10-35, Subsequent Measurement and FASB ASC 820-10-50, Disclosures. This ASU is effective for interim and annual periods beginning after December 15, 2011.

In June 2011, FASB issued Accounting Standards Update No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income. - ASU 2011-05. Current US GAAP allows companies to present the components of comprehensive income as a part of the statement of changes in stockholders' equity. This ASU eliminates that option. In this update, an entity has the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In both choices, an entity is required to present each component of net income along with total net income, each component of other comprehensive income along with a total for other comprehensive income, and a total amount for comprehensive income This ASU is effective interim and annual periods beginning after December 15, 2011. This ASU should be applied retrospectively. There are no specific transition disclosures.



13




The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Revenue Recognition

Sales of products and related costs of products sold are recognized when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the price is fixed or determinable, and (iv) collectability is reasonably assured. These terms are typically met upon the prepayment or invoicing and shipment of products.

Allowance for Doubtful Accounts

The Company provides an allowance for estimated uncollectible accounts receivable balances based on historical experience and the aging of the related accounts receivable.

Income Taxes

Deferred taxes are calculated using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

In June 2006, the FASB interpreted its standard for accounting for uncertainty in income taxes, an interpretation of accounting for income taxes.  This interpretation clarifies the accounting for uncertainty in income taxes recognized in an entity’s financial statements in accordance the minimum recognition threshold and measurement attributable to a tax position taken on a tax return is required to be met before being recognized in the financial statements.

The FASB’s interpretation had no material impact on the Company’s financial statements for the quarter ended July 31, 2012 or the year ended April 30, 2012. Current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, the amount available to offset future taxable income may be limited. No tax benefit has been reported in the financial statements, because the Company believes the carry forwards may expire unused, although acquisition of sufficient operating capital to complete the acquisition of all of the assets of SG Austria may change this. Accordingly, the potential tax benefits of the loss carry forwards are offset by a valuation allowance of the same amount.

Research and Development Costs

Expenditures for research and development are expensed as incurred. Such costs are required to be expensed until the point that technological feasibility is established.

Concentration of Credit Risk

The Company has no significant off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. The Company maintains the majority of its cash balances with one financial institution in the form of demand deposits.

Reclassifications

Certain items in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current period’s presentation. These reclassifications have no effect on the previously reported income (loss).

NOTE 4 – ACCOUNTS RECEIVABLE

The Company recognizes receivables predominately on sales of its Cinnergen product.  At July 31, 2012 the company recorded an allowance for doubtful accounts of $6,497.



14




NOTE 5 – ASSET PURCHASE

On June 21, 2012, the Registrant, Nuvilex, Inc. (“Nuvilex”), a Nevada corporation, purchased 100% of the shares of Austrianova Singapore Pte. Ltd. (ASPL) in exchange for 100,000,000 shares of restricted Nuvilex common stock. A copy of the final Asset Purchase Agreement, dated May 26, 2011, is attached as Exhibit 2.1 on the Company’s Form 10-K for the fiscal year ended April 30, 2012.


Under the terms of the Asset Purchase Agreement, the Nuvilex and ASPL shares are held in escrow until the completion of Nuvilex’s financing obligations. The Asset Purchase Agreement, as amended, provides that Nuvilex will fund future ASPL operations in the amount of $2.5 million with a target date to complete the funding by December 31, 2012. Nuvilex will continue current funding of $60,000 monthly in operating capital until the overall funding is completed.


The shares for both ASPL and Nuvilex are being held in escrow and are therefore not reflected in the financial statements.  This is due to the potential unwinding of the agreement in the event Nuvilex is unable to satisfy the Asset Purchase Agreement requirements including monthly maintenance payments or the $2.5 million minimum financing requirement.

NOTE 6 - INVENTORY

On July 31, 2012 and April 30, 2012, inventory consisted of $9,620 and $6,846, respectively of finished goods inventory for Cinnergen products. Inventories are stated at the lower of cost or market. Cost is computed on a weighted-average basis, which approximates the first-in, first-out method; market is based upon estimated replacement costs.

NOTE 7 - FIXED ASSETS

Fixed assets consisted of the following:

 

 

July 31, 2012

 

April 30, 2012

Computers

$

23,664

$

23,664

Furniture and fixtures

 

-

 

-

Lab equipment

 

-

 

-

 

 

 

 

 

Less: accumulated depreciation

 

(23,664)

 

(23,664)

 

$

-

$

-


Depreciation expense for the three months ended July 31, 2012 and fiscal year end April 30, 2012 was $0 and $24,659, respectively.


NOTE 8 – DEBT

As of July 31, 2012 the company owed various individuals a total of $310,000. All notes accrue interest at 10% per annum and are due within one year.


As of July 31, 2012 the company owed $20,000 plus accrued interest to an individual. The note accrues interest at 8% per annum and is past due.


As of July 31, 2012, the Company had an obligation to pay $400,000 in licensing fees for a licensing agreement that since then has been terminated.  The debt is presently under negotiation for settlement.

During the year ended April 30, 2012, the Company settled various debts with a combination of cash payments and the issuance of common stock. In total over $500,000 debt was settled. As a result of those settlements the Company recorded a gain of $370,619.

During the quarter ended July 31, 2012, the Company settled various accounts payable with the issuance of common stock. In total over $132,000 of debt was settled. As a result of those settlements the Company recorded a gain of $71,742.



15




NOTE 9 - COMMON STOCK TRANSACTIONS

During the year ended April 30, 2012, 23,575,000 shares of common stock were issued to officers of the Company for compensation. Shares were valued using the closing stock price on the day of issuance for a total expense of $1,160,880.

During the year ended April 30, 2012, 8,550,000 shares of common stock were issued for various services. Shares were valued using the closing stock price on the day of issuance for a total expense of $409,400.

During the year ended April 30, 2012, 9,250,000 shares of common stock were issued in exchange for $600,000 in cash advances to the Company. In addition, another 1,650,000 shares were issued as incentive for providing the cash advances to the Company. These additional shares were value at $101,750 and charged to interest expense

During the year ended April 30, 2012, 1,025,000 shares of common stock were issued to settle various debts. The shares were valued using the closing stock price on the day of issuance for a total expense of $55,725.

During the quarter ended July 31, 2012, 2,400,000 shares of common stock were issued for various services. Shares were valued using the closing stock price on the day of issuance for a total expense of $147,000.

During the quarter ended July 31, 2012, 1,842,656 shares of common stock were issued to settle various debts. The shares were valued using the closing stock price on the day of issuance for a total expense of $98,596.

During the quarter ended July 31, 2012, 2,885,000 shares of common stock were issued to officers of the Company for compensation. Shares were valued using the closing stock price on the day of issuance for a total expense of $172,181.

During the quarter ended July 31, 2012, the Company issued 100,000,000 shares of restricted common stock to Austrianova Singapore Pte. Ltd. (ASPL). Under the terms of the Asset Purchase Agreement, the shares are held in escrow until the completion of Nuvilex’s financing obligations (refer to Note 5).  The shares for both ASPL and Nuvilex are being held in escrow and are therefore not reflected in the financial statements.  This is due to the potential unwinding of the agreement in shares in the event Nuvilex is unable to satisfy the Asset Purchase Agreement requirements including monthly maintenance payments or the $2.5 million minimum financing requirement.

All shares were issued without registration under the Securities Act of 1933, as amended, in reliance upon the exemption afforded by Section 4(2) of that Act. No underwriters were involved.

NOTE 10 - PREFERRED STOCK

Series E Preferred Stock has, among others, the following features:

·

Series E Preferred Shares will not bear any dividends.

·

Each share of Series E Preferred Stock is entitled to receive its share of assets distributable upon the liquidation, dissolution or winding up of the affairs of the Company. The holders of the Series E Preferred Shares shall be entitled to receive in cash out of the assets of the Company before any amount shall be paid to the holders of any capital stock of the Company of any class junior in rank to the Series E Preferred Shares.

·

Each share of Series E Preferred Stock is convertible, at the holder’s option, into shares of Common Stock, at the average Closing Bid Price of the Company’s common stock for five (5) trading days prior to the Conversion Date.

·

At every meeting of stockholders, every holder of Series E Preferred Stock is entitled to 50,000 votes for each share of Series E Preferred Stock in his name, with the same and identical voting rights as a holder of a share of Common Stock; therefore, the holder of the preferred stock can effectively increase the Company issued Common Stock shares without a vote of the Common Stock shareholders thus enabling any potential shortfall of authorized common shares outstanding from being covered should the Preferred Stockholders wish to convert.

On March 1, 2011, the Company issued 3,500 shares of preferred stock to a shareholder for an $80,000 loan that was made to the company. Based on prior year issuance of preferred stock, the original valuation was $50.00/share and since the valuation of the preferred stock for this loan was set to $80,000 per 3,500 shares or $22.86/share, the Company has recorded a loss on conversion of debt of $95,000 for year ending April 30, 2011.



16




The average Closing Bid Price at April 30, 2011 was $0.03. Based on the Series E Preferred Stock provisions, if converted on April 30, 2011, the outstanding 3,500 Series E Preferred Shares would have converted into 2,666,667 shares of the Company’s common stock.

Under the terms of the Series E Stock Certificate, the holders have specific rights to be paid in cash out of the assets of the Company prior to any junior class shares.  As a result of the obligations for Series E preferred shares, the Company has determined these redemption features have the potential to be outside the control of the Company, and accordingly, the Company has classified the Series E shares outside of shareholder’s equity in accordance with ASC 480 regarding instruments with debt and equity features.  Thus, the full value for the convertible Preferred Stock was recorded outside of stockholders’ equity in the accompanying consolidated balance sheet.  

NOTE 11 – LEGAL PROCEEDINGS

In July 2011 a claim was filed by Cornerstone Bank (“Cornerstone”) against Freedom-2, Inc., a wholly owned subsidiary of the Company, for amounts due under a promissory note (the “Note”), in the original principal amount of $1.6 million (collectively the “Indebtedness”). The bank also sought to foreclose its mortgage on the property securing the Note, which is located in Cherry Hill, New Jersey (the “Property”). Given the passage of time and the Company having made no payments toward the Indebtedness for several years, as of May 2012, the amount due was approximately $2.0 million.

On May 7, 2012, the Company and Cornerstone entered into a comprehensive settlement agreement that resolves all matters related to Cornerstone’s claims (the “Settlement”).  Since that time, the Company and Cornerstone have proceeded to carry out the terms of the Settlement Agreement as follows: (i) the parties stipulated to judgment in the amount of the Indebtedness, with a stay of execution for 2 years pending the Company satisfying the Indebtedness in any of several ways, including direct payments of cash and discounts of up to 30% for early payments, or a combination thereof; (ii) the Company has conveyed the Property to Cornerstone, which will sell the Property and apply the net proceeds to reduce the Indebtedness (in the event the Property is not sold and the Indebtedness satisfied as otherwise described herein, the Property will be reconveyed to the Company); and (iii) the Company has transferred 14,605,614 shares of the Company’s common stock as security for payment of the Indebtedness (the “Stock Collateral”), which can be liquidated by Cornerstone from time to time in accordance with an SEC Rule 10b5-1 plan, with the proceeds being applied to reduce the Indebtedness.  Any excess Stock Collateral will be returned to the Company upon payment of the Indebtedness in full.  When the property is sold and any and all remaining payments, if any, are made by Nuvilex directly or through liquidation of the transferred stock collateral sold over time, the proceeds will be used to eliminate the Indebtedness, which, together with the Stock Collateral will remain on the Company’s financial statements in the then outstanding amount/value until fully satisfied.  The building is listed as a Company asset under “Settlement Obligation Asset” and the indebtedness is listed as a Company liability as “Settlement Obligation Liabilities.” 

To date, the Company has completed all paperwork and signed the Deed In Lieu to Cornerstone Bank, provided all necessary paperwork for transfer of the property and the stock issuance and is awaiting delivery of final signed paperwork from Cornerstone Bank.  Therefore, we have come to completion of this issue.  Nonetheless, until the property is sold, payments made by Nuvilex, or the stock sold over time, any or all of which are expected to eliminate the debt, such amounts will continue to be reported in the financial statements under the headings of “Settlement Obligation Asset” and  “Settlement Obligation Liabilities.”  All assets and amounts due under the settlement, including the building, principle, interest and all applicable fees have thus been reported.

NOTE 12 - RELATED PARTY TRANSACTIONS

During the quarter ended July 31, 2012 and the year ended April 30, 2012 a shareholder loaned the Company a total of $360,258 and $337,408, respectively for operating expenses. All loans bear interest at 6% and are due on demand.

As of July 31, 2012 and April 30, 2012, the Company owed a Director and shareholder $22,700; the loan accrues interest at 8% and is due on demand.

As of July 31, 2012, Dr. Robert Ryan, CEO, loaned the Company $202,769, at 8% interest, to provide for payment of operating expenses.


During the year ended April 30, 2012 three shareholders advanced $600,000 to the company. These funds were repaid with the issuance of 9,250,000 shares of common stock and an additional 1,650,000 shares as an incentive for making the advances.

NOTE 13 - SUBSEQUENT EVENTS

The Company has performed an evaluation of subsequent events in accordance with ASC Topic 855, noting no additional subsequent events other than those noted below.

Subsequent to July 31, 2012, the Company granted 530,000 shares of common stock for services.




17




ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JULY 31, 2012 AND 2011

The following discussion may contain forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed here. Factors that could cause or contribute to such differences include, but are not limited to, any factors discussed in this section as well as factors described in “Part II, Item 1A – Risk Factors.”

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JULY 31, 2012 AND 2011

SALES

Revenues from operations for the three months ending July 31, 2012 compared to 2011 decreased 66% from $19,762 to $6,626. Although product sales have continued, few funds have been committed to initiate any marketing given that the majority of funds have been directed toward the goal of maintaining and acquiring ASPL and the opportunity to complete the forth coming acquisition.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

During the three months ended July 31, 2012, sales and marketing expenses decreased $43,148 to $81,982 from $125,130 in the prior period. This decrease can be attributed to the completion of internet infrastructure in the prior year and a general decrease in sales and marketing expenses related to the company as a whole.  The overall general and administrative expenses during the three months ended July 31, 2012 compared to the three months ended July 31, 2011, increased $63,967 to $230,006 in the current period. The increase can be largely attributed to an increase in costs incurred for investor relations.  Importantly, the total operating expenses decreased during the three months ended July 31, 2012 to $545,412 compared to $656,687 from the same period ending July 31, 2011.

For the three months ended July 31, 2012 compensation expense decreased $124,383 to $181,181 from $305,564 for the same period in the prior year. The decrease is a result of fewer shares being issued to officers for compensation.

During the three months ended July 31, 2012, there was a substantial decrease in the net loss of $175,503 to $510,517 compared to $686,020 in the prior period. The decrease was primarily due to the decrease in operating expenses as well as total other income of $28,269 in the current period versus a total other expense of $33,420 in the same period in the prior year.

LIQUIDITY AND CAPITAL RESOURCES

By adjusting the Company’s operations and through bridge financing being provided by the CEO and existing interested investors and shareholders, management continues to work to maintain sufficient capital resources to meet projected cash flow needs. Failure by the Company to generate sufficient liquidity from operations or in raising sufficient capital resources on acceptable terms may have a materially adverse effect on the Company’s business, results of operations, liquidity and financial condition.  

We have no off-balance sheet arrangements, special purpose entities, financing partnerships or guarantees.

ITEM 3. QUANTITATIVE AND QUALITIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of and Report on Internal Control over Financial Reporting

The management of Nuvilex, Inc. is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Securities Exchange Act of 1934 as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:  

·

Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;



18




·

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and

·

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.  


In connection with the preparation of this Quarterly Report on Form 10-Q for the quarter ended July 31, 2012, management, with the participation of our Chief Executive Officer/Interim Chief Financial Officer, and Chief Operating Officer, have evaluated the effectiveness of our internal controls over financial reporting, pursuant to Rule 13a-15 under the Exchange Act, as of July 31, 2012 in order to determine the potential for or the existence of material weaknesses, defined as a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our Chief Executive/ Interim Chief Financial Officer and Chief Operating Officer, have concluded the design and operation of our internal controls and procedures are not effective as of July 31, 2012. As a result, the following aspects of the Company were noted as potential material weaknesses:


1.

Although they have communicated to their employees, Management has begun to be in compliance and has not fully developed its accounting policies and procedures as a direct result of its present size and staffing.  In addition, no Director of the Board of Directors qualifies as an Audit Committee Financial expert as defined in Item 407(d)(5)(ii) of Regulation S-B which may therefore, constitute a material weakness.


Because of these material weaknesses, Management has concluded the Company did not maintain effective internal control over financial reporting as of July 31, 2012, based on the criteria established in "Internal Control-Integrated Framework" issued by the COSO, criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework.  The Management is initiating study of COSO in coordination with ASPL in order to establish COSO Control-Integrated Framework within Nuvilex, ASPL, and all of its subsidiaries shortly as we begin to change and expand our present number of personnel and activities.

Changes in Internal Control

During the three months ended July 31, 2012 there were no substantial changes in our internal control over financial reporting (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, even though effort has been initiated to advance this area in terms of acquiring sufficient internal control over financial reporting.


PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

In July 2011 a claim was filed by Cornerstone Bank (“Cornerstone”) against Freedom-2, Inc., a wholly owned subsidiary of the Company, for amounts due under a promissory note (the “Note”), in the original principal amount of $1.6 million (collectively the “Indebtedness”). The bank also sought to foreclose its mortgage on the property securing the Note, which is located in Cherry Hill, New Jersey (the “Property”). Given the passage of time and the Company having made no payments toward the Indebtedness for several years, as of May 2012, the amount due was approximately $2.0 million.

On May 7, 2012, the Company and Cornerstone entered into a comprehensive settlement agreement that resolves all matters related to Cornerstone’s claims (the “Settlement”).  Since that time, the Company and Cornerstone have proceeded to carry out the terms of the Settlement Agreement as follows: (i) the parties stipulated to judgment in the amount of the Indebtedness, with a stay of execution for 2 years pending the Company satisfying the Indebtedness in any of several ways, including direct payments of cash and discounts of up to 30% for early payments, or a combination thereof; (ii) the Company has conveyed the Property to Cornerstone, which will sell the Property and apply the net proceeds to reduce the Indebtedness (in the event the Property is not sold and the Indebtedness satisfied as otherwise described herein, the Property will be reconveyed to the Company); and (iii) the Company has transferred 14,605,614 shares of the Company’s common stock as security for payment of the Indebtedness (the “Stock Collateral”), which can be liquidated by Cornerstone from time to time in accordance with an SEC Rule 10b5-1 plan, with the proceeds being applied to reduce the Indebtedness.  Any excess Stock Collateral will be returned to the Company upon payment of the Indebtedness in full.  When the property is sold and any and all remaining payments, if any, are made by Nuvilex directly or through liquidation of the transferred stock collateral sold over time, the proceeds will be used to eliminate the Indebtedness, which, together with the Stock Collateral will remain on the Company’s financial statements in the then outstanding amount/value until fully satisfied.  The building is listed as a Company asset under “Settlement Obligation Asset” and the indebtedness is listed as a Company liability as “Settlement Obligation Liabilities.”  All assets and amounts due under the settlement, including the building, principal, interest and any and all applicable fees are therefore fully reported herein.



19




ITEM 1A. RISK FACTORS

You should carefully consider these factors that may affect future results, together with all of the other information included in this Form 10QK, in evaluating the business and the Company. The risks and uncertainties described below are those that the Company currently believes may materially affect its business and results of operations.  Additional risks and uncertainties that Nuvilex is unaware of or that it currently deems immaterial also may become important factors that affect its business and result of operations.  Nuvilex’ common shares involve a high degree of risk and should be purchased only by investors who can afford a loss of their entire investment.  Prospective investors should carefully consider the following risk factors concerning the Company’s business before making an investment.

In addition, you should carefully consider these risks when you read “forward-looking” statements elsewhere in this Form 10-Q.  These are statements that relate to the Company’s expectations for future events and time periods.  Generally, the words “anticipate,” “expect,” “intend,” and similar expressions identify forward-looking statements.  Forward-looking statements involve risks and uncertainties, and future events and circumstances could differ significantly from those anticipated in the forward-looking statements.

Doubt Regarding Ability to Continue as a Going Concern 

Nuvilex’s financial statements have been presented that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has minimal revenues and incurred net operating losses as of July 31, 2012. As the Company’s independent auditors have concluded, these factors create an uncertainty about Nuvilex’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent, among other factors, on its success in marketing its products, containing costs, establishing a credit facility, and/or raising additional equity capital. The financial statements of Nuvilex do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Early Revenue Stage Company:  Generation of Revenues

Nuvilex is an early revenue stage company and an investor may not be able to determine if the Company will ever be profitable. Nuvilex may continue to experience financial difficulties during its early revenue stage and beyond. The Company may be unable to operate profitably, even if it generates additional revenues. Nuvilex may not obtain the necessary working capital to continue developing and marketing its products. Furthermore, Nuvilex’s products may not receive sufficient interest to generate revenues or achieve profitability.

Need for Future Capital: Long-Term Viability of Company

As a result of Nuvilex’s limited operating history; the Company is currently unable to accurately forecast its revenues. Current and future expense levels are based largely on the Company’s marketing and development plans and estimates of future revenue.  Sales and operating results generally depend on volume and timing of orders and on the Company’s ability to fulfill such orders, both of which are difficult to forecast.  Nuvilex may be unable to adjust spending in a timely manner to compensate for any unexpected revenue shortfall. Accordingly, any significant shortfall in revenues in relation to planned expenditures could have an immediate adverse effect on the Company’s business, prospects, financial condition and results of operations. Further, as a strategic response to changes in the competitive environment, Nuvilex may from time to time make certain pricing, service or marketing decisions that could have a material adverse effect on its business, prospects, financial condition and results of operations.

Nuvilex may experience significant fluctuations in future operating results due to a variety of factors, many of which are outside the Company’s control.  Factors that may affect operating results include:  (i) ability to obtain and retain customers, (ii) attract new customers at a steady rate and maintain customer satisfaction with products, (iii) the announcement or introduction of new services by Nuvilex or its competitors, (iv) price competition, (v) the level of use and consumer acceptance of its products, (vi) the amount and timing of operating costs and capital expenditures relating to expansion of the business, operations and infrastructure, (vii) governmental regulations, and (viii) general economic conditions.



20




Unpredictability of Future Revenues:  Potential Fluctuations in Operating Results 

As a result of Nuvilex’s limited operating history; the Company is currently unable to accurately forecast its revenues. Current and future expense levels are based largely on the Company’s marketing and development plans and estimates of future revenue.  Sales and operating results generally depend on volume and timing of orders and on the Company’s ability to fulfill such orders, both of which are difficult to forecast.  Nuvilex may be unable to adjust spending in a timely manner to compensate for any unexpected revenue shortfall. Accordingly, any significant shortfall in revenues in relation to planned expenditures could have an immediate adverse effect on the Company’s business, prospects, financial condition and results of operations. Further, as a strategic response to changes in the competitive environment, Nuvilex may from time to time make certain pricing, service or marketing decisions that could have a material adverse effect on its business, prospects, financial condition and results of operations.

Nuvilex may experience significant fluctuations in future operating results due to a variety of factors, many of which are outside the Company’s control.  Factors that may affect operating results include:  (i) ability to obtain and retain customers, (ii) attract new customers at a steady rate and maintain customer satisfaction with products, (iii) the announcement or introduction of new services by Nuvilex or its competitors, (iv) price competition, (v) the level of use and consumer acceptance of its products, (vi) the amount and timing of operating costs and capital expenditures relating to expansion of the business, operations and infrastructure, (vii) governmental regulations, and (viii) general economic conditions.

Flaws and Defects in Products

Products offered by Nuvilex may contain undetected flaws or defects when first introduced or as new versions are released. Any inaccuracy or defects may result in adverse product reviews and a loss or delay in market acceptance. There can be no assurance flaws or defects will not be found in Nuvilex products and if found, could have a materially adverse effect upon business operations and financial condition of the Company. Marketing of any of the Company’s potential products may expose the Company to liability claims resulting from use of the Company’s products. These claims might be made by consumers, health care providers, sellers of the Company’s products or others. A claim, particularly resulting from a clinical trial, or a product recall may have the potential to harm the Company’s business, results of operations, financial condition, cash flow and future prospects.

Stock Price Volatility

The market price of the Company’s stock has fluctuated in the past and may continue to fluctuate in the future.  The Company believes such fluctuations will continue as a result of many factors, including US and World markets, financing plans, future announcements concerning the Company, the Company’s competitors, principal customers regarding financial results or expectations, industry supply or demand dynamics, new product introductions, governmental regulations, the commencement or results of litigation or changes in earnings estimates by analysts.  In addition, in recent years the stock market has experienced significant price and volume fluctuations often for reasons outside the control of the particular companies.  These fluctuations as well as general economic, political and market conditions may have an adverse affect on the market price of the Company’s common stock.

Worldwide Economic Conditions

The Company’s financial performance depends significantly on worldwide economic conditions and the related impact on levels of consumer spending, which has recently deteriorated significantly in many countries and regions, including the U.S., and may remain depressed for the foreseeable future.  Demand for the Company’s products may be adversely affected by negative macroeconomic factors affecting consumer spending.  Substantial tightening of consumer credit, low consumer liquidity, and extreme volatility in credit and equity markets have weakened consumer confidence and decreased consumer spending.  These and other economic factors have reduced demand for the Company’s products and harmed the Company’s business, financial condition and results of operations, and to the extent such economic conditions continue, they could cause further harm to the Company’s business, financial condition and operations.

Dependence on Sales through Retailers and Distributors

The Company’s business that depends significantly upon sales through retailers and distributors may be affected if the Company’s retailers and distributors are not successful.  As a result, the Company could experience reduced sales, substantial product returns or increased price protection, any of which would negatively impact the Company’s business, financial condition and results of operations.  A significant portion of the Company’s sales are made through retailers, either directly or through distributors.  If the Company’s retailers and distributors are not successful, due to weak consumer retail demand caused by the current worldwide economic downturn, decline in consumer confidence, or other factors, the Company could continue to experience reduced sales as well as substantial product returns or price protection claims, which could harm the Company’s business, financial condition and operations.  



21




Limited Senior Management Personnel:  Management of Potential Growth; New Management Team 

Under Nuvilex’s business plan, significant and material matters of business must be conducted and concluded in a timely fashion.  The execution of the Company’s business plan places a significant strain on the Company’s management while providing little or no immediate compensation.

There can be no assurance that Nuvilex’s planned personnel, systems, procedures and controls will be adequate to support its future operations, management will be able to hire, train, retain, motivate and manage personnel or that its management will be able to successfully identify, manage and exploit existing and potential market opportunities. If Nuvilex is unable to manage growth effectively, the Company’s business, prospects, financial condition, results and operations could be adversely affected.  Nonetheless, management for Nuvilex and ASPL are working together to acquire the training and expertise as well as create the necessary internal controls for financial reporting.

Competition

The market in which Nuvilex competes is highly competitive, and the Company has no assurance it will be able to compete effectively, especially against established industry competitors with significantly greater financial resources. The Company expects it may face competition from a few competitors with potentially greater financial resources, well-established brand names and large, pre-existing customer bases. From the research efforts underway in so many countries around the world, Nuvilex expects the level of competition may intensify in the future.


Dependence on Management

Nuvilex’s performance will be substantially dependent on continued services and performance of the current senior management and other key personnel of the Company. Nuvilex’s performance will also depend on the Company’s ability to retain and motivate its other officers and key employees.  Nuvilex’s inability to retain its executive officers or other key employees could have a material adverse effect on the Company’s business, prospects, financial condition and results of operations.  The Company’s future success depends to a great extent on its ability to identify, attract, hire, train, retain and motivate other highly skilled technical, managerial, merchandising, marketing and customer service personnel.  Competition for such personnel can be intense and there is no assurance Nuvilex will be able to successfully attract, assimilate and retain sufficiently qualified personnel. The failure to retain and attract the necessary technical and managerial personnel could have a material adverse effect on the Company’s business, prospects, financial condition and results of operations. 

Development of Brand Awareness 

For certain market segments that Nuvilex plans to pursue, the development of its brand awareness is essential for it to reduce its marketing expenditures over time and realize greater benefits from marketing expenditures.  If the Company’s brand-marketing efforts are unsuccessful, growth prospects, financial condition and results of operations would be adversely affected. Nuvilex’s brand awareness efforts have required, and will most likely continue to require additional expenses.

Intellectual Property Protection:  Uncertainty of Protection of Proprietary Rights

Nuvilex currently relies on a combination of patents, trademarks, trade secret protection, non-disclosure agreements and licensing arrangements to establish and protect its proprietary rights. Despite efforts to safeguard and maintain Nuvilex’s proprietary rights, there can be no assurance the Company will be successful in doing so or its competitors will not independently develop products substantially equivalent or superior.

Nuvilex also relies on trade secrets and proprietary know-how, which the Company seeks to protect by confidentiality and non-disclosure agreements with its employees, consultants, and third parties.  There can be no assurance that these agreements will not be breached, that the Company will have adequate remedies for any breach, or that certain of Nuvilex’s trade secrets and proprietary know-how will not otherwise become known or be discovered by competitors.

Protecting or defending the Company’s IP rights, to protect trade secrets, to determine the validity and scope of the proprietary rights of others, or to defend against claims of infringement or invalidity may require litigation. Such litigation, whether successful or unsuccessful, could result in substantial costs and diversions of management resources, either of which could have a materially adverse effect on Nuvilex’ business, prospects, financial condition, or operating results.


Availability and Coverage of Insurance


For certain risks, the Company does not maintain insurance coverage because of cost and/or availability. Because the Company retains some portion of its insurable risks, and in some cases self-insures completely, unforeseen or catastrophic losses in excess of insured limits could have a material adverse effect on the Company’s financial condition and operating results.



22





Federal, State, Local and Foreign Laws and Regulations


For some of research, development and products the Company is working on, there is potential they may be subject to laws and regulations enforced by the FDA, DEA, USDA, EPA, the CDHS, foreign health authorities and other regulatory bodies throughout the world and statutes including the Occupational Safety and Health Act, the Environmental Protection Act, the Toxic Substances Control Act, the Food, Drug and Cosmetic Act, the Resource Conservation and Recovery Act, and other current and potential federal, state, local and foreign laws and regulations governing the use, manufacture, storage, handling and disposal of the Company’s products, materials used to develop the Company’s products, and resulting waste products. Furthermore, some of the Company’s past research, product development and manufacturing activities have involved the controlled use of hazardous materials and the Company may incur costs as a result of the need to comply with these laws and regulations.


Penny Stock Regulation

The Company’s securities sold as part of financing provided to the Company may be subject to “penny stock rules” that impose additional sales requirements on broker-dealers who sell such securities to persons other than established customers and accredited investors, the latter of which are generally people with assets in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly. For transactions covered by these rules, the Company and/or broker-dealer must make a special suitability determination for the purchase of such securities and have received the purchaser’s written consent to the transaction prior to the purchase.  Additionally, for any transaction involving a penny stock, unless exempt, the “penny stock rules” require the delivery, prior to the transaction, of a disclosure schedule prescribed by the Securities and Exchange Commission relating to the penny stock market. The broker-dealer must also disclose the commissions payable to both the broker-dealer and the registered representative and current quotations for the securities. Finally, monthly statements must be sent disclosing recent price information on the limited market in penny stocks. Consequently, the “penny stock rules” may restrict the ability of broker-dealers to sell the Company’s securities. The foregoing required penny stock restrictions will not apply to the Company’s common stock if such securities maintain a market price of $5.00 or greater. Therefore the challenge for the Company is that the market price of the Company’s common stock may not reach or remain at such a level.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.



23





ITEM 6. EXHIBITS.

Except as so indicated in Exhibits 32.1 and 32.2, the following exhibits are filed as part of, or incorporated by reference, this Quarterly Report on Form 10-Q.


Exhibit No.

 

Description

 

Location

2.1

 

Asset Purchase Agreement, dated August 24, 2005, between the Company and Mark Taggatz.

 

Incorporated by reference from the Company’s Current Report on Form 8-K filed with the SEC on August 30, 2005.

2.2

 

Share Purchase Agreement, dated August 31, 2005, between the Company and Dr. Richard Goldfarb.

 

Incorporated by reference from the Company’s Current Report on Form 8-K filed with the SEC on September 7, 2005.

2.3

 

Addendum to Share Purchase Agreement, dated August 31, 2005, between the Company and Dr. Richard Goldfarb.

 

Incorporated by reference from the Company’s Current Report on Form 8-K filed with the SEC on September 7, 2005.

2.4

 

Share Exchange Agreement, dated January 12, 2009, between the Company and Freedom2 Holdings, Inc.

 

Incorporated by reference from the Company’s Current Report on Form 10-K filed with the SEC on August 13, 2009.

2.5

 

Share Exchange Agreement, dated May 26, 2011 between the Company and SG Austria Private Limited.

 

Incorporated by reference from the Company’s Current Report on Form 10-Q filed with the SEC on September 14, 2011.

3.1

 

Articles of Incorporation of DJH International, Inc. dated October 25, 1996.

 

Incorporated by reference from the Company’s Registration Statement on Form SB-2 (File No. 333-68008) filed with the SEC on August 20, 2001.  

3.2

 

Certificate of Amendment of Articles of Incorporation of DJH International, Inc. dated October 20, 2000.

 

Incorporated by reference from the Company’s Registration Statement on Form SB-2 (File No. 333-68008) filed with the SEC on August 20, 2001.

3.3

 

Certificate of Amendment of Articles of Incorporation dated November 14, 2003.

 

Incorporated by reference from the Company’s Registration Statement on Form.

3.4

 

Certificate of Amendment of Articles of Incorporation dated June 30, 2008.

 

Incorporated by reference from the Company’s Registration Statement on Form.

3.5

 

Certificate of Amendment of Articles of Incorporation dated January 22, 2009.

 

Incorporated by reference from the Company’s Current Report on Form 8-K filed with the SEC on March 26, 2009.

3.6

 

Corporate Bylaws.

 

Incorporated by reference from the Company’s Registration Statement on Form SB-2 (File No. 333-68008) filed with the SEC on August 20, 2001.   

3.7

 

Certificate of Designations, Preferences and Rights of Series E Convertible Preferred Stock dated December 20, 2007.

 

Incorporated by reference from the Company’s Current Report on Form 10-K filed with the SEC on August 13, 2009.



24







3.8

 

Certificate of Designations, Preferences and Rights of Series E Convertible Preferred Stock, dated April 29, 2008.

 

Incorporated by reference from the Company’s Current Report on Form 10-K filed with the SEC on August 13, 2009.

4.1

 

Reference is made to Exhibits 3.1, 3.2 and 3.3.

 

 

4.2

 

Form of Common Stock Certificate.

 

Incorporated by reference from the Company’s Registration Statement on Form SB-2 (File No. 333-68008) filed with the SEC on August 20, 2001.   

31.1

 

Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under Sarbanes-Oxley Act of 1934, as amended.

 

Filed herewith.

32.1

 

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*.

 

Filed herewith.

 

 

 

 

 

101

 

Interactive Data Files for Nuvilex, Inc. Form 10-Q for the period ended July 31, 2012

 

Filed herewith.


*Exhibits 32.1 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Securities Exchange Act, except as otherwise stated in such filing.



25





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


NUVILEX, INC.

 

 

September 19, 2012

By: /s/ Robert F. Ryan
 Robert F. Ryan, M.S., Ph.D.

  President, Chief Executive Officer and Interim Chief Financial Officer
 (Principal Executive Officer On behalf of the Registrant)

 

 


Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


September 19, 2012

By: /s/ Patricia Gruden

Patricia Gruden, Chairman of the Board of Directors

 

September 19, 2012

By: /s/ Robert Bowker

Robert Bowker, Director


September 19, 2012

By: /s/ Richard Goldfarb

Richard Goldfarb, M.D., FACS, Director


September 19, 2012

By: /s/ Timothy Matula

Timothy Matula, Director


 

 




26

 




 

EX-31 2 nuvilex10qex31.htm EXHIBIT 31 Exhibit 31

EXHIBIT 31.1

SECTION 302 CERTIFICATION

I, Robert F. Ryan, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Nuvilex, Inc.:

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

4. The small business issuer’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and

5. The small business owner’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small issuer's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.


Date: September 19, 2012


By: /s/ Robert F. Ryan

Robert F. Ryan, M.S., Ph.D.

President and Chief Executive Officer (Principal Executive Officer)






EXHIBIT 31.2

SECTION 302 CERTIFICATION

I, Robert F. Ryan, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Nuvilex, Inc.:

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

4. The small business owner’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and

5. The small business owner’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small issuer's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.


Date: September 19, 2012

By: /s/ Robert F. Ryan

Robert F. Ryan

Interim Chief Financial Officer

(Interim Principal Financial Officer)






EX-32 3 nuvilex10qex32.htm EXHIBIT 32 Exhibit 32

EXHIBIT 32.1

SECTION 906 CERTIFICATION

In connection with the Quarterly Report of Nuvilex, Inc. on Form 10-Q for the period ending July 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert F. Ryan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


 

By: /s/ Robert F. Ryan
Robert F. Ryan, M.S., Ph.D.,

President and Chief Executive Officer

(Principal Executive Officer)

 

Date: September 19, 2012



EXHIBIT 32.2

SECTION 906 CERTIFICATION

In connection with the Quarterly Report of Nuvilex, Inc. on Form 10-Q for the period ending July 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert F. Ryan, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


 

By: /s/ Robert F. Ryan
Robert F. Ryan

Interim Chief Financial Officer

(Interim Principal Financial Officer)


Date: September 19, 2012





EX-101.INS 4 nvlx-20120731.xml XBRL INSTANCE DOCUMENT 0001157075 2012-05-01 2012-07-31 0001157075 2012-09-10 0001157075 2012-04-30 0001157075 2012-07-31 0001157075 us-gaap:SeriesEPreferredStockMember 2012-07-31 0001157075 us-gaap:SeriesEPreferredStockMember 2012-04-30 0001157075 2011-05-01 2011-07-31 0001157075 2011-04-30 0001157075 2011-07-31 0001157075 us-gaap:CommonStockMember 2011-04-30 0001157075 us-gaap:AdditionalPaidInCapitalMember 2011-04-30 0001157075 NVLX:CommonStockNotYetIssuedMember 2011-04-30 0001157075 us-gaap:RetainedEarningsMember 2011-04-30 0001157075 2010-05-01 2011-04-30 0001157075 us-gaap:CommonStockMember 2011-05-01 2012-04-30 0001157075 us-gaap:CommonStockMember 2012-04-30 0001157075 us-gaap:AdditionalPaidInCapitalMember 2011-05-01 2012-04-30 0001157075 us-gaap:AdditionalPaidInCapitalMember 2012-04-30 0001157075 NVLX:CommonStockNotYetIssuedMember 2011-05-01 2012-04-30 0001157075 us-gaap:RetainedEarningsMember 2011-05-01 2012-04-30 0001157075 2011-05-01 2012-04-30 0001157075 us-gaap:CommonStockMember 2012-05-01 2012-07-31 0001157075 us-gaap:CommonStockMember 2012-07-31 0001157075 us-gaap:AdditionalPaidInCapitalMember 2012-05-01 2012-07-31 0001157075 us-gaap:AdditionalPaidInCapitalMember 2012-07-31 0001157075 NVLX:CommonStockNotYetIssuedMember 2012-05-01 2012-07-31 0001157075 NVLX:CommonStockNotYetIssuedMember 2012-04-30 0001157075 NVLX:CommonStockNotYetIssuedMember 2012-07-31 0001157075 NVLX:TotalMember 2011-05-01 2012-04-30 0001157075 NVLX:TotalMember 2012-05-01 2012-07-31 0001157075 NVLX:TotalMember 2011-04-30 0001157075 NVLX:TotalMember 2012-04-30 0001157075 NVLX:TotalMember 2012-07-31 0001157075 us-gaap:ComputerEquipmentMember 2012-07-31 0001157075 us-gaap:ComputerEquipmentMember 2012-04-30 0001157075 us-gaap:FurnitureAndFixturesMember 2012-07-31 0001157075 us-gaap:FurnitureAndFixturesMember 2012-04-30 0001157075 NVLX:AustrianovaSingaporePteLtdMember 2012-06-21 0001157075 us-gaap:FurnitureAndFixturesMember 2012-05-01 2012-07-31 0001157075 us-gaap:OtherMachineryAndEquipmentMember 2012-05-01 2012-07-31 0001157075 us-gaap:BuildingImprovementsMember 2012-05-01 2012-07-31 0001157075 us-gaap:BuildingMember 2012-05-01 2012-07-31 0001157075 us-gaap:IssuanceOfEquityMember 2012-08-01 2012-09-10 0001157075 us-gaap:EquityMethodInvesteeMember 2012-07-31 0001157075 us-gaap:EquityMethodInvesteeMember 2012-04-30 0001157075 us-gaap:DirectorMember 2012-07-31 0001157075 us-gaap:DirectorMember 2012-04-30 0001157075 us-gaap:ChiefExecutiveOfficerMember 2012-07-31 0001157075 us-gaap:ChiefExecutiveOfficerMember 2012-04-30 0001157075 us-gaap:EquityMethodInvesteeMember 2012-05-01 2012-07-31 0001157075 us-gaap:EquityMethodInvesteeMember 2011-05-01 2012-04-30 0001157075 us-gaap:DirectorMember 2012-05-01 2012-07-31 0001157075 us-gaap:DirectorMember 2011-05-01 2012-04-30 0001157075 us-gaap:ChiefExecutiveOfficerMember 2012-05-01 2012-07-31 0001157075 2011-03-01 0001157075 us-gaap:ComputerEquipmentMember 2012-05-01 2012-07-31 0001157075 us-gaap:OtherMachineryAndEquipmentMember 2012-07-31 0001157075 us-gaap:OtherMachineryAndEquipmentMember 2012-04-30 0001157075 2011-07-01 2011-07-31 0001157075 2012-05-01 2012-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure NUVILEX, INC. 0001157075 10-Q 2012-07-31 false --04-30 No No No Smaller Reporting Company Q1 2012 423950851 15723 24342 2581 6846 9620 874230 1069980 159350 101716 1058730 1205658 1028778 1028778 2087508 2234436 730068 424181 407463 41103 11461 20702 360108 382958 185862 202769 202769 0 2225313 2092396 730000 3787358 4027026 3787358 4027026 41631 42345 37526524 37943587 -39848005 -40358522 -2279850 -2372590 35714 34415655 -37948693 768031 41631 37526524 42345 37943587 -39848005 -40358522 -2729293 -2279850 -2372590 2087508 2234436 10000000 10000000 8500 8500 3500 0.0001 0.0001 1490000000 1490000000 416293195 423420851 100000000 0.0001 0.0001 6626 19762 6626 19762 15675 6626 4087 81982 125130 52243 59954 230006 166039 545412 656687 -538786 -652600 71742 -2590 46063 33420 -510517 -686020 -1899312 -510517 -1899312 -510517 -0.00 -0.00 419566403 367294646 28269 -33420 319181 536213 8523 -5695 -2699 2581 -6291 -2774 11089 88821 -3355 -124935 -13207 66967 36120 -85388 -119627 195750 320000 -195750 -320000 473000 39757 1500 9000 289757 465500 8619 25873 15723 24342 57201 83074 98596 9241 250000 357137581 416293195 423420851 23575000 2885000 2358 1196272 -37750 290 171891 1160880 172181 8550000 2400000 855 408545 240 146760 409400 147000 14605614 1461 728820 -730281 9250000 1650000 1025000 1842656 <p style="font: 10pt Times New Roman, Times, Serif; margin: 9.9pt 0 0"><font style="font-size: 12pt"><b>NOTE 1 &#150; BACKGROUND, ACQUISITION AND LIQUIDITY</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-align: justify"><font style="font-size: 12pt">This summary of accounting policies for Nuvilex, Inc. and Subsidiaries is presented to assist in understanding the Company's consolidated financial statements. The accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the consolidated financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-align: justify"><font style="font-size: 12pt"><b>History of the Company</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-align: justify"><font style="font-size: 12pt"><b></b>The Company was founded as DJH International, Inc., a Nevada corporation, on October 28, 1996, changing its name to eFoodSafety.com, Inc. following the October 16, 2000 acquisition of Global Procurement Systems, Inc. The Company acquired Ozone Safe Food, Inc. for Common Stock on October 29, 2003. The Company&#146;s early mission provided methods and products to ensure safety of marketed fruits and vegetables worldwide. On February 4, 2004, the Company registered shares with the Securities and Exchange Commission and its Common Stock began publicly trading on the OTC Bulletin Board under the trading symbol EFSF. The Company did not issue shares of Common Stock pursuant to an initial public offering. With less than projected demand for its produce sterilization methods and software tracking products, the Company changed its strategy and acquired Knock-Out Technologies, Ltd. and MedElite, Inc. in May 2004 and August 2005, respectively, of which Knock-Out Technologies, Ltd. was a developer of products using organic, non-toxic, food based substances and MedElite, Inc. was the exclusive U.S. distributor of Talsyn<sup>TM</sup>-CI Scar Cream (&#147;Talsyn&#148;), a topical scar- reducing cream. The Company&#146;s strategy was to bring to market scientifically derived products. The Company sold its Ozone Safe Food, Inc. operations in August 2005. In November 2006, the Company formed Cinnergen, Inc., a wholly-owned subsidiary, to manufacture and market a non-prescription liquid nutritional supplement designed to promote healthy glucose metabolism, and purEffect, Inc., another wholly-owned subsidiary, to manufacture and market purEffect<sup>TM</sup>, a four-step non-prescription acne treatment. On March 10, 2006, the Company licensed the marketing rights for purEffect<sup>TM </sup>to Charlston Kentrist 41 Direct, Inc. (&#147;CK41&#148;). In July 2007, I-Boost, Inc., a wholly-owned subsidiary was formed to market products to support the immune system. In March 2008, Cinnechol, Inc. became a wholly-owned subsidiary to promote cardiovascular health. In February 2009, the Company sold the rights to the purEffect<sup>TM</sup> product to CK41 for an equity position in CK41 and future royalty compensation. In March 2009, Freedom2 Holdings, Inc. was acquired to manufacture and market products including Infinitink&#174;, a permanent tattoo ink designed to be removed more easily using conventional laser light. The Company changed its name to Nuvilex, Inc. on March 18, 2009 as part of the process.</font></p> <p style="margin: 0pt">&#160;<b>NOTE 2 - Going Concern and Management&#146;s Plans</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-align: justify">The Company's financial statements are prepared using accounting principles generally accepted in the United States of America (GAAP) applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenue sufficient to cover its operating costs and allow it to continue as a going concern. In addition, as of July 31, 2012, the Company had an accumulated deficit of $40,358,522, had incurred a net loss for the period ended July 31, 2012 of $510,517 and had negative working capital of $2,821,368. Funding has been provided by the Company&#146;s CEO, Dr. Robert Ryan as well as old and new investors committed to make it possible to maintain, expand, and ensure the advancement of Nuvilex and help the Company see its vision through to providing a pancreatic cancer treatment in the future. Lastly, although the Company&#146;s current business plan includes funding requirements beyond the anticipated cash flows from operations, we continue to acquire such funds as the Company moves forward toward its pancreatic cancer treatment and the numerous other opportunities being advanced at this point. Therefore, doubt exists as to the Company's ability to continue as a going concern. All of us at Nuvilex are nonetheless actively undertaking the necessary steps and are committed to working with the myriad of personnel and interested investors to ensure our success.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-align: justify"><b>Strategy</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-align: justify">The Company has been in existence for more than a decade. During this time products were brought into the Company with the intention to work toward seeing them become household names and products. Several have become well used, but the challenge with all products is to make them well recognized, useful, important, and valuable enough that everyday consumers use them consistently. As a result, the overall Company structure of Nuvilex has changed in many ways over the years. On a daily basis, the Company receives different inquiries for our products, indicating they still retain value. From those humble beginnings we are now pushing to move this Company forward into a modern one with clarity and vision.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-align: justify">Thus, since June 2011, we have been working with the Chief Executives of Austrianova Singapore Private Limited (&#147;Austrianova Singapore&#148; or ASPL), previously assets of SG Austria Private Limited or &#147;SG Austria,&#148; across a wide swath of areas. Much of the effort has been on establishing plans for our future. Therefore, and in conjunction with maintenance of the company, funding has been provided to ASPL and its personnel in order to ensure ASPL&#146;s functionality and maintain its ability to accomplish numerous goals over the year. This first vision has been noted as one of the most valuable advances for this company, enabling the creation of a biotechnology/life technology company. Unlike most companies of this type and entirely due to the Company&#146;s extensive array of products already in-house, Nuvilex exists as a Biotech Company with a broad company base, much like that of larger biotechnology or pharmaceutical companies after years of advances and purchasing of products from the outside. Thus, with an overall goal of long-term growth, the Company is poised to be thrust into a very different position, particularly as a result of the stabilizing of its financial condition that has been occurring over the past year.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-align: justify">Management believes its vision to become an important industry-leading Biotechnology company, with a multi-part strategy like those of larger pharmaceutical companies will strengthen the Company&#146;s position in both the short and long term.&#160; Notwithstanding and as the financial experts accurately point out, Nuvilex may seek to raise capital to fund growth opportunities and provide for its working capital needs as the vision of the company is executed. &#160;The Company&#146;s efforts to achieve financial stability and enable carrying out the strategy of the company include several primary components:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-indent: 19.8pt">1. Continued elimination of prior operation-associated debt from the Parent Company and all subsidiaries;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-indent: 19.8pt">2. Advance and develop the biotechnology through ongoing research;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-indent: 19.8pt">3. Acquisition of new contracts utilizing the biotechnology;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0 6pt; text-indent: 0.25in">4. Expand and Market products and their uses</p> <p style="margin: 0pt"></p> <p style="margin: 0pt">&#160;<b>NOTE 3 &#150; Significant Accounting Policies</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><b>Unaudited Financial Statements</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify">The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#147;GAAP&#148;), for interim financial information and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;While these statements reflect all normal recurring adjustments which are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The unaudited interim financial statements should be read in conjunction with the Company&#146;s annual report on Form 10-K, which contains the audited financial statements and notes thereto, together with Management&#146;s Discussion and Analysis, for the fiscal year ended April 30, 2012.&#160;&#160;The interim results for the three months ended July 31, 2012 are not necessarily indicative of the results for the full fiscal year.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify">Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company's system of internal accounting control is designed to assure, among other items, that 1) recorded transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"><b>Principles of Consolidation</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify">The consolidated financial statements include the accounts of Nuvilex, Inc. and its subsidiaries, Knock-Out Technologies, Ltd., MedElite, Inc.,&#160;Cinnergen, Inc., I-Boost, Inc., Cinnechol Inc., Nuvilex GmbH, Berlin, Freedom-2 Creditor Partners, Freedom-2 Holdings, Inc, Freedom-2, Inc., Exceptional Equipment and Ink Supply Company, Inc. With respect to the latter three subsidiaries the financials include the profit and loss activity from the date of purchase March 2, 2009 to July 31, 2012 as the acquisition was accounted for under the purchase method of accounting.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify">All significant intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"><b>Cash and Cash Equivalents</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify">For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes. There were no cash equivalents as of July 31, 2012 or April 30, 2012.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><b>Inventories</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify">Inventories are stated at the lower of cost or market. Cost is computed on a weighted-average basis, which approximates the first-in, first-out method; market is based upon estimated replacement costs.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"><b>Use of Estimates</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"><b>Property and Equipment</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify">Property and equipment are recorded at cost. Expenditures that increase the useful lives or capacities of the plant and equipment are capitalized. Expenditures for repairs and maintenance are charged to income as incurred. Depreciation is provided using the straight-line method over the estimated useful lives as follows:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt">Computer equipment/software - 3 years</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt">Furniture and fixtures - 7 years</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt">Machinery and equipment - 7 years</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt">Building improvements - 15 years</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt">Building - 40 years</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"><b>&#160;Goodwill and other indefinite-lived intangibles</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify">The Company records the excess of purchase price over the fair value of the identifiable net assets acquired as goodwill and other indefinite-lived intangibles. The FASB standard on goodwill and other intangible assets, prescribes a two-step process for impairment testing of goodwill and indefinite-lived intangibles, which is performed annually, as well as when an event triggering impairment may have occurred. The first step tests for impairment, while the second step, if necessary, measures the impairment. The Company has elected to perform its annual analysis at the end of its reporting year.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><b>Valuation of long-lived assets</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify">The Company accounts for the valuation of long-lived assets under the FASB standard for accounting for the impairment or disposal of Long-Lived Assets. The FASB standard requires that long-lived assets and certain identifiable intangible assets be reviewed for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the long-lived assets is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less cost to sell. &#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><b>Basic and Diluted Earnings (Loss) per Share</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify">Basic and diluted earnings per share is calculated using the weighted-average number of common shares outstanding during the period without consideration of the dilutive effect of stock warrants, convertible notes and convertible preferred shares.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><b>Fair value of financial instruments</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify">For certain of the Company&#146;s non-derivative financial instruments, including cash and cash equivalents, receivables, accounts payable, and other accrued liabilities, the carrying amount approximates fair value due to the short-term maturities of these instruments. The estimated fair value of long-term debt is based primarily on borrowing rates currently available to the Company for similar debt issues. The fair value approximates the carrying value of long-term debt.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify">ASC Topic 820, &#147;Fair Value Measurements and Disclosures,&#148; requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, &#147;Financial Instruments,&#148; defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. &#160;The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:</p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr> <td style="width: 4%">&#160;</td> <td style="width: 4%">&#160;</td> <td style="width: 92%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt">&#160;</td> <td style="padding-bottom: 14.3pt; font-family: Symbol">&#183;</td> <td style="padding-bottom: 14.3pt">Level&#160;1. Observable inputs such as quoted prices in active markets;</td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt">&#160;</td> <td style="padding-bottom: 14.3pt; font-family: Symbol">&#183;</td> <td style="padding-bottom: 14.3pt">Level&#160;2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt">&#160;</td> <td style="padding-bottom: 14.3pt; font-family: Symbol">&#183;</td> <td style="padding-bottom: 14.3pt">Level&#160;3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">The following presents the gross value of assets and liabilities that were measured and recognized at fair value as of July 31, 2012 and April 30, 2012.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr> <td style="width: 8%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 84%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt">&#160;</td> <td style="padding-bottom: 14.3pt; font-family: Symbol">&#183;</td> <td style="padding-bottom: 14.3pt">Level&#160;1: none</td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt">&#160;</td> <td style="padding-bottom: 14.3pt; font-family: Symbol">&#183;</td> <td style="padding-bottom: 14.3pt">Level&#160;2: none</td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt">&#160;</td> <td style="padding-bottom: 14.3pt; font-family: Symbol">&#183;</td> <td style="padding-bottom: 14.3pt">Level&#160;3: none</td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">Effective October&#160;1, 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&#34;ASC&#160;820-10&#34;) and Accounting Standards Codification subtopic 825-10, Financial Instruments (&#34;ASC&#160;825-10&#34;), which permits entities to choose to measure many financial instruments and certain other items at fair value. Neither of these statements had an impact on the Company's financial position, results of operations or cash flows. The carrying value of cash, accounts payable and accrued expenses, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">As of July 31, 2012 and April 30, 2012 the Company has recorded several of its assets and liabilities at fair value. The building or &#147;Settlement Obligation Asset&#148; (Note 11) was written down in the last quarter of fiscal 2010 to its fair value based upon a pending sale agreement. Although the agreement was not finalized it established the current market value for the property. &#160;In Jan-March 2009, through the acquisition of another company the Company acquired certain debt. As part of the acquisition, these were evaluated by a third party and valued at fair value at the time they were recorded. As a result of this the Company is amortizing the associated discount and premium for two of the liabilities.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><b>Recent accounting pronouncements</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">In September 2011 the Accounting Standards Update No. 2011-08, Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for impairment. This ASU's objective is to simplify the process of performing impairment testing for Goodwill. With this update a company is allowed to asses qualitative factors, first, to determine if it is more likely than not (greater than 50%) that the FV is less than the carrying amount. This would be done, prior to performing the two-step goodwill impairment testing, as prescribed by Topic 350. &#160;Prior to this ASU, all entities were required to test, annually, their good will for impairment by Step 1 - comparing the FV to the carrying amount, and if impaired, then step 2 - calculate and recognize the impairment. Therefore, the fair value measurement is not required, until the &#34;more likely than not&#34; reasonableness test is concluded. Effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">In May 2011, FASB issued Accounting Standards Update No. 2011-04, Fair Value Measurement (Topic 820):<i> Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs</i>. &#160;&#160;&#160;This ASU clarifies the board's intent of current guidance, modifies and changes certain guidance and principles, and adds additional disclosure requirements concerning the 3 levels of fair value measurements. Specific amendments are applied to FASB ASC 820-10-35, Subsequent Measurement and FASB ASC 820-10-50, Disclosures. This ASU is effective for interim and annual periods beginning after December 15, 2011.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">In June 2011, FASB issued Accounting Standards Update No. 2011-05, Comprehensive Income (Topic 220):<i> Presentation of Comprehensive Income</i>. - ASU 2011-05. Current US GAAP allows companies to present the components of comprehensive income as a part of the statement of changes in stockholders' equity. This ASU eliminates that option. In this update, an<font style="font-family: Arial, Helvetica, Sans-Serif"> </font>entity has the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In both choices, an entity is required to present each component of net income along with total net income, each component of other comprehensive income along with a total for other comprehensive income, and a total amount for comprehensive income This ASU is effective interim and annual periods beginning after December 15, 2011. &#160;This ASU should be applied retrospectively. There are no specific transition disclosures.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">The Company has implemented all new accounting pronouncements that are in effect. &#160;These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><b>Revenue Recognition</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">Sales of products and related costs of products sold are recognized when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the price is fixed or determinable, and (iv) collectability is reasonably assured. These terms are typically met upon the prepayment or invoicing and shipment of products.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0"><b>Allowance for Doubtful Accounts</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">The Company provides an allowance for estimated uncollectible accounts receivable balances based on historical experience and the aging of the related accounts receivable.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0"><b>Income Taxes</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">Deferred taxes are calculated using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.&#160; Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">In June&#160;2006, the FASB interpreted its standard for accounting for uncertainty in income taxes, an interpretation of accounting for income taxes.&#160; This interpretation clarifies the accounting for uncertainty in income taxes recognized in an entity&#146;s financial statements in accordance the minimum recognition threshold and measurement attributable to a tax position taken on a tax return is required to be met before being recognized in the financial statements.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">The FASB&#146;s interpretation had no material impact on the Company&#146;s financial statements for the quarter ended July 31, 2012 or the year ended April 30, 2012. Current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, the amount available to offset future taxable income may be limited. No tax benefit has been reported in the financial statements, because the Company believes the carry forwards may expire unused, although acquisition of sufficient operating capital to complete the acquisition of all of the assets of SG Austria may change this. Accordingly, the potential tax benefits of the loss carry forwards are offset by a valuation allowance of the same amount.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0"><b>Research and Development Costs</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">Expenditures for research and development are expensed as incurred. Such costs are required to be expensed until the point that technological feasibility is established.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0"><b>Concentration of Credit Risk</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">The Company has no significant off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. The Company maintains the majority of its cash balances with one financial institution in the form of demand deposits.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0"><b>Reclassifications</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">Certain items in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current period&#146;s presentation. These reclassifications have no effect on the previously reported income (loss).</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt"><b>NOTE 4 &#150; ACCOUNTS RECEIVABLE</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">The Company recognizes receivables predominately on sales of its Cinnergen product. &#160;At July 31, 2012 the company recorded an allowance for doubtful accounts of $6,497.</font></p> <p style="margin: 0pt">&#160;</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt"><b>NOTE 6 - INVENTORY</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">On July 31, 2012 and April 30, 2012, inventory consisted of $9,620 and $6,846, respectively of finished goods inventory for Cinnergen&#153; products. Inventories are stated at the lower of cost or market. Cost is computed on a weighted-average basis, which approximates the first-in, first-out method; market is based upon estimated replacement costs.</font></p> <p style="margin: 0pt">&#160;</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt"><b>NOTE 7 - FIXED ASSETS</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt">Fixed assets consisted of the following:</font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">July 31, 2012</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">April 30, 2012</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%">Computers</td><td style="width: 8%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">23,664</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">23,664</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#151;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#151;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Lab equipment</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#151;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(23,664</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(23,664</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#151;&#160;&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 9.9pt 0 0"><font style="font-size: 12pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 12pt">Depreciation expense for the three months ended July 31, 2012 and fiscal year ended April 30, 2012 was $0 and $24,659, respectively.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"></p> <p style="margin: 0pt">&#160;</p> <p style="margin: 0pt"><font style="font-size: 12pt"><b>NOTE 8 &#150; DEBT</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 12pt">&#160;</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">As of July 31, 2012 the company owed various individuals a total of $310,000. All notes accrue interest at 10% per annum and are due within one year.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">As of July 31, 2012 the company owed $20,000 plus accrued interest to an individual. The note accrues interest at 8% per annum and is past due.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">As of July 31, 2012, the Company had an obligation to pay $400,000 in licensing fees for a licensing agreement that since then has been terminated. The debt is presently under negotiation for settlement.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 8.8pt 0 0; text-align: justify">During the year ended April 30, 2012, the Company settled various debts with a combination of cash payments and the issuance of common stock. In total over $500,000 debt was settled. As a result of those settlements the Company recorded a gain of $370,619.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 8.8pt 0 0; text-align: justify">During the quarter ended July 31, 2012, the Company settled various accounts payable with the issuance of common stock. In total over $132,000 of debt was settled. As a result of those settlements the Company recorded a gain of $71,742.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 8.8pt 0 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 8.8pt 0 0; text-align: justify">&#160;</p> <p style="margin: 0pt">&#160;</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt"><b>NOTE 9 - COMMON STOCK TRANSACTIONS</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">During the year ended April 30, 2012, 23,575,000 shares of common stock were issued to officers of the Company for compensation. Shares were valued using the closing stock price on the day of issuance for a total expense of $1,160,880.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">During the year ended April 30, 2012, 8,550,000 shares of common stock were issued for various services. Shares were valued using the closing stock price on the day of issuance for a total expense of $409,400.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">During the year ended April 30, 2012, 9,250,000 shares of common stock were issued in exchange for $600,000 in cash advances to the Company. In addition, another 1,650,000 shares were issued as incentive for providing the cash advances to the Company. These additional shares were value at $101,750 and charged to interest expense</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">During the year ended April 30, 2012, 1,025,000 shares of common stock were issued to settle various debts. The shares were valued using the closing stock price on the day of issuance for a total expense of $55,725.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">During the quarter ended July 31, 2012, 2,400,000 shares of common stock were issued for various services. Shares were valued using the closing stock price on the day of issuance for a total expense of $147,000.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">During the quarter ended July 31, 2012, 1,842,656 shares of common stock were issued to settle various debts. The shares were valued using the closing stock price on the day of issuance for a total expense of $98,596.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">During the quarter ended July 31, 2012, 2,885,000 shares of common stock were issued to officers of the Company for compensation. Shares were valued using the closing stock price on the day of issuance for a total expense of $172,181.</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="color: black">During the quarter ended July 31, 2012, the Company issued 100,000,000 shares of restricted common stock to </font>Austrianova Singapore Pte. Ltd. (ASPL)<font style="color: black">. </font>Under the terms of the Asset Purchase Agreement, the shares are held in escrow until the completion of Nuvilex&#146;s financing obligations (refer to Note 5). <font style="color: black">The shares for both ASPL and Nuvilex are being held in escrow and are therefore not reflected in the financial statements. This is due to the potential unwinding of the agreement in shares in the event Nuvilex is unable to satisfy the Asset Purchase Agreement requirements including monthly maintenance payments or the $2.5 million minimum financing requirement.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">All shares were issued without registration under the Securities Act of 1933, as amended, in reliance upon the exemption afforded by Section 4(2) of that Act. No underwriters were involved.</font></p> <p style="margin: 0pt">&#160;</p> <p style="margin: 0pt"><font style="font-size: 12pt"><b>NOTE 10 - PREFERRED STOCK</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt">Series E Preferred Stock has, among others, the following features:</font></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0.2in; margin-bottom: 0.2in"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><font style="font: 12pt Symbol">&#183;</font></td><td><font style="font-size: 12pt">Series E Preferred Shares will not bear any dividends.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0.2in; margin-bottom: 0.2in"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><font style="font: 12pt Symbol">&#183;</font></td><td style="text-align: justify"><font style="font-size: 12pt">Each share of Series E Preferred Stock is entitled to receive its share of assets distributable upon the liquidation, dissolution or winding up of the affairs of the Company. The holders of the Series E Preferred Shares shall be entitled to receive in cash out of the assets of the Company before any amount shall be paid to the holders of any capital stock of the Company of any class junior in rank to the Series E Preferred Shares.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0.2in; margin-bottom: 0.2in"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><font style="font: 12pt Symbol">&#183;</font></td><td style="text-align: justify"><font style="font-size: 12pt">Each share of Series E Preferred Stock is convertible, at the holder&#146;s option, into shares of Common Stock, at the average Closing Bid Price of the Company&#146;s common stock for five (5) trading days prior to the Conversion Date.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0.2in; margin-bottom: 0.2in"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><font style="font: 12pt Symbol">&#183;</font></td><td style="text-align: justify"><font style="font-size: 12pt">At every meeting of stockholders, every holder of Series E Preferred Stock is entitled to 50,000 votes for each share of Series E Preferred Stock in his name, with the same and identical voting rights as a holder of a share of Common Stock; therefore, the holder of the preferred stock can effectively increase the Company issued Common Stock shares without a vote of the Common Stock shareholders thus enabling any potential shortfall of authorized common shares outstanding from being covered should the Preferred Stockholders wish to convert.</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">On March 1, 2011, the Company issued 3,500 shares of preferred stock to a shareholder for an $80,000 loan that was made to the company. Based on prior year issuance of preferred stock, the original valuation was $50.00/share and since the valuation of the preferred stock for this loan was set to $80,000 per 3,500 shares or $22.86/share, the Company has recorded a loss on conversion of debt&#160;of $95,000 for year ending April 30, 2011.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt">The average Closing Bid Price at April 30, 2011 was $0.03. Based on the Series E Preferred Stock provisions, if converted on April 30, 2011, the outstanding 3,500 Series E Preferred Shares would have converted into 2,666,667 shares of the Company&#146;s common stock.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">Under the terms of the Series E Stock Certificate, the holders have specific rights to be paid in cash out of the assets of the Company prior to any junior class shares. &#160;As a result of the obligations for Series E preferred shares, the Company has determined these redemption features have the potential to be outside the control of the Company, and accordingly, the Company has classified the Series E shares outside of shareholder&#146;s equity in accordance with ASC 480 regarding instruments with debt and equity features. &#160;Thus, the full value for the convertible Preferred Stock was recorded outside of stockholders&#146; equity in the accompanying consolidated balance sheet.</font> &#160;</p> <p style="margin: 0pt">&#160;</p> <p style="margin: 0pt"><b>NOTE 11 &#150; LEGAL PROCEEDINGS</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 16.2pt; text-align: justify; background-color: white; color: #2A2A2A">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 16.2pt; text-align: justify; background-color: white; color: #2A2A2A">In July 2011 a claim was filed by Cornerstone Bank (&#147;Cornerstone&#148;) against Freedom-2, Inc., a wholly owned subsidiary of the Company, for amounts due under a promissory note (the &#147;Note&#148;), in the original principal amount of $1.6 million (collectively the &#147;Indebtedness&#148;). The bank also sought to foreclose its mortgage on the property securing the Note, which is located in Cherry Hill, New Jersey (the &#147;Property&#148;). Given the passage of time and the Company having made no payments toward the Indebtedness for several years, as of May 2012, the amount due was approximately $2.0 million.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 16.2pt; text-align: justify; background-color: white; color: #2A2A2A"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 11pt">On May 7, 2012, the Company and Cornerstone entered into a comprehensive settlement agreement that resolves all matters related to Cornerstone&#146;s claims (the &#147;Settlement&#148;). Since that time, the Company and Cornerstone have proceeded to carry out the terms of the Settlement Agreement as follows: (i) the parties stipulated to judgment in the amount of the Indebtedness, with a stay of execution for 2 years pending the Company satisfying the Indebtedness in any of several ways, including direct payments of cash and discounts of up to 30% for early payments, or a combination thereof; (ii) the Company has conveyed the Property to Cornerstone, which will sell the Property and apply the net proceeds to reduce the Indebtedness (in the event the Property is not sold and the Indebtedness satisfied as otherwise described herein, the Property will be reconveyed to the Company); and (iii) the Company has transferred 14,605,614 shares of the Company&#146;s common stock as security for payment of the Indebtedness (the &#147;Stock Collateral&#148;), which can be liquidated by Cornerstone from time to time in accordance with an SEC Rule 10b5-1 plan, with the proceeds being applied to reduce the Indebtedness. Any excess Stock Collateral will be returned to the Company upon payment of the Indebtedness in full. When the property is sold and any and all remaining payments, if any, are made by Nuvilex directly or through liquidation of the transferred stock collateral sold over time, the proceeds will be used to eliminate the Indebtedness, which, together with the Stock Collateral will remain on the Company&#146;s financial statements in the then outstanding amount/value until fully satisfied. The building is listed as a Company asset under &#147;Settlement Obligation Asset&#148; and the indebtedness is listed as a Company liability as &#147;Settlement Obligation Liabilities.&#148; All assets and amounts due under the settlement, including the building, principal, interest and any and all applicable fees are therefore fully reported herein.</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 16.2pt; text-align: justify; background-color: white; color: #2A2A2A"></p> <p style="margin: 0">To date, the Company has completed all paperwork and signed the Deed In Lieu to Cornerstone Bank, provided all necessary paperwork for transfer of the property and the stock issuance and is awaiting delivery of final signed paperwork from Cornerstone Bank. Therefore, we have come to completion of this issue. Nonetheless, until the property is sold, payments made by Nuvilex, or the stock sold over time, any or all of which are expected to eliminate the debt, such amounts will continue to be reported in the financial statements under the headings of &#147;Settlement Obligation Asset&#148; and &#147;Settlement Obligation Liabilities.&#148; All assets and amounts due under the settlement, including the building, principle, interest and all applicable fees have thus been reported.</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt"><b>NOTE 12 - RELATED PARTY TRANSACTIONS</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 9.9pt 0 0; text-align: justify"><font style="font-size: 12pt">During the quarter ended July 31, 2012 and the year ended April 30, 2012 a shareholder loaned the Company a total of $360,258 and $337,408, respectively for operating expenses. All loans bear interest at 6% and are due on demand.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 9.9pt 0 0; text-align: justify"><font style="font-size: 12pt">As of July 31, 2012 and April 30, 2012, the Company owed a Director and shareholder $22,700; the loan accrues interest at 8% and is due on demand.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 9.9pt 0 0; text-align: justify"><font style="font-size: 12pt">As of July 31, 2012, Dr. Robert Ryan, CEO, loaned the Company $202,769, at 8% interest, to provide for payment of operating expenses.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 9.9pt 0 0; text-align: justify"><font style="font-size: 12pt">&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 12pt">During the year ended April 30, 2012 three shareholders advanced $600,000 to the company. These funds were repaid with the issuance of 9,250,000 shares of common stock and an additional 1,650,000 shares as an incentive for making the advances.</font></p> <p style="margin: 0pt"></p> <p style="margin: 0pt"><b>NOTE 13 - SUBSEQUENT EVENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">The Company has performed an evaluation of subsequent events in accordance with ASC Topic 855, noting no additional subsequent events other than those noted below.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">Subsequent to July 31, 2012, the Company granted 530,000 shares of common stock for services.</font></p> <p style="margin: 0pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt"><b>Unaudited Financial Statements</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><font style="font-size: 12pt">The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#147;GAAP&#148;), for interim financial information and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X.&#160;While these statements reflect all normal recurring adjustments which are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The unaudited interim financial statements should be read in conjunction with the Company&#146;s annual report on Form 10-K, which contains the audited financial statements and notes thereto, together with Management&#146;s Discussion and Analysis, for the fiscal year ended April 30, 2012.&#160;&#160;The interim results for the three months ended July 31, 2012 are not necessarily indicative of the results for the full fiscal year.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><font style="font-size: 12pt">Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company's system of internal accounting control is designed to assure, among other items, that 1) recorded transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"><font style="font-size: 12pt"><b>Principles of Consolidation</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><font style="font-size: 12pt">The consolidated financial statements include the accounts of Nuvilex, Inc. and its subsidiaries, Knock-Out Technologies, Ltd., MedElite, Inc.,&#160;Cinnergen, Inc., I-Boost, Inc., Cinnechol Inc., Freedom-2 GmbH, Berlin, Freedom-2 Creditor Partners, Freedom-2 Holdings, Inc, Freedom-2, Inc., Exceptional Equipment and Ink Supply Company, Inc. With respect to the latter three subsidiaries the financials include the profit and loss activity from the date of purchase March 2, 2009 to July 31, 2012 as the acquisition was accounted for under the purchase method of accounting.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><font style="font-size: 12pt">All significant intercompany balances and transactions have been eliminated in consolidation.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"><font style="font-size: 12pt"><b>Cash and Cash Equivalents</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><font style="font-size: 12pt">For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes. There were no cash equivalents as of July 31, 2012 or April 30, 2012.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><font style="font-size: 12pt"><b>Inventories</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><font style="font-size: 12pt">Inventories are stated at the lower of cost or market. Cost is computed on a weighted-average basis, which approximates the first-in, first-out method; market is based upon estimated replacement costs.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"><font style="font-size: 12pt"><b>Use of Estimates</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><font style="font-size: 12pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in"><font style="font-size: 12pt"><b>Property and Equipment</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.2in; text-align: justify"><font style="font-size: 12pt">Property and equipment are recorded at cost. Expenditures that increase the useful lives or capacities of the plant and equipment are capitalized. Expenditures for repairs and maintenance are charged to income as incurred. Depreciation is provided using the straight-line method over the estimated useful lives as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt"><font style="font-size: 12pt">Computer equipment/software - 3 years</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt"><font style="font-size: 12pt">Furniture and fixtures - 7 years</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt"><font style="font-size: 12pt">Machinery and equipment - 7 years</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt"><font style="font-size: 12pt">Building improvements - 15 years</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 59.75pt"><font style="font-size: 12pt">Building - 40 years</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in"><font style="font-size: 12pt"><b>Goodwill and other indefinite-lived intangibles</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><font style="font-size: 12pt">The Company records the excess of purchase price over the fair value of the identifiable net assets acquired as goodwill and other indefinite-lived intangibles. The FASB standard on goodwill and other intangible assets, prescribes a two-step process for impairment testing of goodwill and indefinite-lived intangibles, which is performed annually, as well as when an event triggering impairment may have occurred. The first step tests for impairment, while the second step, if necessary, measures the impairment. The Company has elected to perform its annual analysis at the end of its reporting year.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><font style="font-size: 12pt"><b>Basic and Diluted Earnings (Loss) per Share</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><font style="font-size: 12pt">Basic and diluted earnings per share is calculated using the weighted-average number of common shares outstanding during the period without consideration of the dilutive effect of stock warrants, convertible notes and convertible preferred shares.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><font style="font-size: 12pt"><b>Fair value of financial instruments</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><font style="font-size: 12pt">For certain of the Company&#146;s non-derivative financial instruments, including cash and cash equivalents, receivables, accounts payable, and other accrued liabilities, the carrying amount approximates fair value due to the short-term maturities of these instruments. The estimated fair value of long-term debt is based primarily on borrowing rates currently available to the Company for similar debt issues. The fair value approximates the carrying value of long-term debt.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><font style="font-size: 12pt">ASC Topic 820, &#147;Fair Value Measurements and Disclosures,&#148; requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, &#147;Financial Instruments,&#148; defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. &#160;The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr> <td style="width: 4%; font-size: 8pt"><font style="font-size: 12pt">&#160;</font></td> <td style="width: 4%; font-size: 8pt"><font style="font-size: 12pt">&#160;</font></td> <td style="width: 92%; font-size: 8pt"><font style="font-size: 12pt">&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">&#160;</font></td> <td style="padding-bottom: 14.3pt; font-family: Symbol"><font style="font-size: 12pt">&#183;</font></td> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">Level&#160;1. Observable inputs such as quoted prices in active markets;</font></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">&#160;</font></td> <td style="padding-bottom: 14.3pt; font-family: Symbol"><font style="font-size: 12pt">&#183;</font></td> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">Level&#160;2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</font></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">&#160;</font></td> <td style="padding-bottom: 14.3pt; font-family: Symbol"><font style="font-size: 12pt">&#183;</font></td> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">Level&#160;3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 12pt">The following presents the gross value of assets and liabilities that were measured and recognized at fair value as of July 31, 2012 and April 30, 2012.</font></p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr> <td style="width: 8%; font-size: 8pt"><font style="font-size: 12pt">&#160;</font></td> <td style="width: 8%; font-size: 8pt"><font style="font-size: 12pt">&#160;</font></td> <td style="width: 84%; font-size: 8pt"><font style="font-size: 12pt">&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">&#160;</font></td> <td style="padding-bottom: 14.3pt; font-family: Symbol"><font style="font-size: 12pt">&#183;</font></td> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">Level&#160;1: none</font></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">&#160;</font></td> <td style="padding-bottom: 14.3pt; font-family: Symbol"><font style="font-size: 12pt">&#183;</font></td> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">Level&#160;2: none</font></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">&#160;</font></td> <td style="padding-bottom: 14.3pt; font-family: Symbol"><font style="font-size: 12pt">&#183;</font></td> <td style="padding-bottom: 14.3pt"><font style="font-size: 12pt">Level&#160;3: none</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">Effective October&#160;1, 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&#34;ASC&#160;820-10&#34;) and Accounting Standards Codification subtopic 825-10, Financial Instruments (&#34;ASC&#160;825-10&#34;), which permits entities to choose to measure many financial instruments and certain other items at fair value. Neither of these statements had an impact on the Company's financial position, results of operations or cash flows. The carrying value of cash, accounts payable and accrued expenses, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">As of July 31, 2012 and April 30, 2012 the Company has recorded several of its assets and liabilities at fair value. The building or &#147;asset held for obligation on settlement&#148; (Note 11) was written down in the last quarter of fiscal 2010 to its fair value based upon a pending sale agreement. Although the agreement was not finalized it established the current market value for the property. &#160;In March of 2009 through the acquisition of another company the Company acquired certain debt. As part of the acquisition these liabilities were evaluated by a third party and valued at fair value at which they were recorded. As a result of this the Company is amortizing the associated discount and premium for two of the liabilities</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt"><b>Recent accounting pronouncements</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">In September 2011 the Accounting Standards Update No. 2011-08, Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for impairment. This ASU's objective is to simplify the process of performing impairment testing for Goodwill. With this update a company is allowed to asses qualitative factors, first, to determine if it is more likely than not (greater than 50%) that the FV is less than the carrying amount. This would be done, prior to performing the two-step goodwill impairment testing, as prescribed by Topic 350. &#160;Prior to this ASU, all entities were required to test, annually, their good will for impairment by Step 1 - comparing the FV to the carrying amount, and if impaired, then step 2 - calculate and recognize the impairment. Therefore, the fair value measurement is not required, until the &#34;more likely than not&#34; reasonableness test is concluded. Effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">In May 2011, FASB issued Accounting Standards Update No. 2011-04, Fair Value Measurement (Topic 820):<i> Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs</i>. &#160;&#160;&#160;This ASU clarifies the board's intent of current guidance, modifies and changes certain guidance and principles, and adds additional disclosure requirements concerning the 3 levels of fair value measurements. Specific amendments are applied to FASB ASC 820-10-35, Subsequent Measurement and FASB ASC 820-10-50, Disclosures. This ASU is effective for interim and annual periods beginning after December 15, 2011.</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">In June 2011, FASB issued Accounting Standards Update No. 2011-05, Comprehensive Income (Topic 220):<i> Presentation of Comprehensive Income</i>. - ASU 2011-05. Current US GAAP allows companies to present the components of comprehensive income as a part of the statement of changes in stockholders' equity. This ASU eliminates that option. In this update, an entity has the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In both choices, an entity is required to present each component of net income along with total net income, each component of other comprehensive income along with a total for other comprehensive income, and a total amount for comprehensive income This ASU is effective interim and annual periods beginning after December 15, 2011. &#160;This ASU should be applied retrospectively. There are no specific transition disclosures.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">The Company has implemented all new accounting pronouncements that are in effect. &#160;These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt"><b>Revenue Recognition</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">Sales of products and related costs of products sold are recognized when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the price is fixed or determinable, and (iv) collectability is reasonably assured. These terms are typically met upon the prepayment or invoicing and shipment of products.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt"><b>Income Taxes</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">Deferred taxes are calculated using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.&#160; Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">In June&#160;2006, the FASB interpreted its standard for accounting for uncertainty in income taxes, an interpretation of accounting for income taxes.&#160; This interpretation clarifies the accounting for uncertainty in income taxes recognized in an entity&#146;s financial statements in accordance the minimum recognition threshold and measurement attributable to a tax position taken on a tax return is required to be met before being recognized in the financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">The FASB&#146;s interpretation had no material impact on the Company&#146;s financial statements for the quarter ended July 31, 2012 or the year ended April 30, 2012. Current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, the amount available to offset future taxable income may be limited. No tax benefit has been reported in the financial statements, because the Company believes the carry forwards may expire unused, although acquisition of sufficient operating capital to complete the acquisition of all of the assets of SG Austria may change this. Accordingly, the potential tax benefits of the loss carry forwards are offset by a valuation allowance of the same amount.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt"><b>Research and Development Costs</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">Expenditures for research and development are expensed as incurred. Such costs are required to be expensed until the point that technological feasibility is established.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt"><b>Concentration of Credit Risk</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">The Company has no significant off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. The Company maintains the majority of its cash balances with one financial institution in the form of demand deposits.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><font style="font-size: 12pt"><b>Valuation of long-lived assets</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0.25in; text-align: justify"><font style="font-size: 12pt">The Company accounts for the valuation of long-lived assets under the FASB standard for accounting for the impairment or disposal of Long-Lived Assets. The FASB standard requires that long-lived assets and certain identifiable intangible assets be reviewed for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the long-lived assets is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less cost to sell. &#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt"><b>Allowance for Doubtful Accounts</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">The Company provides an allowance for estimated uncollectible accounts receivable balances based on historical experience and the aging of the related accounts receivable.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0">Fixed assets consisted of the following:</p> <table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr> <td style="width: 46%; vertical-align: top">&#160;</td> <td style="width: 3%; vertical-align: top; text-align: center">&#160;</td> <td style="width: 19%; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center">July 31, 2012</td> <td style="width: 9%; vertical-align: bottom; padding-top: 12pt; text-align: center">&#160;</td> <td style="width: 23%; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center">April 30, 2012</td></tr> <tr> <td style="vertical-align: bottom">Computers</td> <td style="vertical-align: top; text-align: right">$</td> <td style="vertical-align: bottom; text-align: right">23,664</td> <td style="vertical-align: bottom; text-align: right">$</td> <td style="vertical-align: bottom; text-align: right">23,664</td></tr> <tr style="vertical-align: bottom"> <td>Furniture and fixtures</td> <td style="text-align: right">&#160;</td> <td style="text-align: right">-</td> <td style="padding-top: 10pt; text-align: right">&#160;</td> <td style="text-align: right">-</td></tr> <tr style="vertical-align: bottom"> <td>Lab equipment</td> <td style="text-align: right">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td> <td style="padding-top: 10pt; text-align: right">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">-</td></tr> <tr> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="vertical-align: bottom; text-align: right">&#160;</td> <td style="vertical-align: bottom; text-align: right">&#160;</td> <td style="vertical-align: bottom; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: bottom">Less: accumulated depreciation</td> <td style="vertical-align: top; text-align: right">&#160;</td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right">(23,664)</td> <td style="vertical-align: bottom; padding-top: 10pt; text-align: right">&#160;</td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right">(23,664)</td></tr> <tr> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: top; text-align: right">$</td> <td style="border-bottom: windowtext 1.5pt double; vertical-align: bottom; text-align: right">-</td> <td style="vertical-align: bottom; text-align: right">$</td> <td style="border-bottom: windowtext 1.5pt double; vertical-align: bottom; text-align: right">-</td></tr> </table> 580000 580000 80000 181181 305564 500000 50 20950 21000 925 599075 600000 165 101585 101750 103 55622 184 98412 55725 98596 6497 <p style="margin: 0pt">&#160;<b>NOTE 5 &#150; ASSET PURCHASE</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 21, 2012, the Registrant, Nuvilex, Inc. (&#147;Nuvilex&#148;), a Nevada corporation, purchased 100% of the shares of Austrianova Singapore Pte. Ltd. (ASPL) in exchange for 100,000,000 shares of restricted Nuvilex common stock. A copy of the final Asset Purchase Agreement, dated May 26, 2011, is attached as Exhibit 2.1 on the Company&#146;s Form 10-K for the fiscal year ended April 30, 2012.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Asset Purchase Agreement, the Nuvilex and ASPL shares are held in escrow until the completion of Nuvilex&#146;s financing obligations. The Asset Purchase Agreement, as amended, provides that Nuvilex will fund future ASPL operations in the amount of $2.5 million with a target date to complete the funding by December 31, 2012. Nuvilex will continue current funding of $60,000 monthly in operating capital until the overall funding is completed.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The shares for both ASPL and Nuvilex are being held in escrow and are therefore not reflected in the financial statements. This is due to the potential unwinding of the agreement in the event Nuvilex is unable to satisfy the Asset Purchase Agreement requirements including monthly maintenance payments or the $2.5 million minimum financing requirement.</p> <p style="margin: 0pt"></p> 1 2500000 0 24659 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0"><font style="font-size: 12pt"><b>Reclassifications</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify"><font style="font-size: 12pt">Certain items in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current period&#146;s presentation. These reclassifications have no effect on the previously reported income</font> (loss).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.2in 0; text-align: justify">&#160;</p> Common Stock Issued for Services 2821368 0.10 310000 132000 500000 360258 337408 22700 22700 0.06 0.06 0.08 0.08 0.08 60000 530000 100000000 50000 95000 22.86 2666667 3500 P7Y P7Y P15Y P40Y P3Y 23664 23664 0 0 0 0 23664 23664 0 0 0 0 0 0 0 0 0 0 50 0.03 July 2011 Cornerstone Bank The bank also sought to foreclose its mortgage on the property securing the Note, which is located in Cherry Hill, New Jersey (the “Property”). 1600000 2000000 On May 7, 2012, the Company and Cornerstone entered into a comprehensive settlement agreement that resolves all matters related to Cornerstone&#146;s claims (the &#147;Settlement&#148;). Since that time, the Company and Cornerstone have proceeded to carry out the terms of the Settlement Agreement as follows: (i) the parties stipulated to judgment in the amount of the Indebtedness, with a stay of execution for 2 years pending the Company satisfying the Indebtedness in any of several ways, including direct payments of cash and discounts of up to 30% for early payments, or a combination thereof; (ii) the Company has conveyed the Property to Cornerstone, which will sell the Property and apply the net proceeds to reduce the Indebtedness (in the event the Property is not sold and the Indebtedness satisfied as otherwise described herein, the Property will be reconveyed to the Company); and (iii) the Company has transferred 14,605,614 shares of the Company&#146;s common stock as security for payment of the Indebtedness (the &#147;Stock Collateral&#148;), which can be liquidated by Cornerstone from time to time in accordance with an SEC Rule 10b5-1 plan, with the proceeds being applied to reduce the Indebtedness. Any excess Stock Collateral will be returned to the Company upon payment of the Indebtedness in full. When the property is sold and any and all remaining payments, if any, are made by Nuvilex directly or through liquidation of the transferred stock collateral sold over time, the proceeds will be used to eliminate the Indebtedness, which, together with the Stock Collateral will remain on the Company&#146;s financial statements in the then outstanding amount/value until fully satisfied. The building is listed as a Company asset under &#147;Settlement Obligation Asset&#148; and the indebtedness is listed as a Company liability as &#147;Settlement Obligation Liabilities.&#148; All assets and amounts due under the settlement, including the building, principal, interest and any and all applicable fees are therefore fully reported herein. 400000 20000 0.08 Due on demand Due on Demand <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Purchase Agreement requirements including monthly maintenance payments or the $2.5 million minimum financing requirement.</p> 71742 370619 EX-101.SCH 5 nvlx-20120731.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - Balance Sheet link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - Stockholders Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 0006 - Statement - Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - BACKGROUND,ACQUISITION AND LIQUIDITY link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - GOING CONCERN AND MANAGEMENT'S PLANS link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - ASSET PURCHASE link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - FIXED ASSETS link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - COMMON STOCK TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - LEGAL PROCEEDINGS link:presentationLink link:calculationLink link:definitionLink 0018 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0019 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 0020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (POLICIES) link:presentationLink link:calculationLink link:definitionLink 0021 - Disclosure - FIXED ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 0022 - Disclosure - FIXED ASSETS (DETAILS) link:presentationLink link:calculationLink link:definitionLink 0023 - Disclosure - GOING CONCERN (NARRATIVE) (DETAILS) link:presentationLink link:calculationLink link:definitionLink 0024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (NARRATIVE) (DETAILS) link:presentationLink link:calculationLink link:definitionLink 0025 - Disclosure - ACCOUNTS RECEIVABLE (Details) (Narrative) link:presentationLink link:calculationLink link:definitionLink 0026 - Disclosure - ASSET PURCHASE (Details) (Narrative) link:presentationLink link:calculationLink link:definitionLink 0027 - Disclosure - FIXED ASSETS (Details) (Narrative) link:presentationLink link:calculationLink link:definitionLink 0028 - Disclosure - DEBT (Details) (Narrative) link:presentationLink link:calculationLink link:definitionLink 0029 - Disclosure - COMMON STOCK TRANSACTIONS (Details) (Narrative) link:presentationLink link:calculationLink link:definitionLink 0030 - Disclosure - PREFERRED STOCK (Details) (Narrative) link:presentationLink link:calculationLink link:definitionLink 0031 - Disclosure - LEGAL PROCEEDINGS (Details) (Narrative) link:presentationLink link:calculationLink link:definitionLink 0032 - Disclosure - RELATED PARTY TRANSACTIONS (Details) (Narrative) link:presentationLink link:calculationLink link:definitionLink 0033 - Disclosure - SUBSEQUENT EVENT (Details) (Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 nvlx-20120731_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 nvlx-20120731_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 nvlx-20120731_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT SeriesEPreferredStockMember StatementClassOfStockAxis Common Stock Equity Components [Axis] Additional Paid-In Capital Common Stock Not Yet Issued Retained Earnings / Accumulated Deficit Total Computer Property, Plant and Equipment, Type [Axis] Furniture and Fixtures Lab Equipment AustrianovaSingaporePteLtdMember Equity Method Investee, Name [Axis] Computer and Software Machinery and Equipment Building Improvements Building Cornerstone Loss Contingency Nature [Axis] Equity Member Financing [Axis] Shareholder Related Party [Axis] Director and Shareholder Dr. Robert Ryan Due Within One Year Debt Instrument [Axis] Past Due Computer Equipment/ Software Machinery and Equipment Lab Equipment Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash Accounts receivable - net Inventory Prepaid on acquisition Prepaid and other assets Total Current Assets Property, plant and equipment - net Settlement Obligation Asset Total Assets LIABILITIES AND STOCKHOLERS' EQUITY (DEFICIT) Current Liabilities Accounts payable Accrued expenses Accrued interest, related party Due to related parties Due to an officer Settlement Obligation Liabilities Loans payable Total Current Liabilities Long-term Liabilities Long-term debt, related party Total Liabilities Commitments and Contingencies Preferred stock, authorized 10,000,000 shares, $0.0001 par value, 8,500 and 8,500 shares issued and outstanding, respectively Stockholders' Equity (Deficit) Common Stock, authorized 1,490,000,000 shares, $0.0001 par value, 423,420,851 and 416,293,195 shares issued and outstanding, respectively Additional paid in capital Accumulated deficit Total Stockholders' Equity (Deficit) Total Liabilities and Stockholders' Equity (Deficit) Statement [Table] Statement [Line Items] Class of Stock [Axis] Preferred Stock, authorized Preferred Stock, Issued and outstanding Preferred Stock, par value Common Stock, authorized Common Stock, issued and outstanding Common Stock, par value Income Statement [Abstract] Revenues: Product Sales Total revenue Cost of revenues Gross profit Expenses: Sales and Marketing Compensation Expense Legal and Professional Fees General and Administrative Total Operating Expenses Net loss from operations Other income (expense): Gain on forgiveness of debt Interest expense Other expense Total Other Income (Expense) Net Income (Loss) Basic Income (Loss) per share Weighted average shares outstanding Beginning balance, shares Beginning balance, amount Issuance of common stock for cash, shares Issuance of common stock for cash, amount Issuance of common stock for compensation, shares Issuance of common stock for compensation, amount Issuance of common stock for services, shares Issuance of common stock for services, amount Stock issued on stock payable, shares Stock issued on stock payable, amount Shares issued for repayment of cash advances, shares Shares issued for repayment of cash advances, amount Shares issued for incentive for cash advances, shares Shares issued for incentive for cash advances, amount Shares issued for settlement of debt, shares Shares issued for settlement of debt, amount Net Income (Loss) Ending balance, shares Ending balance, amount Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Income Loss Net loss Adjustments to reconcile net loss to net cash used in operating activities: Stock issued for services Gain on Forgiveness of Debt Depreciation and amortization Net amortization of discount/premium Change in assets and liabilities: (Increase) decrease in accounts receivable (Increase) decrease in inventory (Increase) decrease in prepaid expenses Increase in accounts payable Increase in accrued interest, related party Increase in accrued expenses Net cash used in operating activities Cash flows from investing activities: Payments towards acquisition Net cash used in investing activities Cash flows from financing activities: Proceeds from the sale of common stock Proceeds from notes payable Proceeds from borrowings, related party Repayment of debt, related party Net cash provided by financing activities Net increase (decrease) in cash Cash at beginning of period Cash at end of period Supplementary non-cash disclosures: Cash paid for interest Franchise and income taxes Common stock issued for debt Organization, Consolidation and Presentation of Financial Statements [Abstract] BACKGROUND,ACQUSITION AND LIQUIDITY GOING CONCERN AND MANAGEMENT'S PLANS Accounting Policies [Abstract] SIGNIFICANT ACCOUNTING POLICIES Receivables [Abstract] ACCOUNTS RECEIVABLE Notes to Financial Statements ASSET PURCHASE Inventory Disclosure [Abstract] INVENTORY Property, Plant and Equipment [Abstract] FIXED ASSETS Debt Disclosure [Abstract] DEBT Equity [Abstract] COMMON STOCK TRANSACTIONS PREFERRED STOCK Commitments and Contingencies Disclosure [Abstract] LEGAL PROCEEDINGS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] SUBSEQUENT EVENTS Significant Accounting Policies Policies Unaudited Financial Statements Principles of Consolidation Cash and Cash Equivalents Inventories Use of Estimates Property and Equipment Goodwill and other indefinite-lived intangibles Valuation of long-lived assets Basic and Diluted Earnings (Loss) per Share Fair value of financial instruments Recent accounting pronouncements Revenue Recognition Allowance for Doubtful Accounts Income Taxes Research and Development Costs Concentration of Credit Risk Reclassifications Fixed Assets Tables Schedule of Fixed Assets Property Plant and Equipment Gross Less: Accumulated Depreciation Property Plant and Equipment Net Going Concern Narrative Details Negative Working Capital Estimated Useful Life Accounts Receivable Details Narrative Allowance for doubtful Accounts Percentage of holding Common Stock Issued Funding Obligation Funding Terms Monthly Operating Capital Funding Fixed Assets Details Narrative Depreciation Expenses Debt Details Narrative Notes Payable Current Interest Rate On Notes Payable Current Notes Payable Interest Rate On Notes Payable Repayment Of Debt Gain On Repayment Of Debt Obligation Towards Licensing Fees Common Stock Transactions Details Narrative Restricted Common Stock Issued, Shares Preferred Stock Details Narrative Preferred Stock Voting Rights Preferred Stock Issued, Shares Preferred Stock Issued, Per Share Preferred Stock Issued, Amount Original Valuation Of Preferred Stock Per Share Based On Prior Issuance Loss On Conversion Of Debt Average Closing Bid Price Preferred Stock Outstanding, Shares Preferred Stock Convertible Into Common Stock As Per Preferred Stock Provisions Legal Proceedings Details Narrative Suit Filed Date Plaintiff Name Amount Due Forclose Settlement Agreement Terms Loan Outstanding Loan Outstanding Current Interest Loan Duration Subsequent Event Description Common Stock Machinery and Equipment [Member] Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Revenues Operating Expenses Operating Income (Loss) Interest Expense Other Expenses Other Nonoperating Income (Expense) Shares, Outstanding Net Cash Provided by (Used in) Operating Activities Payments for (Proceeds from) Previous Acquisition Net Cash Provided by (Used in) Investing Activities Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, at Carrying Value CommonStockIssuedSubsequentlyShares Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. EX-101.PRE 9 nvlx-20120731_pre.xml XBRL TAXONOMY PRESENTATION LINKBASE DOCUMENT XML 10 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUBSEQUENT EVENT (Details) (Narrative) (Equity Member)
1 Months Ended
Sep. 10, 2012
Equity Member
 
Subsequent Event Description Common Stock Issued for Services
Common Stock 530,000
XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACCOUNTS RECEIVABLE (Details) (Narrative) (USD $)
Jul. 31, 2012
Accounts Receivable Details Narrative  
Allowance for doubtful Accounts $ 6,497
XML 13 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Jul. 31, 2012
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES

 NOTE 3 – Significant Accounting Policies

Unaudited Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), for interim financial information and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X. While these statements reflect all normal recurring adjustments which are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The unaudited interim financial statements should be read in conjunction with the Company’s annual report on Form 10-K, which contains the audited financial statements and notes thereto, together with Management’s Discussion and Analysis, for the fiscal year ended April 30, 2012.  The interim results for the three months ended July 31, 2012 are not necessarily indicative of the results for the full fiscal year.

Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company's system of internal accounting control is designed to assure, among other items, that 1) recorded transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented.

Principles of Consolidation

The consolidated financial statements include the accounts of Nuvilex, Inc. and its subsidiaries, Knock-Out Technologies, Ltd., MedElite, Inc., Cinnergen, Inc., I-Boost, Inc., Cinnechol Inc., Nuvilex GmbH, Berlin, Freedom-2 Creditor Partners, Freedom-2 Holdings, Inc, Freedom-2, Inc., Exceptional Equipment and Ink Supply Company, Inc. With respect to the latter three subsidiaries the financials include the profit and loss activity from the date of purchase March 2, 2009 to July 31, 2012 as the acquisition was accounted for under the purchase method of accounting.

All significant intercompany balances and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes. There were no cash equivalents as of July 31, 2012 or April 30, 2012.

Inventories

Inventories are stated at the lower of cost or market. Cost is computed on a weighted-average basis, which approximates the first-in, first-out method; market is based upon estimated replacement costs.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Property and Equipment

Property and equipment are recorded at cost. Expenditures that increase the useful lives or capacities of the plant and equipment are capitalized. Expenditures for repairs and maintenance are charged to income as incurred. Depreciation is provided using the straight-line method over the estimated useful lives as follows:

Computer equipment/software - 3 years

Furniture and fixtures - 7 years

Machinery and equipment - 7 years

Building improvements - 15 years

Building - 40 years

 Goodwill and other indefinite-lived intangibles

The Company records the excess of purchase price over the fair value of the identifiable net assets acquired as goodwill and other indefinite-lived intangibles. The FASB standard on goodwill and other intangible assets, prescribes a two-step process for impairment testing of goodwill and indefinite-lived intangibles, which is performed annually, as well as when an event triggering impairment may have occurred. The first step tests for impairment, while the second step, if necessary, measures the impairment. The Company has elected to perform its annual analysis at the end of its reporting year.

Valuation of long-lived assets

The Company accounts for the valuation of long-lived assets under the FASB standard for accounting for the impairment or disposal of Long-Lived Assets. The FASB standard requires that long-lived assets and certain identifiable intangible assets be reviewed for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the long-lived assets is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less cost to sell.  

Basic and Diluted Earnings (Loss) per Share

Basic and diluted earnings per share is calculated using the weighted-average number of common shares outstanding during the period without consideration of the dilutive effect of stock warrants, convertible notes and convertible preferred shares.

Fair value of financial instruments

For certain of the Company’s non-derivative financial instruments, including cash and cash equivalents, receivables, accounts payable, and other accrued liabilities, the carrying amount approximates fair value due to the short-term maturities of these instruments. The estimated fair value of long-term debt is based primarily on borrowing rates currently available to the Company for similar debt issues. The fair value approximates the carrying value of long-term debt.

ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, “Financial Instruments,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures.  The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

     
  · Level 1. Observable inputs such as quoted prices in active markets;
  · Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
  · Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The following presents the gross value of assets and liabilities that were measured and recognized at fair value as of July 31, 2012 and April 30, 2012.

     
  · Level 1: none
  · Level 2: none
  · Level 3: none

Effective October 1, 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures ("ASC 820-10") and Accounting Standards Codification subtopic 825-10, Financial Instruments ("ASC 825-10"), which permits entities to choose to measure many financial instruments and certain other items at fair value. Neither of these statements had an impact on the Company's financial position, results of operations or cash flows. The carrying value of cash, accounts payable and accrued expenses, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments.

As of July 31, 2012 and April 30, 2012 the Company has recorded several of its assets and liabilities at fair value. The building or “Settlement Obligation Asset” (Note 11) was written down in the last quarter of fiscal 2010 to its fair value based upon a pending sale agreement. Although the agreement was not finalized it established the current market value for the property.  In Jan-March 2009, through the acquisition of another company the Company acquired certain debt. As part of the acquisition, these were evaluated by a third party and valued at fair value at the time they were recorded. As a result of this the Company is amortizing the associated discount and premium for two of the liabilities.

Recent accounting pronouncements

In September 2011 the Accounting Standards Update No. 2011-08, Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for impairment. This ASU's objective is to simplify the process of performing impairment testing for Goodwill. With this update a company is allowed to asses qualitative factors, first, to determine if it is more likely than not (greater than 50%) that the FV is less than the carrying amount. This would be done, prior to performing the two-step goodwill impairment testing, as prescribed by Topic 350.  Prior to this ASU, all entities were required to test, annually, their good will for impairment by Step 1 - comparing the FV to the carrying amount, and if impaired, then step 2 - calculate and recognize the impairment. Therefore, the fair value measurement is not required, until the "more likely than not" reasonableness test is concluded. Effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011.

In May 2011, FASB issued Accounting Standards Update No. 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.    This ASU clarifies the board's intent of current guidance, modifies and changes certain guidance and principles, and adds additional disclosure requirements concerning the 3 levels of fair value measurements. Specific amendments are applied to FASB ASC 820-10-35, Subsequent Measurement and FASB ASC 820-10-50, Disclosures. This ASU is effective for interim and annual periods beginning after December 15, 2011.

In June 2011, FASB issued Accounting Standards Update No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income. - ASU 2011-05. Current US GAAP allows companies to present the components of comprehensive income as a part of the statement of changes in stockholders' equity. This ASU eliminates that option. In this update, an entity has the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In both choices, an entity is required to present each component of net income along with total net income, each component of other comprehensive income along with a total for other comprehensive income, and a total amount for comprehensive income This ASU is effective interim and annual periods beginning after December 15, 2011.  This ASU should be applied retrospectively. There are no specific transition disclosures.

The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Revenue Recognition

Sales of products and related costs of products sold are recognized when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the price is fixed or determinable, and (iv) collectability is reasonably assured. These terms are typically met upon the prepayment or invoicing and shipment of products.

Allowance for Doubtful Accounts

The Company provides an allowance for estimated uncollectible accounts receivable balances based on historical experience and the aging of the related accounts receivable.

Income Taxes

Deferred taxes are calculated using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

In June 2006, the FASB interpreted its standard for accounting for uncertainty in income taxes, an interpretation of accounting for income taxes.  This interpretation clarifies the accounting for uncertainty in income taxes recognized in an entity’s financial statements in accordance the minimum recognition threshold and measurement attributable to a tax position taken on a tax return is required to be met before being recognized in the financial statements.

The FASB’s interpretation had no material impact on the Company’s financial statements for the quarter ended July 31, 2012 or the year ended April 30, 2012. Current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, the amount available to offset future taxable income may be limited. No tax benefit has been reported in the financial statements, because the Company believes the carry forwards may expire unused, although acquisition of sufficient operating capital to complete the acquisition of all of the assets of SG Austria may change this. Accordingly, the potential tax benefits of the loss carry forwards are offset by a valuation allowance of the same amount.

Research and Development Costs

Expenditures for research and development are expensed as incurred. Such costs are required to be expensed until the point that technological feasibility is established.

Concentration of Credit Risk

The Company has no significant off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. The Company maintains the majority of its cash balances with one financial institution in the form of demand deposits.

Reclassifications

Certain items in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current period’s presentation. These reclassifications have no effect on the previously reported income (loss).

EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S M83!C93%A9#,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T871E;65N='-?;V9?3W!E#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T871E;65N='-?;V9?0V%S:%]&;&]W#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D)!0TM'4D]53D1!0U%525-) M5$E/3E]!3D1?3$E153PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=/24Y'7T-/3D-%4DY?04Y$7TU!3D%'14U%3E137SPO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-)1TY)1DE#04Y47T%# M0T]53E1)3D=?4$],24-)13PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%#0T]53E137U)%0T5)5D%"3$4\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE.5D5.5$]263PO>#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1%0E0\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-50E-%455%3E1?159%3E13/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9) M6$5$7T%34T544U]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D=/24Y'7T-/3D-%4DY?3D%24D%4 M259%7T1%5$%)3#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-)1TY)1DE#04Y47T%#0T]53E1)3D=?4$],24-)13(\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\ M>#I0#I%>&-E;%=O7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^3E5624Q%6"P@24Y#+CQS<&%N/CPO'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^3F\\2!&:6QE3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^4VUA;&QE3QS<&%N M/CPO'0^43$\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!?8C5F M-5\T9&0S83!C93%A9#,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M8V0S,F4P9C=?-#@V,%\T-60P7V(U9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9#,R93!F M-U\T.#8P7S0U9#!?8C5F-5\T9&0S83!C93%A9#,-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P9C=?-#@V,%\T-60P7V(U9C5?-&1D,V$P M8V4Q860S+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!? M8C5F-5\T9&0S83!C93%A9#,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO8V0S,F4P9C=?-#@V,%\T-60P7V(U9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^ M)FYB'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#$L,3@Q/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E'!E;G-E*3H\+W-T'0^)FYB'!E;G-E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M/B@T-BPP-C,I/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!?8C5F M-5\T9&0S83!C93%A9#,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M8V0S,F4P9C=?-#@V,%\T-60P7V(U9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0@ M;V8@8V%S:"!A9'9A;F-E'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S83!C M93%A9#,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P9C=? M-#@V,%\T-60P7V(U9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$F%T:6]N(&]F(&1I6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S6UE;G1S('1O=V%R9',@86-Q=6ES:71I;VX\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)FYB'0^)FYB'0^ M)FYB'0^)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!O9B!A8V-O=6YT:6YG('!O;&EC:65S(&9O6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0M0T*;V8@=&AE($-O;7!A;GD\ M+V(^/"]F;VYT/CPO<#X-"@T*/'`@2<^/&9O;G0@2!A8W%U:7)E9`T*3WIO;F4@4V%F92!& M;V]D+"!);F,N(&9O2P@;V8@=VAI8V@@2VYO8VLM3W5T M(%1E8VAN;VQO9VEE2!F;W)M960@0VEN;F5R9V5N+`T*26YC M+BP@82!W:&]L;'DM;W=N960@2P@=&\@;6%N=69A8W1U2!L:6-E;G-E9"!T:&4@;6%R:V5T:6YG(')I M9VAT2UO=VYE9"!S=6)S:61I87)Y M('1O('!R;VUO=&4@8V%R9&EO=F%S8W5L87(-"FAE86QT:"X@26X@1F5B2!C M;VUP96YS871I;VXN($EN($UA"P@26YC+B!O;B!- M87)C:"`Q."P@,C`P.2!A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M9#,R93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S83!C93%A9#,-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P9C=?-#@V,%\T-60P7V(U9C5? M-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA2=S(&9I;F%N8VEA;"!S=&%T96UE;G1S#0IA2!A8V-E M<'1E9"!I;B!T:&4@56YI=&5D(%-T871E2!H87,@;F]T#0IY970@97-T86)L:7-H960@86X@ M;VYG;VEN9R!S;W5R8V4@;V8@2!H860@86X@86-C=6UU;&%T960@9&5F M:6-I="!O9B`D-#`L,S4X+#4R,BP@:&%D(&EN8W5R2!T:&4@0V]M<&%N M>28C,30V.W,-"D-%3RP@1'(N(%)O8F5R="!2>6%N(&%S('=E;&P@87,@;VQD M(&%N9"!N97<@:6YV97-T;W)S(&-O;6UI='1E9"!T;R!M86ME(&ET('!O'!A;F0L(&%N9"!E;G-U2P@86QT:&]U M9V@-"G1H92!#;VUP86YY)B,Q-#8[2!M;W9E M&ES=',@87,@=&\@=&AE($-O;7!A;GDG2!U;F1E6QE/3-$ M)V9O;G0Z(#$R<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU2<^5&AE($-O;7!A;GD@:&%S(&)E96X@ M:6X@97AIF5D+`T*=7-E9G5L+"!I;7!O61A>2!C;VYS=6UE2!S=')U8W1U M2!W87ES(&]V97(@ M=&AE('EE87)S+B!/;B!A(&1A:6QY(&)A2!R96-E M:79E2!F;W)W87)D(&EN=&\@82!M;V1E6QE/3-$)V9O;G0Z M(#$R<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU2X@56YL:6ME(&UO'1E;G-I=F4@87)R87D@;V8@<')O9'5C=',@86QR M96%D>0T*:6XM:&]U65A28C,30V.W,@969F;W)T2!C;VUP;VYE;G1S M.CPO<#X-"@T*/'`@0T*=&AR M;W5G:"!O;F=O:6YG(')E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!F;W(-"F9A:7(@<')E2!D;R!N M;W0@:6YC;'5D92!A;&P@;V8@=&AE(&EN9F]R;6%T:6]N(&%N9"!F;V]T;F]T M97,@2`S M,2P@,C`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`@'!E;G-E6QE/3-$)V9O;G0Z(#$R<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M:6YD M96YT.B`U.2XW-7!T)SY#;VUP=71E'0M:6YD96YT M.B`U.2XW-7!T)SY&=7)N:71U'1U'0M:6YD96YT.B`U.2XW-7!T)SY"=6EL M9&EN9R!I;7!R;W9E;65N=',@+2`Q-2!Y96%R2P@87,@=V5L;"!A2P@;65A'0M86QI9VXZ(&IU2!A#0IC;VUP87)I6EN9R!A;6]U M;G0@;V8@=&AE(&%S&-E961S('1H92!E2<^ M/&(^0F%S:6,@86YD($1I;'5T960@16%R;FEN9W,@*$QO2<^1F]R(&-E&EM871E2!O;B!B;W)R;W=I;F<@2!F;W(@&EM871EF%T:6]N M(&%N9"!T:&5I6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT M.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Y M,B4G/B8C,38P.SPO=&0^/"]T6QE M/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F2!O M6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q M,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`X-"4G M/B8C,38P.SPO=&0^/"]T6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&IU2=S(&9I;F%N8VEA;"!P;W-I=&EO;BP@6EN9R!V86QU92!O9B!C87-H+"!A M8V-O=6YT'!E;G-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$R<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^26X@ M36%Y(#(P,3$L($9!4T(@:7-S=65D($%C8V]U;G1I;F<@4W1A;F1A6QE/3-$)V9O;G0Z(#$R<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^26X@2G5N92`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`@("`\=&%B;&4@8VQA'0^/'`@F4Z(#$R<'0G/CQB/DY/5$4@-"`F(S$U M,#L@04-#3U5.5%,-"E)%0T5)5D%"3$4\+V(^/"]F;VYT/CPO<#X-"@T*/'`@ MF4Z(#$R<'0G/E1H92!#;VUP86YY#0IR M96-O9VYI>F5S(')E8V5I=F%B;&5S('!R961O;6EN871E;'D@;VX@7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#$R<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU"8C,30X.RDL(&$@3F5V861A(&-O"!C M;VUM;VX@2!O9B!T:&4@9FEN86P@07-S970@4'5R8VAA M&AI8FET(#(N,2!O;B!T:&4@0V]M<&%N>28C,30V.W,@1F]R;2`Q M,"U+(&9O'0M86QI9VXZ(&IU"8C,30V.W,@9FEN86YC:6YG(&]B;&EG871I;VYS+B!4:&4@07-S M970@4'5R8VAA6QE/3-$)V9O;G0Z(#$R<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU"!A"!I2!T:&4@07-S970@4'5R8VAA2!M86EN=&5N86YC92!P87EM96YT7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'`@F4Z(#$R<'0G/CQB/DY/5$4-"C8@ M+2!)3E9%3E1/4ED\+V(^/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#$R<'0G/D]N($IU;'D-"C,Q+"`R,#$R(&%N9"!!<')I M;"`S,"P@,C`Q,BP@:6YV96YT;W)Y(&-O;G-I2!F;W(@0VEN;F5R9V5N)B,Q-3,[#0IP6QE/3-$)VUA3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S83!C M93%A9#,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P9C=? M-#@V,%\T-60P7V(U9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V)O6QE/3-$)W=I9'1H.B`U-B4G/D-O;7!U=&5R M6QE/3-$)W=I9'1H.B`X)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA M;&EG;CH@;&5F="<^)B,Q-C`[/"]T9#X\=&0@'0M86QI9VXZ(&QE9G0G/B0\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,3(E M.R!T97AT+6%L:6=N.B!R:6=H="<^,C,L-C8T/"]T9#X\=&0@'1U6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0G/B8C,38P.SPO=&0^/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$U,3LF(S$V,#LF(S$V,#L\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F'0M86QI9VXZ(&QE9G0G/B8C M,38P.SPO=&0^/'1D('-T>6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V)O M6QE M/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/BD\+W1D/CQT9"!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/'1D('-T>6QE/3-$)V)O6QE/3-$ M)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&QE9G0G/B0\+W1D/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C M:R`R+C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SXF(S$U,3LF(S$V M,#LF(S$V,#L\+W1D/CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU M<'0[('1E>'0M86QI9VXZ(&QE9G0G/B8C,38P.SPO=&0^/"]T6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UEF4Z(#$R<'0G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2`S,2P@,C`Q,B!A;F0@9FES8V%L('EE87(@96YD960@ M07!R:6P@,S`L(#(P,3(@=V%S("0P(&%N9"`D,C0L-C4Y+"!R97-P96-T:79E M;'DN/"]F;VYT/CPO<#X-"@T*/'`@7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'`@ M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE65A6QE/3-$ M)V9O;G0Z(#$R<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$R<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2`S,2P@,C`Q,BP@ M=&AE($-O;7!A;GD@:&%D(&%N(&]B;&EG871I;VX@=&\@<&%Y("0T,#`L,#`P M#0II;B!L:6-E;G-I;F<@9F5E2<^1'5R:6YG('1H92!Y96%R(&5N9&5D($%P6UE;G1S(&%N9"!T:&4@:7-S M=6%N8V4@;V8@8V]M;6]N('-T;V-K+B!);B!T;W1A;"!O=F5R("0U,#`L,#`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`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!O9B!I'!E M;G-E(&]F("0Q+#$V,"PX.#`N/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#$R<'0G/D1U'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M M65A'!E;G-E/"]F;VYT/CPO<#X-"@T* M/'`@F4Z(#$R<'0G/D1U'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#$R<'0G/D1U2`S,2P@,C`Q,BP@,2PX-#(L-C4V('-H87)E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!O9B!I'!E;G-E(&]F("0Q-S(L,3@Q+CPO9F]N=#X\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#$R<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^/&9O M;G0@6QE/3-$)V-O;&]R.B!B;&%C:R<^+B`\+V9O;G0^56YD97(@ M=&AE('1E6QE/3-$)V-O;&]R.B!B;&%C M:R<^5&AE('-H87)E"!A"!I2!T:&4@07-S970@4'5R8VAAF4Z(#$R<'0G/D%L;"!S:&%R97,-"G=E&5M<'1I M;VX@869F;W)D960@8GD@4V5C=&EO;@T*-"@R*2!O9B!T:&%T($%C="X@3F\@ M=6YD97)W'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q M,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6UB;VPG/B8C,3@S.SPO9F]N=#X\+W1D/CQT9#X\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$R<'0G/E-E6QE/3-$ M)W=I9'1H.B`P+C(U:6XG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$R<'0@4WEM M8F]L)SXF(S$X,SL\+V9O;G0^/"]T9#X\=&0@2<^/&9O;G0@2X@5&AE(&AO;&1E0T*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@8F5F;W)E(&%N>2!A;6]U;G0@ M2!C87!I=&%L('-T;V-K(&]F('1H90T*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@0V]M<&%N>2!O9B!A;GD@8VQA6QE/3-$)W=I M9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6UB;VPG/B8C,3@S M.SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$R<'0G/D5A8V@-"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@('-H87)E(&]F(%-E7,@<')I;W(@=&\@=&AE#0H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("!#;VYV97)S:6]N($1A=&4N/"]F;VYT/CPO=&0^/"]T6QE/3-$)W=I9'1H.B`P+C(U:6XG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$R M<'0@4WEM8F]L)SXF(S$X,SL\+V9O;G0^/"]T9#X\=&0@2!H;VQD97(@;V8@4V5R:65S($4- M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(%!R969E'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0M65A65AF4Z(#$R<'0G/E1H92!A M=F5R86=E($-L;W-I;F<@0FED(%!R:6-E#0IA="!!<')I;"`S,"P@,C`Q,2!W M87,@)#`N,#,N($)AF4Z(#$R<'0G/E5N M9&5R#0IT:&4@=&5R;7,@;V8@=&AE(%-E2!J=6YI;W(@8VQA7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`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`S,"4@9F]R(&5A M6UE;G1S+"!O65D('1H92!02!T;R!#;W)N M97)S=&]N92P@=VAI8V@@=VEL;`T*2D[(&%N9"`H:6EI*2!T:&4@0V]M<&%N>2!H87,@ M=')A;G-F97)R960-"C$T+#8P-2PV,30@6UE;G0@ M;V8@=&AE($EN9&5B=&5D;F5S2!A;F0@ M86QL(')E;6%I;FEN9R!P87EM96YT2!. M=79I;&5X(&1I2!S871I2!A2!R97!O6QE/3-$)V9O;G0Z(#$R<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)VUA2!P87!E2!A;F0@=&AE('-T;V-K(&ES2!O9B!F:6YA;"!S:6=N960@<&%P97)W M;W)K#0IF2!I2!.=79I;&5X+"!O2!O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M2<^/&9O;G0@2<^/&9O;G0@2`S,2P@,C`Q,B!A;F0@07!R:6P@,S`L(#(P,3(L('1H M92!#;VUP86YY(&]W960@82!$:7)E8W1O'!E;G-E2<^/&9O;G0@ M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$ M)VUA'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#$R<'0G/E-U8G-E<75E;G0- M"G1O($IU;'D@,S$L(#(P,3(L('1H92!#;VUP86YY(&=R86YT960@-3,P+#`P M,"!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&9O7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!F;W(@9F%I28C,30V.W,@86YN=6%L M(')E<&]R="!O;B!&;W)M(#$P+4LL('=H:6-H(&-O;G1A:6YS('1H92!A=61I M=&5D(&9I;F%N8VEA;`T*7-I65A2<^/&9O;G0@ M2!R97-P;VYS:6)L92!F M;W(@861O<'1I;F<@7-T96T-"F]F(&EN=&5R;F%L M(&%C8V]U;G1I;F<@8V]N=')O;"!A;F0@<')E=F5N=&EN9R!A;F0@9&5T96-T M:6YG(&9R875D+B!4:&4@0V]M<&%N>2=S('-Y&-E<'1I;VYA;"!%<75I<&UE;G0@86YD($EN:R!3=7!P;'D@0V]M<&%N M>2P@26YC+B!7:71H(')E2!F2`S,2P@,C`Q,B!A'0^/'`@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0^ M/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-EF4Z(#$R<'0G/CQB/E!R;W!E2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M65A'0M:6YD96YT.B`U.2XW-7!T)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$R<'0G/D)U:6QD:6YG("T-"C0P M('EE87)S/"]F;VYT/CPO<#X\'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0M2P@87,@=V5L;"!A M2P@;65A M'0^/'`@'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0M2<^/&9O;G0@0T*;V8@=&AE(&QO M;F2!T:&4@86UO=6YT#0IB>2!W:&EC:"!T:&4@8V%R6EN M9R!A;6]U;G0@;W(@9F%I2<^/&9O;G0@2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$R<'0G/CQB/D9A:7(-"G9A;'5E(&]F(&9I;F%N8VEA M;"!I;G-T2<^/&9O;G0@ M6EN9R!A;6]U;G0@87!P6EN9R!V86QU92!O9B!L;VYG M+71E2<^/&9O;G0@2!T:&4@0V]M<&%N>2X@05-#(%1O M<&EC(#@R-2P@)B,Q-#<[1FEN86YC:6%L($EN2!A6QE/3-$ M)W=I9'1H.B`T)3L@9F]N="US:7IE.B`X<'0G/CQF;VYT('-T>6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`T)3L@9F]N="US:7IE.B`X<'0G/CQF;VYT('-T>6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y,B4[(&9O;G0MF4Z(#$R<'0G/B8C,38P.SPO9F]N=#X\+W1D M/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$R<'0G/B8C,3@S.SPO9F]N=#X\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,30N,W!T M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$R<'0G/DQE=F5L)B,Q-C`[ M,2X@3V)S97)V86)L92!I;G!U=',@6QE/3-$ M)V9O;G0M6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0M3L@86YD/"]F;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0M M6QE M/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`X)3L@9F]N="US M:7IE.B`X<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X)3L@ M9F]N="US:7IE.B`X<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`X-"4[(&9O;G0MF4Z(#$R<'0G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M6QE/3-$ M)W!A9&1I;FF4Z(#$R<'0G/B8C,3@S.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,30N,W!T)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$R<'0G/DQE=F5L)B,Q-C`[,3H@;F]N93PO9F]N=#X\+W1D M/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$R<'0G/B8C,3@S.SPO9F]N=#X\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,30N,W!T M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$R<'0G/DQE=F5L)B,Q-C`[ M,CH@;F]N93PO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$R M<'0G/B8C,3@S.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,30N,W!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$R<'0G/DQE=F5L)B,Q-C`[,SH@;F]N93PO9F]N=#X\+W1D/CPO='(^#0H\ M+W1A8FQE/@T*/'`@F4Z(#$R<'0G/D5F M9F5C=&EV90T*3V-T;V)E'!E;G-E'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0MF5D(&ET(&5S=&%B;&ES:&5D('1H92!C=7)R96YT(&UA2X@)B,Q-C`[26X@36%R8V@@;V8@,C`P.2!T:')O M=6=H('1H92!A8W%U:7-I=&EO;B!O9B!A;F]T:&5R(&-O;7!A;GD@=&AE($-O M;7!A;GD@86-Q=6ER960@8V5R=&%I;B!D96)T+B!!2!A;F0@=F%L=65D(&%T(&9A:7(@=F%L=64@870@ M=VAI8V@@=&AE>2!W97)E(')E8V]R9&5D+B!!2!I'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0M6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@2!T:&4@<')O8V5S'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#$R<'0G M/E1H92!#;VUP86YY#0IH87,@:6UP;&5M96YT960@86QL(&YE=R!A8V-O=6YT M:6YG('!R;VYO=6YC96UE;G1S('1H870@87)E(&EN(&5F9F5C="X@)B,Q-C`[ M5&AE2!M871E'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#$R<'0G/E-A;&5S#0IO9B!PF5D('=H96X@*&DI('!E0T*;65T('5P;VX@=&AE('!R M97!A>6UE;G0@;W(@:6YV;VEC:6YG(&%N9"!S:&EP;65N="!O9B!P'0^/'`@F4Z(#$R<'0G M/CQB/D%L;&]W86YC92!F;W(@1&]U8G1F=6P@06-C;W5N=',\+V(^/"]F;VYT M/CPO<#X-"@T*/'`@F4Z(#$R<'0G/E1H M92!#;VUP86YY#0IP'!E'0^/'`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`T*8VAA;F=E M(&EN(&]W;F5R2!B96QI979E2!C:&%N9V4@ M=&AI"!B96YE9FET M2!F;W)W87)D'0^/'`@F4Z(#$R<'0G/CQB/E)EF4Z(#$R<'0G/D5X<&5N9&ET=7)E M6QE M/3-$)V9O;G0MF4Z(#$R<'0G/E1H92!#;VUP86YY#0IH87,@;F\@6QE/3-$)V9O;G0MF4Z M(#$R<'0G/D-E3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S M83!C93%A9#,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P M9C=?-#@V,%\T-60P7V(U9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R&5D($%S&5D(&%S6QE/3-$)W=I9'1H M.B`Q,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W=I9'1H.B`Q.24[('9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXD/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SXD/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^+3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT)SXH,C,L-C8T*3PO=&0^/"]T6QE/3-$)V)O M'0@,2XU<'0@9&]U8FQE.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H="<^+3PO=&0^/"]T M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S83!C93%A9#,- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P9C=?-#@V,%\T M-60P7V(U9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!0;&%N="!A;F0@17%U:7!M96YT($YE=#PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S2!0;&%N="!A;F0@17%U:7!M96YT($YE=#PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2!A;F0@17%U:7!M96YT M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S83!C93%A9#,- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P9C=?-#@V,%\T M-60P7V(U9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'1U'0^-R!Y96%R'0^,34@>65A'0^-#`@>65A2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^-R!Y96%R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U9#!? M8C5F-5\T9&0S83!C93%A9#,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO8V0S,F4P9C=?-#@V,%\T-60P7V(U9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0M86QI9VXZ(&IU'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9#,R M93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S83!C93%A9#,-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P9C=?-#@V,%\T-60P7V(U9C5?-&1D M,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^ M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9#,R M93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S83!C93%A9#,-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P9C=?-#@V,%\T-60P7V(U9C5?-&1D M,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!S96-U2`H=&AE(,*34')O<&5R='G" ME"DN/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^3VX@36%Y(#2!A;F0@0V]R;F5R2!A;F0@0V]R;F5R6UE;G1S M(&]F(&-A2!P87EM96YT2!T:&4@;F5T('!R;V-E961S('1O(')E9'5C92!T:&4@26YD96)T961N97-S M("AI;B!T:&4@979E;G0@=&AE(%!R;W!E2!W:6QL(&)E(')E8V]N=F5Y960@ M=&\@=&AE($-O;7!A;GDI.R!A;F0@*&EI:2D@=&AE($-O;7!A;GD@:&%S('1R M86YS9F5R28C M,30V.W,@8V]M;6]N('-T;V-K(&%S('-E8W5R:71Y(&9O2!E>&-E M2!A M7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^ M1'5E(&]N(&1E;6%N9#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]C9#,R93!F-U\T.#8P7S0U9#!?8C5F-5\T9&0S83!C93%A9#,-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V0S,F4P9C=?-#@V,%\T-60P7V(U M9C5?-&1D,V$P8V4Q860S+U=O'0O:'1M;#L@8VAA2!-96UB97(I/&)R M/CPO2!- M96UB97(\+W1D/@T*("`@("`@("`\=&0@8VQA'0^0V]M;6]N(%-T;V-K($ES7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL M('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC&UL/@T*+2TM+2TM/5].97AT4&%R=%]C9#,R93!F-U\T.#8P7S0U 89#!?8C5F-5\T9&0S83!C93%A9#,M+0T* ` end XML 15 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMON STOCK TRANSACTIONS (Details) (Narrative)
3 Months Ended
Jul. 31, 2012
Common Stock Transactions Details Narrative  
Restricted Common Stock Issued, Shares 100,000,000
XML 16 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
DEBT (Details) (Narrative) (USD $)
3 Months Ended 12 Months Ended
Jul. 31, 2012
Apr. 30, 2012
Debt Details Narrative    
Notes Payable Current $ 310,000  
Interest Rate On Notes Payable Current 10.00%  
Notes Payable 20,000  
Interest Rate On Notes Payable 8.00%  
Repayment Of Debt 132,000 500,000
Gain On Repayment Of Debt 71,742 370,619
Obligation Towards Licensing Fees $ 400,000  
XML 17 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
PREFERRED STOCK (Details) (Narrative) (USD $)
3 Months Ended 12 Months Ended
Jul. 31, 2012
Apr. 30, 2011
Apr. 30, 2012
Mar. 01, 2011
Preferred Stock Details Narrative        
Preferred Stock Voting Rights 50000      
Preferred Stock Issued, Shares       3,500
Preferred Stock Issued, Per Share       $ 22.86
Preferred Stock Issued, Amount $ 580,000   $ 580,000 $ 80,000
Original Valuation Of Preferred Stock Per Share Based On Prior Issuance       $ 50
Loss On Conversion Of Debt   $ 95,000    
Average Closing Bid Price   $ 0.03    
Preferred Stock Outstanding, Shares   3,500    
Preferred Stock Convertible Into Common Stock As Per Preferred Stock Provisions   2,666,667    
XML 18 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
LEGAL PROCEEDINGS (Details) (Narrative) (USD $)
1 Months Ended 12 Months Ended
May 31, 2012
Jul. 31, 2011
Apr. 30, 2012
Legal Proceedings Details Narrative      
Suit Filed Date     July 2011
Plaintiff Name     Cornerstone Bank
Amount Due $ 2,000,000 $ 1,600,000  
Forclose     The bank also sought to foreclose its mortgage on the property securing the Note, which is located in Cherry Hill, New Jersey (the “Property”).
Settlement Agreement Terms     On May 7, 2012, the Company and Cornerstone entered into a comprehensive settlement agreement that resolves all matters related to Cornerstone’s claims (the “Settlement”). Since that time, the Company and Cornerstone have proceeded to carry out the terms of the Settlement Agreement as follows: (i) the parties stipulated to judgment in the amount of the Indebtedness, with a stay of execution for 2 years pending the Company satisfying the Indebtedness in any of several ways, including direct payments of cash and discounts of up to 30% for early payments, or a combination thereof; (ii) the Company has conveyed the Property to Cornerstone, which will sell the Property and apply the net proceeds to reduce the Indebtedness (in the event the Property is not sold and the Indebtedness satisfied as otherwise described herein, the Property will be reconveyed to the Company); and (iii) the Company has transferred 14,605,614 shares of the Company’s common stock as security for payment of the Indebtedness (the “Stock Collateral”), which can be liquidated by Cornerstone from time to time in accordance with an SEC Rule 10b5-1 plan, with the proceeds being applied to reduce the Indebtedness. Any excess Stock Collateral will be returned to the Company upon payment of the Indebtedness in full. When the property is sold and any and all remaining payments, if any, are made by Nuvilex directly or through liquidation of the transferred stock collateral sold over time, the proceeds will be used to eliminate the Indebtedness, which, together with the Stock Collateral will remain on the Company’s financial statements in the then outstanding amount/value until fully satisfied. The building is listed as a Company asset under “Settlement Obligation Asset” and the indebtedness is listed as a Company liability as “Settlement Obligation Liabilities.” All assets and amounts due under the settlement, including the building, principal, interest and any and all applicable fees are therefore fully reported herein.
XML 19 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
GOING CONCERN AND MANAGEMENT'S PLANS
3 Months Ended
Jul. 31, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN AND MANAGEMENT'S PLANS

 NOTE 2 - Going Concern and Management’s Plans

The Company's financial statements are prepared using accounting principles generally accepted in the United States of America (GAAP) applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenue sufficient to cover its operating costs and allow it to continue as a going concern. In addition, as of July 31, 2012, the Company had an accumulated deficit of $40,358,522, had incurred a net loss for the period ended July 31, 2012 of $510,517 and had negative working capital of $2,821,368. Funding has been provided by the Company’s CEO, Dr. Robert Ryan as well as old and new investors committed to make it possible to maintain, expand, and ensure the advancement of Nuvilex and help the Company see its vision through to providing a pancreatic cancer treatment in the future. Lastly, although the Company’s current business plan includes funding requirements beyond the anticipated cash flows from operations, we continue to acquire such funds as the Company moves forward toward its pancreatic cancer treatment and the numerous other opportunities being advanced at this point. Therefore, doubt exists as to the Company's ability to continue as a going concern. All of us at Nuvilex are nonetheless actively undertaking the necessary steps and are committed to working with the myriad of personnel and interested investors to ensure our success.

Strategy

The Company has been in existence for more than a decade. During this time products were brought into the Company with the intention to work toward seeing them become household names and products. Several have become well used, but the challenge with all products is to make them well recognized, useful, important, and valuable enough that everyday consumers use them consistently. As a result, the overall Company structure of Nuvilex has changed in many ways over the years. On a daily basis, the Company receives different inquiries for our products, indicating they still retain value. From those humble beginnings we are now pushing to move this Company forward into a modern one with clarity and vision.

Thus, since June 2011, we have been working with the Chief Executives of Austrianova Singapore Private Limited (“Austrianova Singapore” or ASPL), previously assets of SG Austria Private Limited or “SG Austria,” across a wide swath of areas. Much of the effort has been on establishing plans for our future. Therefore, and in conjunction with maintenance of the company, funding has been provided to ASPL and its personnel in order to ensure ASPL’s functionality and maintain its ability to accomplish numerous goals over the year. This first vision has been noted as one of the most valuable advances for this company, enabling the creation of a biotechnology/life technology company. Unlike most companies of this type and entirely due to the Company’s extensive array of products already in-house, Nuvilex exists as a Biotech Company with a broad company base, much like that of larger biotechnology or pharmaceutical companies after years of advances and purchasing of products from the outside. Thus, with an overall goal of long-term growth, the Company is poised to be thrust into a very different position, particularly as a result of the stabilizing of its financial condition that has been occurring over the past year.

Management believes its vision to become an important industry-leading Biotechnology company, with a multi-part strategy like those of larger pharmaceutical companies will strengthen the Company’s position in both the short and long term.  Notwithstanding and as the financial experts accurately point out, Nuvilex may seek to raise capital to fund growth opportunities and provide for its working capital needs as the vision of the company is executed.  The Company’s efforts to achieve financial stability and enable carrying out the strategy of the company include several primary components:

1. Continued elimination of prior operation-associated debt from the Parent Company and all subsidiaries;

2. Advance and develop the biotechnology through ongoing research;

3. Acquisition of new contracts utilizing the biotechnology;

4. Expand and Market products and their uses

XML 20 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
RELATED PARTY TRANSACTIONS (Details) (Narrative) (USD $)
3 Months Ended 12 Months Ended
Jul. 31, 2012
Apr. 30, 2012
Loan Outstanding Current $ 202,769 $ 185,862
Shareholder
   
Loan Outstanding 360,258 337,408
Interest 6.00% 6.00%
Loan Duration Due on demand  
Director and Shareholder
   
Loan Outstanding 22,700 22,700
Interest 8.00% 8.00%
Loan Duration Due on Demand  
Dr. Robert Ryan
   
Loan Outstanding Current $ 202,769 $ 0
Interest 8.00%  
XML 21 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Balance Sheet (USD $)
Jul. 31, 2012
Apr. 30, 2012
Current Assets    
Cash $ 24,342 $ 15,723
Accounts receivable - net    2,581
Inventory 9,620 6,846
Prepaid on acquisition 1,069,980 874,230
Prepaid and other assets 101,716 159,350
Total Current Assets 1,205,658 1,058,730
Settlement Obligation Asset 1,028,778 1,028,778
Total Assets 2,234,436 2,087,508
Current Liabilities    
Accounts payable 424,181 730,068
Accrued expenses 41,103 407,463
Accrued interest, related party 20,702 11,461
Due to related parties 382,958 360,108
Due to an officer 202,769 185,862
Settlement Obligation Liabilities 2,225,313   
Loans payable 730,000 2,092,396
Total Current Liabilities 4,027,026 3,787,358
Long-term Liabilities    
Long-term debt, related party      
Total Liabilities 4,027,026 3,787,358
Commitments and Contingencies    
Preferred stock, authorized 10,000,000 shares, $0.0001 par value, 8,500 and 8,500 shares issued and outstanding, respectively 580,000 580,000
Stockholders' Equity (Deficit)    
Common Stock, authorized 1,490,000,000 shares, $0.0001 par value, 423,420,851 and 416,293,195 shares issued and outstanding, respectively 42,345 41,631
Additional paid in capital 37,943,587 37,526,524
Accumulated deficit (40,358,522) (39,848,005)
Total Stockholders' Equity (Deficit) (2,372,590) (2,279,850)
Total Liabilities and Stockholders' Equity (Deficit) $ 2,234,436 $ 2,087,508
XML 22 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Cash Flows (USD $)
3 Months Ended
Jul. 31, 2012
Jul. 31, 2011
Net Income Loss    
Net loss $ (510,517) $ (686,020)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock issued for services 319,181 536,213
Gain on Forgiveness of Debt 71,742   
Depreciation and amortization    8,523
Net amortization of discount/premium (5,695) (2,699)
Change in assets and liabilities:    
(Increase) decrease in accounts receivable 2,581 (6,291)
(Increase) decrease in inventory (2,774) 11,089
(Increase) decrease in prepaid expenses 88,821 (3,355)
Increase in accounts payable (124,935) (13,207)
Increase in accrued interest, related party 9,241   
Increase in accrued expenses 66,967 36,120
Net cash used in operating activities (85,388) (119,627)
Cash flows from investing activities:    
Payments towards acquisition (195,750) (320,000)
Net cash used in investing activities (195,750) (320,000)
Cash flows from financing activities:    
Proceeds from the sale of common stock    473,000
Proceeds from notes payable 250,000   
Proceeds from borrowings, related party 39,757 1,500
Repayment of debt, related party    (9,000)
Net cash provided by financing activities 289,757 465,500
Net increase (decrease) in cash 8,619 25,873
Cash at beginning of period 15,723 57,201
Cash at end of period 24,342 83,074
Supplementary non-cash disclosures:    
Cash paid for interest      
Franchise and income taxes      
Common stock issued for debt $ 98,596   
ZIP 23 0001262463-12-000355-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001262463-12-000355-xbrl.zip M4$L#!!0````(`(N#,T&"/+^K,6X``$/1`@`1`!P`;G9L>"TR,#$R,#1*TT0]3'Q/AXH1_*!A#R;.-@;?#SX]M`Z?3B_OCZ0 M_O[I/_]#@G\?_JO5DJXPH%1!Z(GVWW)!= M(;^?W7^!/Z/^CZ7.4<>66JT"G7U'GD/HM_OK>6?#(!@?M]O/S\]''IE8SX3^ MZ1_9I%AW#R2D-IKWY4W^H#[P@K@+KO?.$:&# MMBK+2OOWKU\>["$:62WL^8'EV>@@;N5B[\^T=HIIFFU^-WYTY4E&/*;1:;/; M3Y:_Z)D!S'A^!0G<=8)Y`_%AK1W=3#R*4Q_5HT=Q_*B#EI[SD7TT(),VW&@S MY;1DI=51XLH&_Y3_SAV8T4 M,'"'$A?YJ6WXG91&'O&\<)2.RPEH.YB.41L>:L%3B&)[WBZ_4;(!8&"7T]'Q M.RGH;KY_^7W>P`LGV,7H!3QOU([]YR#V#69/QSZWVGO4E[@I'@^Y@IC+M>(& M1R^^FE22**[;5)( M?SQ`)\B_O(.@B2A%SD-`[#^_HM$3HF\FP$7D0H,1$CB?WW(`S,O8Q38.(JR2 M@^')**NIX^``!&:Y=Q9V MKKUS:XP#RWU7NL^4P3NQ`\'^;TCP3Q1<^WZ(G'=A!VQ-Z#A3`._$".Y18&$/ M.9<6];`W\-^%]N/'TIG_434_2]3E9**^@\ED(E&7*R;JHIR;3=13)D3J/M5Z MVU2K_MQ.W:3)+*VA[,WD[3/RUUXS4??9^79FY[L5.O;FLV7FLP4A93_1VZ:) MWI;'DPP[VL\5WWRNN+/&L\M3S*V5\DIN/H%=O=K2D6SCKV-[#.*M**FO5W\:+5+2RGC7L$_>#JX5_"/ MENJMYOOC,$"4"67,V/@QE'U'"8@GF-ZY(+E3SYFS=S9]G([1REITF@Q^?`N( MI_U["]A&"WBU('\54@\'(44@IBO\PG[[06H*2AG!>C&\DTBPMX.MMH/7B`=Z M2U7^.`W]@&*+G8[T@+V!-284W07H2_"C+`,"%B=TT6T_2@6_HF!(G&MO@OQ@ MD2"*5Q%B!S,)B6*>B-[64I@67_W5TSYZ;%GTV/*UH@Q3N@V&B'ZU["'V$)V* M$G^'!I4GC+U9%36KLQ"[[$#"Z]&8D@E?"WB/$6J]&/:F5-:4WK'Y[$TFTV1Z M@LFPX^/^8.^1V9F7BZSS1S"=*^P!4V`.22-)9_:MC:57Q5C$L_\V6L^7-NWX M,8SD'KD@-><.)#Y]I);G6S8KVO//IN*=I`6ME\8[68W9F\,NF,.K+=)>8(KL M@-#W:P))";R3*+!7^S:I_?7*,(<8]2]?D!T&>`)95!_;Z!W;0(8XWDD*VYDJ[L9B15K5]]ZB=L"B=JI&?)_(OFTBN[NQ:&\Y6V0Y M.Q5S]DGSMB;-6QZ-%OM8.@!LQ\[,2>X%Z0B2?UO3_,+0H\M>2F`F!/U29!N"[6T/'P1-0 MXZIL6=L;]B%9]G'GU6!90@;+&--Z%8A>((^,L)='-E\NRW33.H[O)Z100*!W MB-I@XCE:&\.OQ77F('Q\R=WF'@VP'\!$,6`[&:29?=ZS+^IF?0_WYMOWZR^7 MOQ]*US?G1Q_:Z_I;I7<.K%#+O?8<]/(930L3%"/"VMY$U=NJ`?R&7/>S1YZ]![!2XB&'GZ-#BUL>$0U@ M36^K9+\3-_0@O$^OL(NH7Y'<4B\IYAW)X1Z-"0VP-WC@7VRO2"V]LU6B',PY M2'M`:'&/>AA9+K23YMU+;&9J>5,10J+K-#^(-![9[Q5<*\[KKTL^L-+3>G+, MP,H18[^GD9OWE*+*Q8%/T7AV&P8L?NFK'U.2>IB1TG4$MQC9?0;#\X1H$_"CG!0*64`CD98APFJ%V/K3% MKDITSX69U;W:[735[.Y/;9N`$_GWR$9X8CVYZ`8%5=E1M9ZR()?:=1WZ:?R^ M^/C8P^['@X"&X@?EYR7.W@3,"]RE!EMZKZLOV!)[K$`M5VFFKLK%J)V%/LPO M??_4AMFEST_8O`NI/;1\=$>QC4Y=E]@6NSR+7:>^CP+_CJ*QA9W+ES',<=D& M.#Y;C>Y5%5'/`#\28&\`VMMQGZLR1=9-L_>Z[&<].^NT>E0R.YK`30%2S:$K M(&S%4/1:Z)J1DJSU#-'F:Y/,9UV5-5WKE2+Y"W)A`*1B@+S`^8*M)^Q"'$9UO;XK&UV]DX"13J`N MDGR!*(I<$8@H.`B8C0M)4;KZ>E5E46P>;+Y'R8:L-@+V(D2/1'BQ7U^0'5U6 MQ(BRGD)M++ERZO144ZN.95;(X-]2/JT:$M>!O^H:6D_KZ>H2IDQ*C6$K8%>J MH9MOABVSK&9+<>?6T&?AENM`YHE!K0"8-Q$M1Z%`'J!J'46(_VOZ7X;QA5A> M0UF!*IMJQQ12D92^JY//E0!+2F2Y'/7&1KB.`;F_&`T+2+ZYD1\\5%;U,L13 M@G6EB4">E5>A4V591^!X$RHL3ZZ6TE;6_!;+C]\M-T25DU5%[PAYV'*W%^KW[4+M.<-4/I;@Y,]F>R,H%UNXJF:]JK""KE M:RO9#@=!H*>;G_)XKC0H%E7,*RE0:II,#4,:V4@:=C_RPHJ M.:PV#::.H)9'N@U:5&D/7!GR-JC%LN!6![RFPX/X:8#LX<903743@4HMC63# MPVX)).6'8"&K/_680:`E;^A4198'<4]1',#QVAW.(T#(:$XK^0 MDZ7'!T2!R&6R@Q6]KJG[4.3H7^)%8@:01F!S1]@ZV%&\VIBDP9=SX$8`:D.M M+]W7@1IO6,N%TVD$SIU%V1HHFS/Q^?<=HKQQ?84+U<7+T.4C5B.Z#OPZ2(TR M4L(<-L[(2D%9H5!1(!QTS96`D$&K/JRE\>"58.6Z?8$Z/T6']$8QTQ>FLKRI M')IB`F*YO!I5'6X43;$O!10>=;+4F0NW@OM6<]$"-)N#N9H@;1`FJV'Q[]$$ M>>%*G61&P6UF<:,N+DHO$:A`7SP;0BE2M&,:XAO<'`"S.X5+C8MS'O=1/"=^<-N?W:W(:=X+E%P:I7G3=",16X7^EXG_3(GOWU'2QQLP8:'SDG3+ MLMR5Q36/#+H/R'79X\]6B?R)6WC\K5VR"_9YB]D0/6DNL'JS2!J%JBE@> M61P7$R+R?;X6=86:<79-5;L=,8M+DJ@"H:Q`--/4NL4A_(P\1"V7%2`Y(^SQ M?5RL(J)!RU'9*W31=;))-H"PM!'INMPQ*R.\';,-APM+:\:4NEI7$1QNA4@E M%&4EHVNZ+H:?XBBN/9N,T!>(5DU(HZ5U>D9/3P&RH%,12EF1M'1-U<4P&\F^]RQ?V<(C](=N3=-N_0$^-#%"&8HC[<')I-@*R@/3R-\\$"#+9 MH,&0TTHNJ"Y1J`"@`39YZ523$:*KR_IR:=9:M\PC7M8+.FQF69`X9-A-1P-% MUA0A+"4HE"9?/@+T=%GDOCGR#;R*4GJFV1%'CGKH4G13!]WF-%?Z#=`K"*HP MEE)BB5_"Q_/W,\O'=B6_6K>(T&*K"`LTJ00KH\IUMR91_8;P8!@@YW0"@_0` MW81,%[?]E?VV%66X=AG0A,2I*^Z<*`6D<2ZR9;[NQ8!NJ&97%[>EUN(BWA=% MD@E3DU.-GBH6E6<3K`^O],"1-FH6QA<;.7+8IGUX@F_M;$)L'<5,['I*IU0= M3^DY;$=7Q:KS8G@NT)A"+_P>F[J-V!$'?]414FX=QS$`[,&2'!(BL#P+E#T_[6W M>I1`(X$K<:9!$:I-(2V?_*IFXU#C\P>6*]\K3_\,HYN%4:!7&USIQ29%[IF- M@4ON2V]DH;?74S,5G"39!,0*XZA8B5L?XM)VS$9L4%&[9B<3Y1+51F"6%J72 M466C:91+.UF;>?UBZGDXE\@V!;7TVHBN)`]7*0\5YG_L')T[2MC!<<[9]!LD M/]?>?*GQU`[PI#'9MGI:I]=+S#X+4F\6=WGC54Q=-9H`#M;-/WY\12BTMA%R M?`8*`LD$DU`\8J4)@K.X2UNVNE056!GW&DU%7U1IWL"7!5Z< M?+/`RX]T2Q*O#EQ4T.*3O,)2WH8F297HEGY)SO?I)EY[9A/-0BE^-:&IES,= MT]",='S+Y.I"*U]3L4YR>T`O&L`&[6[-1SV'^LY']BN4Q/T5F2RRE7(_,B M71&F;66H-XV\K,Q5=H38)J&?@@XIG8*Z:FTD3SFG,I=6DP"KG'3Y>@"5`A($ M`29J/U\;8+X3=61Q9:82P/AU/=M`N*%1)H]$C7*`F^]??A>+=^=PXUH`XZC8B%;6KS(12B&8S*!LH'Q'S MLAL2H";7JE1M>;-7.JTZF!HI%&)OQQZM%T9H@[Z?2Z4!7@H=+UWD#(6UF[H, MI6-H*V_ULLZ8+GKD=55,*9MC&L.4N].]^!:9?$R+T'@14G@@RIVB=M7>BM:0 MJMIA2QOR\O[AMI2!ET/6/%]-#=Q= M^17XXAK?B+K2:K*6S_@IBN=5F*D>!KN0!*\<_/1FO#4P-75 M#7UK>*LS2G5ELUL@.+RAE@H/35VC2)C+YH0O,2U%0G;<\&Q1);JSP4$(#$O6 M=';\8B$D2=@+AF_CPP:BD^U'K'AH,[$X.O^_"/U-8*WNP0;,9UF!T%LAKS+# M,3JRVJLD[:09S=^HWO;%->6-&[<9KW&6!I7%S;7'/M.))VAIB7SSOJIGL).- M:K6(_2DX)]X$4;9+//HM8$O;?D#Y5_/$WI5-\B2KR56>)B)]X4<`?-H/VLOGWV$MUR^9DOO(R!E;N[A'TI]A&8 M/7-+E/U\^LD-3L:2'TQ=]/&@#XV.)44>!](C'H&MWZ!GZ9Z,+.\PNG`HL4.Q M^B?2R*(#[!U+YI$)#\N2?/#3(#AAG;$^Q/Y:/OX+0:?J.)@_\\1^N;E]O)04 MZ2=K-#[YFZ+))]+9Z?GGG^]OO]U<'/[T-Z5S\*>/@Q.)";1EN7@`-_X5 M^@'N3PNS_3C$/@?DAR/H?"J1OF1%1;AL_7M,V+?<`5&?4.DFG&`7O1Q*X/-' MDN4YTD/XY&,'6[Q<'?O2.#()Y$@!D2S?QWX@`<[08VH/H(`5WRAY$8X9";`&9D8W'+K1A MR(?6!$E/"/&%`X83R+"6X[&+9T``.(,Z9N7=-%ID`.&P2R)F*17OSNA_;O:_ M@`P(G7)P,S9G2MI!JYYSM<#^N&!(>K:803.K!!/QI8M__"+QEZN>%>58D84? M2A9`GEB.!0JG8Q+9P*$$=G!K!P3"L:3V#B7%-/5#R1Y:WH#9&0XB?_+8UZ[! M*F%<),Z#U4?!],@FHYGS](GKDN?8&^+N%.B(E6""W2XJ:4$9/[OD">R+O0&% M8,HL3'J8@LF._%EW(G.\+9W9\.U?Q$,2(R\Q''/J5(K&%BDJBA19,CF&3J+3 M63#LZB>^A"P*CC+"_)P7\(ZHEDH:H6!(G,BYX*(3VH$/_',4R&.#@.1S*3"& M1ORX'.8\-`2!\483-(!4\8DYZ#.AKO,,W1Y)MYYTA9YHR$)3ER.#GX)Q2I1_ M#QP!PU+T`77I&0=#_L@#`G'QB*N='GU<,6%R4'$ ML!WL2!Z!Z,C&W1@Y2"8!8AQ25DT:\&CJ020%9L`.(E3P=!^QZ=Z1]!OC&`0' M`A]:7"?_0C83KX-&C#NF;\9AI)<("),9=N,-A*+V?-(/GMGI<,"(_6<4.R-] M)B4?23*2'3^T!@VFO(/8`J7/'G#1N@TA`"![Z!&7##!S^R^!8&[@X M0#/;!(%^M:9A]@>9M+ASFZ!)*`- MV_K*6L7\<`SLNZ:@6)[HV(>@%*\5D!?V:Q\\1GIBZ[J2#P-=$!6DI&!F))AD MT(OM0GC@"';-#"I]"B*N,ZB-D:5./120_Y''S\2L/3[._6N?7',^# M;8%W4F2-I/^-__=T[^3\6G0(RQC8;>*!)"X0#3/&7UJSQ6O^=JXJC M)M(3Y6&(S)P2.L,LH>^SGMUH/`#+!J86?IT,.#`41D:0'FQF^XUAR&2Z%=1Y M!/>E&S+AF2V[HB?MBXWK0/0<>S"NP^`>)5]Q9'X>0@B=MLBS-U,/ST/`*C@G M7MBW[(`%'::N&6<65R[+46R*Q]SN70RF"IX8!G0VOX:^(`>(@JR#?!A^HFP& M>!^1(/*=(;+<8#B5!FYH$Q\Q[['`U;$/X9W'OY!>@G/:P7P@`5)5-R_:8.R,K8'SQJ/K5HN`YBGR8(GF(+FPKF\,OCN*C MS23*MN-'J>`:5'$.$$,#MLXAM+F06GC29R!-64;85:0+B`^Q>$0S/__<500C MYR;RC]#E\<"`QUMGA/@+L:X3Z&R$9_;#,2VL6QB:N*8)#3B7>#0*048^'U8Y MV4A`0!?&>&Z#-M":(7Y"-AO>U]-?&(P$ONE@,K%\.W0M*M@/IS(?W("0F=3" M_[?W[5UM8TN^7T7KW/0]82W9;1M,()D[:SE`^F1.$AA(^LS\-4NV9=")+?E( M,L3SZ6\]]T.6C0%CH#LS=VX'L*7:>U?5KN>O2*[P%[+O\$RR1V]E"%TD?@,W ME$X,[H684=&GF5@62S8$\+"VSR2Q_1X#0#WD<#\%]"_X& M5&)PSZ/`<.ARWUU9A<9VSZ`V5J MP/E>3V8DYX`DYQ`-2/`/2O4-IEBF5BSU`!P\A@V[UHOH^*C:X,`WYH8;,UVM M;#ZC_5;%>>X$C>"W#'<>UC4`LYKOS"B-+HEZ]S8Z&T=I4?$PUG`J.AMV*KYZ M/FF=2\=*-E=_$!B-F:O>Q:SQ1<6=_`;\#3_149+%UYL`O8,H>/U;KW>VPQ[H M@`H;T>H++C-A8=Q((H)M'CK!R71,CR$M`4I%S3ETXGDF,^X\7W+F+V.G`56( M2D%5TE@P,#AC_$Q?IKW[(G(%O`XW&5$Q!RF."S38D^(*_2AX=LK$%O"8`3TF M%S#68H:3*Y.83=D!R"D;I`:+!'Y7"+41>D;P5_XD[BP\@&PX;RN:HC""2$+C M(7X(WDG7Q6X;I;/=\37J541T1G;B%B@1GN\%7WRUUPIWNP=AMP-?PX\F/.5O MB(8#K':,6$RH2DG,*<B#3 MV/##G?"@TPYW]P^:P8<9QTEPMRE"87RL_MSSRZT8L1X_.0V#X[P)X@`&51F< MSW&MX`_%XS'MS7A(M*0@,0FU\&4Y!E#`$2I+U=;?8]QZN"**1%AP$B4IAO!# M,&_AM4,V<<2E0W(BCOB29$OT0'0F+ST>3_U[+8[I\*\3(A"W03<&[R_BL!MT*,N,_D-^VXJ]B(2R=`9Z))O!,9.EF9%I M@]%B=7_[,6TL'Q9P`MH]&+(#H>*;,(_AU>#2#+-9'V3[1T(2:>P.JQY9?!IHBY@S#%CFJ')`IX`T\@TA<.G:BR^B[!D;`Z(*_HWF$=JWH!\(M M=YA6Q?'I)JP`8@G M-M80,'Z+=21\";0;^.L+PAU`" M"_%H!AY#,D%1!,W!FO,Z&L_H>H]3UGM7((I(TGP843]'@9)<(#7\<#=`#4*% M@@8!,S"9%RQS]I'E!3Z!'S>,H+\@[A,.+ MT(#N@QU=5`-N"+4#NSI,,`#%^AA5FZ8)4(9,Q$B$;@@F32E'A20FM%]XK=!^ M`).@%0I_17?Z:C;!_>G'P*"4,T9URCKC!MR?XDH#%D`XS>";<`^!L?0?Z'UB>I/N#I.=8(.OJN!H MGGA@!HJS&6DG8@1F)$9PEB?7H$."3\F$S$['U:[]@O6]`SC)WL79IYT0+5Y" M6)!HD%B6\,Z+W_2U"R^";]M7V<^%S@NB`<++HQ,-QDU0W$2P.C1NI&7S& M:U)\JG@T0C_=:)Z,]\68GV1\HR-A^$]-`^=:HS`OI7O^.4L'I$UH0\F^B='@ MCVU^A]@I-.;`HBDFD6W<(1-`MK<-O"?+*1YL;A;\I&N(C(2(:*SEVE>&=K#<.=^!LB`KG63X0=5( MD3;=L96;%'8G8(/Z8[V6V1@1/R/H)_!@";O.?QTG(S%YS._T*4UP?L;)=WDK M_S)A[N6[83Z-Q;@LP5("]3.3&QJ M+@'D"Z(+?+$&O&427.;937D55FWB@$V_PH1/P`R?%:5J3KR.'`6O(:.00AT) M1;+0M[5WD3(4BB2F%60!R,K&FY9M2-E?XSVT,CU`TYR^IM?1%.QZ9NNGTM`V M9@%$CI,8=:WKNF1B69,-@7Z$7O6PCT/4>//&..9LT'N/18Q<";>!.UHF#8HC MF?B\,%K&'KEPFL]85HCXHL!K%;X/5@OL7[I,;IP`8-#/Y$XIKE#%4K@@0S$' MWFG:`$_P)2N15)/$)TN<)"QG-V,9!SK0!.(O(#T9`+ M\BA!Z`%QAN$7J'6%;WT_1@TY5,$FJ57UIE-L$I6+BNB3P_)U._)_3!=H/&P& M=J'+DIYT`Q6LCJ^0$?P@D6AK5E[#:F)YRV#R0(%^[B5$\'J`K6".;2\!;U';IAK]TDY3HWFN" M#3LE1J#XL)\94(\=Z$UR](:*6CKK*5X(5=<$X%<%R!<*ON%JH)1H6O9,P/=, MBI"V%%;?=6O2'(("2U&@)&TC9+!&!.-;&LV&Y`^8'$9@DQB/2N0^U_\AJ:OC M&FQ>@TK"_9L9@M>J2W/*R$Q:(*$`,YC_I$[H?E^[,NV6'`'1X;APF#'P2@+H M3L0(5S)Q[J>$2N18:XN-:B`MVT?@OQTKXQU4RIJ!%$;N;!![8.!Z4I.XETY#':NU%0SP0_B!G M-B+TUF0GLFF2BDZ;&%LL=.*"([F`1E&2:_FA5ZO'YFFA/^KN,9D4,7EW%]\2#E7"PG+AZH ML[=@MLW&0\Y_4LI"C6S?R5UB"49I.J/3H#PX?%B/_N]A8--,.*J'H]]"42TE ME%K()!N5QV4F/D=V&7/M`])1GP1$!3RSQ5@]<(KG%'?2;,L(/@!O0U\@X'1+ M#W9T'.RV.-_B\*!ORNG>"1>8,"75:5WE,?JB*9BU05T2AT-.I>$V#(AI*.LZ MKC*8H74&[.,0_!C.RUK*S7%>1K.:7N'(KHY17OR*"TBT9#(%M>PW\-W06>'_[7X`?WJ.UK#[L[R3ZBJ`\-G M*F2P"%EH10\&J!3'\XJ39ASPT-6-3I66&EY. M?LLO"#:L;LOQ1)^B+\^L(77@C\S\OK5Q9I4L55(Z-17/P]2XM6Y MQ_D8<\12%]3H8`DC\!EP"@)5P=,+]X]>U9#S!WW9R0^\0RD\2K0@8-O4Y#L_ MIM^#"RS3FRM+RJ90(:QPI5HW8*V4%%!";>_NEB\71>#N^Y0GJG(XI-"(!J%# MSJU+BP=)?C`'[6*MD)+*(""@HX:UPO18<<(UCXPT9M%?)Y=5XK@6O%)I)3`]887AM M:"*243FC1!F]UK&4@"0N-:>P,;Z!S$35(- M`KHRNQ$3!#872[+PM+ED$\.`!1F**.#6(INC0W`M#$W<+B-WH3J,[OO9[RJ1ZZ_IF;<43 M74:25"1:(F*=4SK4*A7](AFR9-9B?+5D1YD-Y@$YW9P?4W,`\S1FN[9L]Z+U M+ND'8RD]/7-Z=,76@G.<'SX&EF6*!L?HG,QR<4_1)F-D:CP6+J@!EJ"2AQPS M/M&`64.+K\>1F(C^ZR0WA+4YE;=H_(AF^.2%=5ZE(H"^?86Y-W(M[/$O*J,`V=8U\5:<-&T.X^+3F-8*_U:!0LU8K6N_TMRX:4&L=C MXO)8I)=:3>+&F%K;,%R57F+4:TNW>O>V:]VIMP-5:1H,T?06P]_XAV#P#F*K M3R@63F5U)HP]Y)8^RDQC+;O>L-JI$V%)T9UVB>OOD=`/O8OW`14&8.D=Z,#: M)^D7Y=54588-:GW42*EH"T M5A=`='!N)"AB#,'19\,@&=ED1@@W0U3(Y1<[WU[LPHC'W."+\4!>E\0O34P_ MDB"Z6DUQ.M2"'&O>/'I\>B67&U%%J"K;GH*E2WR0S"K/3!Y-2$ZCH-=*O3I. M"RMP8CJ^L%"`W4:K]8D.R\%OP$P&GYCKNC[AHS_1HWOT:&8-[ZEBSXA13V;4 M(D4HF@.LM<=Z0U<[+$@JYY:ND_A&`E0.=2@T6++"4L-&69(/9A-IEG:K?Z5H MCLI>I#9&#'-R%5)^'^W`P^CKC'0W=:*K$U M'&,J[G@?8TY">LHNT]5S.7EU3?0N)AM^8@5WVYKX*/#^B/4N,4[UXGT1"6\Q MCPE!S(?Q4(IT'??*"1XLW=^<7D-4T*M"CB)1D`%[<4$-NW583Z^4>+PYRLEQ M,J9XAT*8!:\_946QHZF:@!"4GH&6LA0/A>)8*48R"62")1+V/1H/I`7.NBD+ ML9R41JZS=TZX%`I4X4#D.WZSY*TPM(!Q'>5X+Q]/I('`,C]R_`#^5!#@Q0T6 M\J9H'0P8J(KT$&>526,YOP7[`;QOB_OQ#.ZQ#YX@N048)M#Z#-@$@\JJ^BM( M/Y6.0L01(.P'3GC7+BBT+=RL'.F<*N':4+I&(K;)S!4Z922_T+$4(QYVX@9^ M;/%R5:MXX45'C3EUXU37RJ70$M*V\8(B=E?"5^D2M4@DV*IJCI]+H%+*-;$\ M(,.*VCQG:)^CTSSGH\/P#D7D>'BL)]VQIC&:G!M,GS3&6%1J MC<7@*@'-"`X<'[]=4J%FI+.FB=TAZ1=+K[AGP-D*KV=U)!>N_X"B6NI<$:C" M7NI22516T]:2W0.YBF-YCR/;+/W28^O&;N,(C)1_@6,"S$%1K=HCTOY.["J( MP%K#9_)%(5(IYYVXBRL(CF-6&&;@4G:YC/!WV'/8C\N;6&KB,_#NG#)FLM:J M9/!;,#H\T,BQ%+E1JHRD+,6?0B`5(^=2Q`2Z<&6JX3MROY#)S ML)L*#(.FEXB=2C]/L25>?A81OTF&Y16"L;5^>1>L+^]]ZF)J#("4:%K$;P/] MUU\L/4A*;G[$JEGZU;#RZKU?:HI;?RV'C_G-P\ZJK](_\\I"]`ED9H"1I'JM MS*9_6?%"V?)&/RO+;`*;N]?T1Q0@\9$JC2F!K0T.GFGZ@"[>>IK'$J MN]B@F"UP/AR"\;%AW\'J@SNM'.,U@J4)HO?A=HPTVB@W<267B$$6[NC4_A*" M0+E)W;QJ\Y:3^I74OO>KAX3O373+`E)*[1X;EY?4HFL,JQ4)7>)+*M7'^U`++;K^WA$WR[5A_7Y;IQ8C":*!(?B_CAR$`G[H!H@H`H$=`9B`L(F+"TD](!+' MD(I"R;]PFT#UUC)K3&C% MS>F:AA#M`I=T[?)J.)<]\)CZ6G'AHZ_$:*U2[.BT#Q2S0%!JQX:RB*+7.%(K308HHDJ)S9&2(9_S:*\9$Z4/B=84XO*HTHO#,O142KA1`Q/ MSA<4$?+)91['G-KN"6H;/I\%6O]&5&`N$'EWS)DP'W20HE-^_(7?;&#ZI`3- MC7LAI&R4-EPT4X-!YU?G:R1.X7NUPMT].5-"H2),,5>$:7)109V'AL*I9"O' M'`B27"7\)V\#;Y*L8SYG)^U%Y"@WL4WN!:R_C_%`&!,LR)!J*'1W&@H+&2TDSP1V6Y9+UH;J:D)UF M5/E8/YF@7J2D.$)<(4P*-;E%!'$4O+Y$="*-J71;O^S8PH,/OY/[;I#R:W)* MLCLWTE9+1`S!;@L9[<*IN%'),;5+IC)I<7?H_C,53R3MYL16/E&N>$/+7I)1]Q[^NEDDQN2JI&S?-D;#JUW6&`0K+F+YA[#`\?T[,^3Q@ M/N"D$0CL$W>*6QBXUPNK@8T%S"C94CQEVZZ7G:I;46:ZT&W;;V'QZP3PZ1BT M%.F`=I>L@/:3*,V/.E\!H>:H;HB2C?4V=+U"VEMFR*L:`CM]A_(6";X1T0O2 MX40[@WJ"GR.3+I8\R?<(@G,GMR5%13QC@3H8J"?PP_D%*WIZJ5=+4ML(`C;0?LXRR/OQ:".$F&KI@7EPBA#!=*B*B"_`4RW`E0L=#;GVC3C\K]J4VI M+$3@+Q8&LQAX95D"3U!4531WG>11O<0@LN4T'J#+PP:#W75*J?%D(\)WP%/' MQ"?[4XU=X$>-EFX6U&[3;\J9F M<,0LRL)Z(2)!R4,'9(\ZQ[DMO!3D*4:6DNH>YX6VR2'RC%BW\]`P?I)R[0[" MK<9Y\5=V^VC2@,,9IM=3"A*SJ9DJX!@)*"&XSH7Q3AJDZ>4)3F?Z6SR^CC&0 M!(<;I46#3IC.CJ(S!G:?(^Y$T97TWO*+J[M19H+#7;<18D$%]1!% M/C+2&Q1UB>B]_R]ET_*_5`BJVRL%VU*DI5DPDCW5D]!347BD5D496;QV6>V<%% MVMO*W;!!X2IM:I7FSG"G(N1)U&"UY!P=`V*GF(';$&.L@N+A>UTV58E(T;3I ME?(3:EWPOJ)CL:C*GC#1T92GB!G%MG0`5VW?WRQ%RYZ==N2;&\05E&V,AU90 MS0RN+"ZDUIBP'8V?((>#GV$&]-=:)5J`++6OG2\+FQ2;8%&EK*AN/1Y&I@5G MI,*:FOC<4[O:/-'AG,W[1\?6N)6RBTCP/ES@.-@YKFWEL1+:+Z.?H,DZVH8H MV4GJ_WB=[!"*[RPBY1%C'Y_@`F.!.A:G2H,L(\B&\`WXRC#&$O2`#; M=^5\RA.[L+V08VZE-@?/M94@2:]!]ZNXTK"W*VE:&BED*:/B M/L:Y`]CZ*&;6$X=M7/TG+9T%<8%+M%>^):`N;JF@=O[H);OS['@SCS$Z=AP-0.59^)L/3Y5G+J3Y9&#CZS8S7::#8V* MH2.$IPX("(=-+PRK*$I](?!6#@%>?'^1"OA(M)0$4`GUE$DABO,[HL4MB%R_ M>=\I?$2"D8L+%R?X>.E^(FB5A+G]CBDK4*B#;X/^6Q'YH]NV0.ZDDAN^0QTP MO[JSQLB.U+I+SY&VB=>NI+H9:"40@*&>T%4LIDY1<9+H>*,;N9X8V#$U>`:: M:8A3,`HH3/:$GJ^3WS>C`=D-1GL9;I32&9.VJI<-320*B^`UEJHM3N)*WH=Y MGO%\*P]PO^%R&1G;_K=9OKQ@SOK4>,U6J76,/,#^.I/3!_M4;0-W>C*93?2I M@G8.UMR5SF!R(YU1R5-"[YQA2%H:A9CK"_Q`VHP+6O/26534Y>U,[OL$)0E()-( MB`1;K#QC9*-T>_*H`P/UO]ONT4.R'_,Z4/%]R5BUQVF,&&@& MH=]I#3"<7K?9H4G8N\Z6P<\WZ05[#R(%8/LDU'#)4WATEE=U%+8S2260'!I&%$^"J[2Z9I@QLA ML;&Q[.Y:FDG!#TZ8GMO"I>BP%< M=[':S?0YW&BI.AGZ."T7,XI)%<8B\=2G^8[-,_'<`@X*%M--'.%[4NF=. M1<+6#HPF:R+`NXD9DY49G"?%]^?C-_'`2`\J$(2@(4Y0@^I^6'K=Y;#IQ.O) M83VF]P"5'#P*83!81`W&?2B!W<*!O3?A0_T:G`]Y4XX?7RQ.9E?H6M94D^B? MF588H;E#E5'&B:-X)8[3\2N[@%=UO@9=N0BJ#-^7:>S#F.[V[;G9YS'8145A MBN&>6)Z/%':`JMP,^BTFONGN]>?%U(*MYV9%8G=S'IOK!PQ@(L\GI-W7VK`D^F>CISDEQ/FW@3HK8>;OL)U,&C*[]S";V(G.SW+N3\T!X1^S46;&D-1MFX8MX0+`Q M=4QR>*@Q/Q?H^-5^N'?X9MD$[77EHP9*PIG]<1^>KPJ.8FD^XH3M9\I3GM`0 M5?M!(_CXY?>3+U]/S__[A4G(:4K\2_2L*-H-":B6#MS,Y*3^XE>'X7ZG1=\` MUCW8VP\=9/3Q7#K2N6(5JXD*YT$H!$:X5/?(WMB1I6N@M@:/@-AJB@#O@-H: MK(?8^DARO4HDJ^*K\)0X@KX$#6"0,U^@.-_SNGL#4OOAXW^='`>]BXL3N.FV M+;AKT_V!DF;BLGO29T(1VL'X=BW:;0.AVS!8;2@4BI9V`KX+[M5;6&T@7-8? MQ5U%=2U2RWN@5KY'^O[_LFHUPU2PZ;'%NVB3U%>]!W+_CBP(" MC:#7^3C=SYS82JO&?7O;^!7P1GC#98[#4Y!_LOQMD%_V7W=:>V%G]R#L=+L[ MJUK@A+VZ^[]XJ*S%TDU\<-MH^Q?_-AW'(SZ&5[>]L]VI?#7'BX:^V]D-]_?W M;GW`LE>OP>E_KG5O@@W_<04>^"K>JR6I'H-W885W/83['GO]MJLAU:ZM_5WK M8>L0\2=8Y+;U796Z=\&R6^%3U+>8RX]SI_BW_Y([X_XJZR[/??"QUVS$_2G_ MN:N;V]5'5>4O08']X33RGT+[QD7Q%J-VLXD47`V=,0A_(L7Q^A83;WT-L?-S MUS:P:UNQC*OD=9K=E4?RH"_?X3SI4114'\=W]F;N^,2-WYWTJLW9)#^W]0'; M>ALLS08B@(?-0T:173]VZ5/[F-')M6GRAO](#8FI-B/43RY?6S%EF-SHU?.- M"0GCE:08.GOA?O?0SS'<,:A^]QTAQ-_U@MAWB]C?)0I?C>`?Q_W'#=;?+9I^ MX":/CT_>?Z7U;B><_BA"M+&2$(ZKUD#CN)EB0H2XCG(LF2#\RNMD.,/!K-+D MIR5VKW;;K;#5:B%TS%C!X0ESR(#N8F:LW?J%8.^QJ6]BD(41&1RK=K":,HT? M;0!*:RGG/\6FONK0A@73\:PP`.NZ5YSDR[@>6S>=\81P;^7SA;>W!]6MQ?DZ M"`T$V_M'VTY_J*H@;6462`G[9:-Y\&JO19O,A?%I,$X&V(**M>>QU"U&SB\M MR!%W+212/Y[:>EMI#BNEV\M@SDM9$I#(8V72^#(KY08B)'F#]_081W'0/.!K M>T5CCIT(L?1&LYC^NK-,MM4`N-Q".X*!G?L.8C=5X4E?FYWWB(V76DBK\RJP M-9W;S+G%&X?5O.HZ1T6[BM>KO+\&.PFAW.RF^D!*MKPEN)2!"J]VW[3"_?;A MT^_^BFKWV_=_`=N-6[WOLL_MW0[I':I]7-QFKM=]T%:_:8=O]I:@Q&[J;EUC MSQ_A1E_GK>OKP[O99$OLJJKY=>'@/IP0X@-65/UYJB<.@T9P=/KY\^F7X.+K MZ='?@Z_GO2\7O:.O'T^_;+^4XF$U4*PUC%)8KK>#SF[8?=,EN=9I0+X:8"PZ M@4SAYA.X]G(SI-6=>H)F"MR(7&++@Y0UD?IEJ#':(7!]>'#0>G27:*4`#%K&*J_*KG()>P:MV M"Z[C;DN!L>S09/$M_IK[[VAV,4?;O_;X<%>!Y30_B-(`5&P42O@$&[+P_T_ MWBETP+)YP;;9FT[8/FC?[UCN,;5\C0.1C&`?LS9+W&NBJ/8TW!V5/6^SDJH< M$=Z.L&&,6.2<%IR0MQ?2I9QFUU%P`61$4\3!."OC9O"I'+)Y\+IW$^C5KPV60#&56FX'MHUQ2#/;KB)UEY;W)`M MP9LOL^MD'/^HZ=E'I!L36"N"US3A$S>!<,F[.TSSRF4Y"@2Y#$'O`MP0CC6` M72)O)Z(9(Z%"ND:*2VVK%QS:"G9]+8Z"`%,4[@!*TR_.6BR]21@'7;O032`P M,>-5Y14\BEP)1I3$5!OZ42J+T7SE&?EXHF9*I\U'C:79-4Y)*DT\3;)7KSK- M;C!)QF,\-X6TL"?E/'T-@7U6&A7S!D5%GXE\ZNS:/+Y,"FVOMN.[+^*!CA#M M\>#:]N'N+J$[$]XJ0AZ\[ M.\P48$KWL,/N2\9O1B!^U-%,9WJ=C:^UT_R1VFC6CNPL]M0(:@X]XOPW-/`K.+`6TCI@0X7AM-$"63/+Y"T+/- MW*Y1'%$I]B.TO]QS?A;O0Z/,IK(7YE=:FT"_-?NSYIP@O]Q!:'-RTRL*[7EB M[=(#D64M'P7D[>I"W>':1VQJ3Q[_?SQF$L-:(:^V0P$#:T4YP6E2?A'T9%T7 MX&+UR8K"DY_\NU'^K2L`O>NM>A(-KK;(5W2!$WK/@MK<(A6LH!,9`35FKXK[ MZN,MDD%(;+HA$7=)#M&`46"Q+=)B;)YQ\B]$PN=`)5!39..9,7>V0PN8LFIO MSZ;&Y!XA@OXVM;#O77.80\RK[5/QM/+"=Q#P*MC@"+LD8K-%$JR`FG@[6OP" M$KPE&CS\,1?);GLT,%@@7GLE4*P.E,ANHIBT1L]R1P^8H=QT$7IZ=\ M.R1HB(A0IN&GBWC(#BC9HFV0(<(X"X!Q)ZN)] MLDVV..,4B7_]V]/9(B5>S@'#YB,TCEYW=[;)H7E$9OHPFA=VU-ZV+V*4SP*C MM,=1&?^\?_YP]T]OFTHWIID@DS@N)=_C#LK:IKIC0OC%[FWX-+9=-6*R7==/ MJJ2NJ6T$=5W\)S9):/I(D$8X3@LS7UNV2!CI&MM'AL@,V`('YZ(YRNW00?V6 M!0^[LQ(2/05'N-;0.YM_WJ:FL':B&B;3)^!.-D0&46IGM8UQ9L,`!R%MTR"H M*>#@0]JZJ&I1E*2G(U)@3Q+!-"S*-&T_C%E>S?#R0,AU;*3"\4Q>B<5VJ"BN MLKPPVL6;FI4TBF6[VG.49Q,IHQE@ST\\E/F'6Q;2BGFQ M?::\28HK`1Q'P_JAKL-35\BV@BUR%85, MV0Y>';`=-LYH#'O$S6&3:&CJI@9NS?M[G9;FX,2[;6B5US*I()&P(VA4F&$; MU$??;35;K5_YVJ49>-I\Z7RP]O:S#C(-K27:I:<-J=8U86NLOR]Y\*K3:1[L M\TNK':6%V]I&PT.`@('U1:5]SI;L2(#\U2&7>HYT1V+.='D%ZO>LIGS$,I>O M]9$7CH=PF4M968/@'S1;N\W`L$)]+DON)NIPP-T#>I.1BB5_T7^V\$I%??+Y MU3U>+F(:\DJX__;9%-WJA/O[^_!_;QRI6#*JR&N>?!&UR%0F:NHZO5)1LU=\ M`#CE@2JOG-,U@H&>3GY&[)E)E`$4H2ITPD?\*;[\'45_MZ M8Z_:%*7(K,'1)_2<19'5X9UFTBM/AAAJF9^68_%Z*X.#>!X4L%PRC$79I66> MC2M+E!G'U0E$+AEV#H8Y%;,(QS+`]V``PBIBEP]Y7'=EF!FU^^+8][V#%I9# M1D0#S3?)9UPH2A^ASEZDDY]"9.CB_7F_,ZU9FXW'TC6D2"E.9'Q!E&]DN MQKWIS6KL8LR&X*)HQ]A,20F9BC#+9)!+0(-H?`D,'JV[=DF-Y,)8#MCR\>>H MQ-+/7CH\RFB:1YQZLSPV5UCI%$VV71R33R>_]3X%9^>G1RJ@/KND&PKG>!_/1_.CW\WRW@16R2TH_,K-0^0/==A(*= M3(CW1\F8JX6/LASGOY4(7/(>4[6OE>W?O'/^IK\\>+=CALU]R&,<[]'HA,'' M=-`,<0P`B`X.)[A)46H'N%,72'-?R\ZYH4%GZE[SM$_W#1]35#_Q M,,7!W_9-7&'3QSV*QD46%#A*CFPT#*C0/'`JF9J`#W>)=HB9V,-@1#6R? M!RZ#@S`\(H%,OT$DS0!'5S%.>OL;4!P2V_P'G$,\K^Z%XAQY5/X&:Y(W@QHG M0F#GDXF=_VMU_362@P8R49)FMEZ_S'#&''W:B.-P]>BRUS)"!56!DQ^*KN)?X"\F])$ ME)L.2TPP%9_*0TKAYAO]M2=S-#V6GJF2=Q/-T0?1]IM@F.0X(\QVVPB<#8V& M2PH9?2Y:>#;%E>VV?I%410XBJ=\,:;RQ!XU#,>,,V/>U3I[W;$4TLN;Q4"(F MHNI\]M`Q,*9(O(C'8_\+9)-.IZ*+4_!]Y9`++JW#0<^+&_/::VKR'H@IB(P` M0X=&[WF*G>B@34^XFYTZ(&Z2`D&1BD&>].'7N'2<4.,]&I?!8YWMXKW^]IUW M]$K8KYH-*_,H+1S_O[T7[K>ZX7Y[[VZ^74`Q`NHHD8`DBR.M1LJVX&3L'%C8AQ+"^"@-4I,3QY^'YV&:,\ MF$-B95J[S;SFNTY/%M$M<6N=0(EHV%_9E>.YJ7@0JB&3>&C&)@;]63)F!Q)' M)M/P'LJYF=N#NAC9L*R[AX)3"[E&'8]6$"P`F,<5WGN(#GV7CG#'M][ZLD]V MWGO3>2?V$$9V*ORB=4P)3O/$L-*`63I;$EH[.'1@]BKL2J(VH)(20I3S>U1Y MW\V825:&#^W+?+9VG`_:]S4+AB;,Y%]X/`B:-W`:@3ZXR?+O$O2]3.4J/`;) M0^BR3TD\JUR'Y&>%@I@Z?E<:HR\!=0U;**C,JV1ZD\!O8@U.LL;W6[!+;E,N9C%V MF::H/L:D4ISAQQ7U&5J+Q3@A5CF&VC3,ZZNJ.#*)4.+XEI1G-@W<$#Y%O'_T.E)*[!_D^B[+E/A_AX*(U)C M!=SA0E]`E)WUB_A?,R#Y!,-$CYSGVH5K]^+;^XN3__QV\N5K<(+3J^^1WGKJ M@>[HZ8"*@`.>\)CUV"MC*"#7+J18`%'RAB MJY%ZEDE,5;3>XY#OT]$9@\<3=X")?@$[1E4::=ECO&\X][,,'(B'9YF?Z#B- MD']+(_"=2O':/QBO\,)XA=NSJO?Y.N4&G0<*/P;%O0!.&T8-`0Q@+_$4PJA&/ZP[B?;DHC>!#9A$+EI MZM]ZO3,O(XR"0D90,G'H35+49JS"\*Z;SG*\(4N]6KD(A:\5_-T'^#1'Z%N- M_V1[%IN;*(J-E)S'EY@GPL==-/ZK:47J'U?)F`(.B#MO-TG0WLB?3I$2C)P. M9CE9"=$0#TTJ8#24H;EM3MQ,DU2T+_!$="G>O`T:48]=E.0ZR\&K.>02)9-; MT-T!%9]D0])&\V"84-/O+-<(<](^XY"M+_SE+!URDJ79137P:1X[0:6`$`ST( M/'HXY<;?-7.%N@J+'MC,$8J64H+;PUM#L=0RJ\;3/YL#=,E`6V96%,J?/;@? MYZ!?0U/0=-M$)X<'W1*I6`2*]T\YP9LG%:R:)25HARR%X.\.D-J$-G<.A6-]H4`;=0I^> M;]U,<\3W[E;9F;U7J.7-6Q M\3[+,.#$/]+?!U>@/_AG4R@8_#;I_RT,WL?Y&*LJ[.^/P'Q(,`R(#GY*0)3V MCW_+*$-1&%K"Q=+#DQ]H;;!/::;]TSF!>H0S\(S!6(Q#0K;%&549ZF1(YN:C\>@]R2?F8HI6: MY?.G%Y$-Q81T10C"^_(DQ:5>[6N2DJ$B&H&`X;(*\%"5# M4$VF,^F#BX#SL/TJ'C:T'Z\?D1RU?CF2:()8RVH(X50P-I5072[H7PP&:D2J<")EJ%HGT??8L(Z4RX`W MR\UUXM1'!`YA:@Q,'9#6U5@H7++U;$V.J;7F=!3+B]2JE$N_4WJVH6=DUD65 MEI%$KO],B-",;C"T&4C^$OF8Y'$V<1H`![W8CQU0\&R8C+#03(S63'`QS)9M MTX9Q]9'<^,Y$2OQ)OAS MU"3!W:X<;1.D%F+G61&/9N,`ZQK)IAI$"'Y&(J5%DGC^P>*K!)85836XCMA[ M$QI5E$C/"QN/DU$F]&UW`!V50?(8O!E693>#XQBTUD#&)M-492[Q="8:X?P/ MO!\;X`&KH\81OFOQXNS=YJW2Z5G95N$#EC[C=[N'S3?=.\S+.&)[(+=;_VN1 MC$F<@,[##G?Q@3FD$;U[&&CY'@RM@M7QNUF`% MXL4LXKTI])^@3$FFE7FIW7UA:V@0-7NME62[K=WKW6C5F_"W+!MB>3-\Y6-: M1NDEYB:H^/C)HQ.KL!R77H:Z'E+,MDH$CP-LIJ2,&Z@H*5$HBWT*\[>[*?O7 MGU!>2%R`NIW<**+,Q-/+@Q+`W#NCN5N"P1LEU.2!C75JB@XD:PL7R^7=MY;S M21]Z%^\#:MW!9F&X]!:?Y'Q)7AU2GH,Z[+!9I[S)&D493[E?25J,09^)7,F&J%T$O(JR;H]IY^%R<FQ8'61M%^"61'4GF6-V+.*58<$)%".H'K$K*6N6SOA*IJI^3*,&J#,K2.K^M`O/<+A:W,'=5%CZ`,/^.2OET9$K& M/MH8,G_[!4L$KH_.RMP\;MF56>=+E`1-)`R`6:C+=6ES=IJE#6#/Y)KK8FIW MP.V^,@WZU?!\**-D(K[%-+'+4;%H'C'2O[E?N2_"BRMQ.H.0$6Q+K1]Z=0P% M9ZXH`5`V$$1!TQC6I2ZTCLBLAN\FZZ_ZQLYG M>-JNF7@G:Y'HWF.HPM=BLBV\WB5^=Z43;']B/FUQAB,-P>4 MD6>$ZQ$@O0V=I>!,I]G!"^Z@A>H@AA6# M%]90$GV,@N8-PG68%B#L^J_*$(7<_(AF!OVJ.C%A3UXL6N/@+N-N5W18">#L M=1WSVV.+OV+/29*V=?+%(L7&-&:K3WFKO;V*GZ]\JNC2*X4^=OO4D: MZQ.S:MK&HVS")Y1XNQ/M9G#:QPX9$M4DGK'-1]_*N5GK93;;S&.%O\\OI=Y?)V?Q_>2CV_W[L>W86-D$\WZ)SK? MBR@Z'90(HN.H&.JX.:C@#&.[)C;4VA[("TEK%_"A(4^=P(A2,>N7&G%MM,'^ M6#/42L1(U_KN'D5O#4G\*/.W';9P[D)*ETFIBZ@&2U_:]5[J(K].<0Q%*>,4 MR6S+@L%5AE`<6$?+R\3JVGE]J)$#E9HRL3VBOG'7!(9@]\K+,'C``@0^@NGP M05E!&/VK&^:<9MPC%0;UC9E4(ZC='APT7$P%X"=X%TPSG>1;=&8&)5JTOI9J M"*2KWX9S_0ANZ*8@7+NV+JCJ)5YY:BA>6 M%U&[//75!8:5[)U-.M`S;`>-'=:"W%74()0'KQ&J/VBW=ZC_[@:.IHS38(@> MG!SY."I*@T9'"1)J>X>U$6X3DC[R,Z1.*T-DX,"+"!E-0)!_2<[@J MFE:VX#26UH>?*SP6\Q21H2-[K(@EA;<"K)W!.0[)_QILJZ+(L+(WMH#JVG4_ M2683[NV^R52>G64LD59;3+!6=4"UI`"$V.GPSK,4_LEM,/*%)ZJWV2SVV=MX&7Z5VSGS.+T]3-&U@^=[%-[A4L_X_!9P@ MH7N_@,]27K%43'$I0>3",[].+M!*/7R)OE%ZK4G*9KR>R"B.A+HL$0Z2M0(A M3,0%9S-+J:6($".RD!:QD(-I,BH+R^@8B6."F-7CY#M/=`&S`;7D:]";4:GA MX&[KEQT.0>%B/OQ.X3WJQY1@L?1+>H43>*4D.IVM'X/JQY$&9DJ8LP^$IZ+E MC*90<7%WR'(P19"DVJL:/B2U=*#9RT/%>>\+VG:W6!I8T56\<#YH].RIO0W'&GN'^1._GA MYCM@P;E;P`$;\:UYT>1V08*)^'!^P5<)O=0UB^I1E5@8<:16CJ/RV'[H9[#D MORH\1*E]YF*,7>)8![BV0E!50_X2^4G`IP@JI-:2?DSL"X4VD<%]0VP'MP"* M2RI46(\!7\=4J$C$[3H5$O5B!I[1A0Y1C.RN4[T(#^4@8#0\<:SJ8;>UL0L, M;"$#W2,PI1[5KW3!]'=\8]&PN)_PG]B30<6M8GA2DD<+FO,H(G67"04;$JG_ MF*7Q@V0*%GSDS77ZR.UI(E$=7Z+.*@AQWE>)#OZZ*P\-.AYY6S,X$I[^=B$R M1*4T;3:5KI(/01S`?F`#2(IB4!B"ESN7V4^H\-& M!OY#,DX9Y=DP1>R:(2%5_7."[DH`5_B3.@K`78*!`Z^C/JQ9)79;Z%^U>]?_ MA/6A%G:#(R.B21`,#(=UQCJK()L5%2R+NF>0^)!;4G`S-7K&7$E-LZFN78!" MVIP^4(21'L8G,[NC]Z]K9^C64.V969:_;F`+1`EC\#W:/G=/%K^Y?#]8E=BG M*3H[.?%+OR4Z4SXK=;`*/;BP7?5*R%%`HL_NJ(2"FFO#@A6J8LWC,L\LEKSB M>##RAYUM2W`WB2EQ=(H:7X;]4-?-@@X&\:`,54F!DJ7NGJW2`&+XE"IEE]05 MY7UEF!`@(S?OH-.!T;B<8I846>0XP,I)'^0E."/">-_1"JU.51QF<2%@+6.R M5-3?D-,D]'OB6'^=HF\6UVI!C>1*H-].L,%"5E1=#\:R*.JT$!\-J*"T)D)Z M>\_#72,.BS,Y"*/@G#V!)X2:VW2(@I9%I^>L[85%)2XB!=ZEP?<(E2B15IWX M2.`J@?M7'H`FL34IWJ!6.ARI"(Q5S"+2KC'VP`L2/0+,8V..@'+$/Y("@^0T M6E#G%!F]H&UVH3-*C_L=$^3M'X@XDYM(@.V+>)U<[P0RX%6'@DN207;+*ZDH]K9G]LEZE:) M6,1.PGOJ:_3C:27G[D(BUBA0OLVFW(U(QG'L#&LL<0&"(U'3]69GP`D"WPUJ M_?X<"\^YP0P>8-(8ON10BP*..N2>-+AYIEF.N,Z,R8("9$OG[?@.1AM,^XHXKY(NL)T`Y*`P&/D5(E?JV.AZ6.T5$46Z?0MD9RKQ$T/, M3B*C':@Y;XH8L5T@O0X,&5+#&=7-0*N!`,+UA*ZTX;%PW"+U%>B(HQM1WPR< MGGHX0W$*1@('?U^""*J#;,M,6JU]._>8O66TTD%%4R:V+&Q3.L7QK#')B)D2 M:L%[(57KGV0[Y`$G\BSC(%<>X'[#!=TVD?3*$_P@T?K4N)*9I(X[=LMP3>,U M6@1^?#%,^(:_ MYT&K@>,C:CB_3S`W\!^:*A.@2[P@-8RD!UPPN6^I)^ MTEI'1*5_U>PS^)V8O91@8PPAQY=(B(^N-,S M0LC16T/XES$5"$,7)+%4/#-657CHV0WB_(+=Q&9>L9`)T*Y5]^WRZOI7(CP# MC2N>(#P_#J'DRR-.8\3F!8N22/"F%:YBO]`4:;CNG7AU3CNIO6F1@OC'%(O` M9^F,O4--XCNI;K6SB]EHA,C`*F>^IN([^_EW>]G(K0$_7?P6](![ M@;^(%-EL#'@U*8Z88YV!Y(38W-B=PPP-(+5FM:HHF> MXCJ@C/6F[:(76<18H]!+A\=<3X]G=<(E.=MMI+^W-:QKX`R%704="8)JOC0; MV<50(Z*X;]59Y="NT@QI30M&G['X:1,IY4GQG4'/\U[/G2(]VR@@0[1S4 M@`6\,'ZL"S)B$-4!%`<=UI!2O0:5ZE$6V.P!V]7L3N5X@MI&B/<3/`:AF%B[ MTJ@,N,FQ[TR`1,VO`@U.JU#05X$!+REP8`,AA0?S8\:`\"4SB?Z9":`TF;94 MR&@PT"D:CN.:_4),$$9&(93[38<9P3-X/B;\AVRY->(4*SA[(4)A,N*G^7%2 MP!NB\>GH4Y9>?D)\IAY=51\5`Z,>4NB/@Q3TNP='H&`3C%3%M_;V!.OQ$,I, ML:P:I]ZHP(4E.P,+?/BP&D_-+Q8)&,6!F$IW%%FK0;S%@[5K@ZW9Q*X9K%81Q#6^W(9),JG\*B*-608`Q+ MO'S%WH:#D])'>!0F\FQ)-=?%T/`O*=4T#V@&'T>J/DV01L&%OX0@YL.8AVSD-K;%(;H* M<'HM+;F':T+Y)0)8QY*[&(OF;IUTZUC/FU>[BX:W@2%Y:='GGO%,4%J/LUF_ M1%S=G@(KO6SC1D"&:31OY*W401).)1W"JDP5MH66L?8$EZ83=$J!8P&P@@TM M[SR)M2:)Z]$9C]%$X31/5//P=+VI=[*13F63=!37]W]:;I9]0_L[(;[^WN;?NH6R*P]JC7.I4(. M*4(7,3U0M/3;EU!/ZEV8O/X)C=N_Z,MXB?PU]ZBL3N;2!G(T!G^\60G>QNK MWVT77_-=L7/_TWD2>7[X(A_**/>QA3=KNE3V"+R/87:#3PO:S2YLU1"\X'%\ MU[U:0X-OW+K9PDIJCMOB6JPQB6.%MRKE/1?8KL`M2JY[VBM.1^R2[C5VP<.; M@?%$?_AV'^&G>WFZT=L$U7_GV MN[\<0SX89AT2//M[C&F@%Q&G!>EG2>2M&RI815O[H`W_SQ*WWILW1V_;H;>] M!KV[K6YW?^^A]-+.?Z1R]&-"[3^C=@AZ1O$EOJ$_UXB/G[Y``S9\GEB/8+67`:QU$9742-1MQ/OD_&HM/=,1^%9E`P_ MID=UE*_9FH2WUV&@>L*__/[IO]XR;_%7/F3YN9:'GXYH,.[P M&@.J/8[V/PH+'7:Z__;K74EY["7M-\]P1>LRU+ZHI$W2_Y$R[\EU M#/_>$E>U]Y>K=JO=/7B6:UJ7LV`%;[I+.&O]%1S'_?*(QMX4 ML(_\+[CW+=2,^^3?&?O_<3BLM2MKN0=)VUK2`_18=[_3>5X+K#%J[WIF!WO/ M?TGW/[/#@[WV,SNSARB,;O>-L0V>R7+JSFO=Y1P>=`_W'[XO;G_7PO`\PC/X3$UD.*Z^H&Z=PD)F/##;;7+8M6"H M5`OQY?3K2=#5(I1NZUW0N[@X^1J+E0ZCR\3'.F,/6-?9M?)./X1*H!&4Y$W$7=0_FAQ!7?"(`*"KJ,A M5F3EV$['`)8ZVG-(&7X+$!G)X"*I\$^SZRBX`#\EFF)?S5D9-X-/Y1!>VKLX M^[1#W?%2HVH*U>"!88O_SWD@SM')$\*P%"K-C#Z\')I!#WZ>SMT!]6,NA@K. M=`QI3^$)PX`'&7V.YD%GGQ$0PB"1UL6RC`977/5]\N,JZ2=ET&FV5S3!?,#1 MENU6X^^F'-`!50IJ.UO^'.SXS11136FAK[%UA[:5W,@5,@I2R0PO<)0 M-OR3,/-7J^!0S`F$ADX9F=0PK'8/LA)K*O?4ME?5LG%-M"SR+ MS,+K0EU5J/EFZ&WN@O'3@9\$ZD5AV#WT7=];8TC MM7JW]O:[A^N]FL`Y.5`,QOPX*@J#SMZCAGW95>>L#717\5+*XX^ MXBX.5LV$.)\H>@O"J)+56-M8;4&62\@.'"$[;+1;_X,A`KQ13T>J#DF1 M_CL'Q@**C`4<1R`^@/5?(RZ>DS-:2H,70?E'EG\'G2W1J.,8F[[+^X87.@>= M]N[^@41#:A^]L%4X7.`KN`D8.[&7V/N8L'ZI=OVCS%,]Q]:DM2A;=IVVFFTW MJW:W5R^@G..\]C.>P:"`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`CT<_TN^7/OR1=<:FR-SR\C>EAU[H M\C>DVU[HZC>D+U_HZC>J@U_H'FQ4KS_6'BS]X)=XXUI]G6L*7KL!$N^M>;=' MXF-;?AO# M^:?HII@EY8=D#+\X7C]%\I=_)UPT_*,]M=N>?0LM7Z))#'LYQC+(9#1:FY*C M+,?:O1+QD=]'Z?>E!%5><`LYO?$XEAKGM4G!&M<^D!#`"65!@3,!&%LUPY*? MK(@)VQGOLTNL>31E/LSM`0YLU,G,`=8NA()SBA.LN8$?2YV.0,CR>?"W9#P. MJ83G/V#Y\3QX35.2J1-!!>C_.*N\93^.HPG07%S0HA8#T'9;WMP% MJ:"]7\DMW/K6C9!9B4MU;RW(J:9`'DKF15R6/`_1U`=_I1K_=5GME&8T!V^D M4<54HAG`YG08N)(14P4.S;C.!!_8SL8L##6V\ID+]$'I9&.49V-,@!!@P6]MK.[D3/MPITVF28VN0P4+SG12:O+UD+51$ZA>1#2EL[M>,C!F\F('@!=3;S_V937-ENZQ=&D8UR4.?Z MS1#+SHE'^CA?ET<(`?=DHW<\Q<^E&7'W!YAHF<>,&JNZI\(>JLNPO8*(0`!D M_PM4X#^=CKF.'L&GY9"I%)-G?BUNS&NO/-][H$R3+W3T4?6[3`=M>L(=2\[T M3RKTZ\.O<>E)&OJ/IBX1`:W6Q6?NQNR\DSF%=1M&$UZ=\6;MO7"_U0WWVWM. MS]:2=BFW;PM)YENCI/DM@9E>N,B;"Y)(#SA"@-@2^Q M/6J>'B4C<[6/9\GA-X->.B>0;UA?=4'.&>'7:?$\.3A^]EEC/)@ M#HF5:>TV\YKO.NI*1+?$K75Q42ZP*XG: M@%J91K$=\2@]5KSOIOZ%R@W*985-314#S4V;1V-F2>];][E6LL]J'+UID MZ262YA8)W[M@NVH=+CYZV>NW4Z_M5GG=[D8/$@VSJB5_V^L;X#,^H8MBW?A]&D]J,=H,_V<=^]P)/6T MHLLQN%>'XVT-;[7[Y\5F;#W6R0]48[.DN&(8ITTU!+QIO]E3Y)'5;WL@87?M M$MA]T]IO'ZY+V;_]^J.?CY.W^/_#C_\?4$L#!!0````(`(N#,T'N-!6P:PP` M`"J2```5`!P`;G9L>"TR,#$R,#&UL550)``/E*EI0Y2I:4'5X M"P`!!"4.```$.0$``.U=;5/C.!+^?E7W'WQL7>ULU84D,"\+.W-;)C&L:T.2 M30(U^VE*V`IQC6-E93O`_?J3',?X398,=B2N;CX,)*CEI_MIM;IEV?K\Z^/: MU;80^P[ROASUCWM'&O0L9#O>_9>CFWE'GP],\TCS`^#9P$4>_'+DH:-?__WW MOVGDW^=_=#K:I0-=^UP;(JMC>DOTBS8&:WBN74$/8A`@_(MV"]R0?H.^7LQ& MY./NV@+'A#^[A];2*R[ M.0JQ!9.^O*W[^,^3X4FO?]+[=-K_MOUP_+@DN(<@('^E7W=[9]W^V:)_=O[A MX_G[4\&K!"`(_>0JO<=>_&\G_MEUO._G]+\[X$.-$.'YYX^^\^4HI=O#Z3'" M]]V37J_?_7H]FELKN`8=QZ.$6/!H+T5[*9/KGYV==:._[IL66C[>87=_C=/N M'D[2,_FK4]$^A<1WSOT(W@A9((C\B7L9C=F"?NKLFW7H5YW^2>>T?_SHVT=[ MXT<6Q,B%,[C4Z$_B([9AA-J0\>$[ZXU+#-)](5QUO=[C$(RT5A$>]^A MW)#A-G+()YM8@^]Y@ATT@_<*D4ER@(BO8WJ5:^"!^YV)IF0$<"TJ*-X0Y\Z] MYQ!?`B2`618Q44`N/D4N\2[(YUY$N!F<`W>*D04A M+1ZXYF&U;P;-#+IDOK))_A$\U2&-)]=0-`[O?/A72(:I0<9RD[K@JF1:S5WJ`JW931NY M35W(8M+MY#YUL8K*MYL;U45=MY]6ZH`7%J[!:P+5"-UHY&I'/&0GX&$#/ MAO:^'PKYE0N2Y&O:1Z_7ZVL=;2^1_A5XMK83US+RK<$N775,8)X0;,ER$?D] M;JWMFL>8]JA<9&60N'3M&.$LC3&0:(%X"?R[:)4X]#OW`&RZT?(\=`-__TU$ M>*?7CQ>+?XB__K:;!08AIFN2^PNXX`ZZT66_C6]'7W-MNO+0TD4V!LC=G_+8 M4OSJV-(0MB'^"VNN<Y5RI"G3UG"LD*4;U!VE4UU!?.>HJ!VZ] ML=9RNE$ZS[T)&Y/J;@-)H43O[47I/HD(&YH@L^>[:A$ETH_RD<#75#EZ=NK\ M!EW[$N$Y<&$T?,?(LP3*A2HQ)=(4]K#A:ZP<52,'W)%Z-'`@9UXI:ZA`R3$% M3S09Y]2AC,:2HS#;]F651[FFRCD4@8M#:`O[545[R4%9F)YJ?55D*.U09%)Y M`6?B/4B.V2\:9"(V48[780@7*+6,S*6Q2D!R,2C&&E]C-4F:+)>D7L7^!*+HJAPW(P0\L6RPM*48)Y_D M?]BXC_5.+>PTY3^PF>-_G\#[+ M:6BII21E3K-;Z(7,ZO+YSS*S?.!"/T;"OC5=:"5YKLA;-A,WRS52+FC&+NK= MQWM(6&Y2TDZFOT"7]'D?/<",O\,4+I;K5`A(]B(F`QEWXBJLG&=-,5I"WX\* MDDO(=*QB,\E9DA`?+.648V'W/AR7WJBSUX[G^,'ND8/JX<*5DIPL"7$DJ+IR ME,7[,TE6MR+IS@7PH3U`:XHY,DLU#Q\A#6.D3_BZ<;4DZ97C(L=(O4QE7;D.IT\/_056^DUV0F M'0;*XX1JR59Y!<]:K&4TEA^17\%3M064(TQZC=-:TO8Z&M]NO3.$&PPM!\2O MI]77"`?.?ZK&8:6$Y`7$U[$H8`OE^$N#W+G:T/&CIW&F&*Z=<,U@44!.\O,0 MK^-2V"[*,4KF;0RCU]CM?IH>^[7"A64)$5')#U"\CMIU_[R*&)(RM<[2O-E9"!WL8(S#T^7F<0%D0% MR55T+:>.>93CEJ$ZG>?]URPPEG8@(I6=B\1CE^>ZU\2'R!SX-9!8?JM M:PP]ZW2@YM)D!:>937*U+:7DG;`R"UPZ'O"L5WAU:0=R=VLF!)F^'])=]Y-E MZCD_EC/SY=3TX0H&RB7#Q.(Q^C`'*27'9S-9?=7\!?F164IBV=TU6L MN5>+J+G<_@+Z6-90CL(9J8:?XIO&@A16BZBYUBY(H8@UU)OWJ<*Z9],?=+O! M%KC1&7D0.\C.I^D,3NMU(7F6?(F^N=O0=0L?%7?=M&2&JH3Y%69H+6BW9(:J MB*'0/B7Q$SV3#4"?Z,D8CF^YR`\QI`^NZH/?KV:3F_'P7_K@CQMS;B[,R5C3 MQT-M9)+/0W/Q9XO[ED2/^4P4^#FOP-7$'%]I@\EX8,QVN*_UL7YE7!OCQ8]S M;3K2Q_,V-UX)G?Z9P#_+PY^;5V/STASHXX6F#P:$B`759SH9F0/3:!-YQ5VJ M/=Q^+P\WACC79L;`,&_UBY'1)L32`T,3=/T"NOG<6&C3F]G@-WW>)K#B*:() MJ),\*'-\2UQQ,FMS&)6=*9H@.LTCNC2_&L.=L=ITL$SBE*!YGT%L$1KS2-($7&%R&1E7^HA`G`P,8TC"6IN6XYY-FL`L3"$S8Z0OB`6G^FSQ MYZ&89IY:FN`LSA4W%W/CCQL2332#QA1I\QIS?CLI3!B<^4U[M_^MS=W1[*-- M$^"%N20=)+5W.[$#86[*5D:LD@N;GN)2\CU'6'INW*64\[ M;#DM=*9S$HL+676V$'TWUF&C^E`K.D^9JO32$KY\[;!]:OQN'/B5*% MC+ZD>J5/9T7]$#62KEI51.A@Z$2'0L*?K7$/#E_DQ.@$?*$@R.4KAX5>>9YT M@KE0'=#Z].!8ZQXIG<`O%`W,*O;@.@F>.;U7Y;102^1JW8,K('P0=:)"H:HH M5,0'5Z+VN=2),H7J@UTW'UPKT8.K$V4*TW>^N*Y2("TR,#$R,#&UL550)``/E*EI0Y2I:4'5X"P`!!"4.```$.0$``.U=6W/B.!I]WZK]#]Y, M;4VZ:@F0=+HGF>F=!F6-.'+=,\ MT/P`>#9PD0>_''CHX/?__O,?&OGWV[]J->W2@:Y]KK6153.],?I5ZX(I/->N MH`>@1/"'_WCRPDE]T0A=B"<5[>H_O\[^/V<:-YW/A\TKQ[/#UZ'A/< M;1"07^GE>N.LWCP;-<_.3S^=?SR1O$L`@M"/[])X;BS^S^'"1\>SHY0OBA?MQH-.M?KSM#:P*GH.9XE!`+'BRM:"Y9=LVS ML[-Z].LR:2KE\SUVE_=)! M%@BBJB=$I#%3T&^U9;(:O51K'M=.FD?/OGVPY"DJ;(Q<.(!CC?Y/*E-\5R]\ M=%P'/I,*-*W3'^N$RW`*O4#W;,,+G."%$HNG$5CB0)3;!,,Q:0ZD\M2658?> M\B<9V^!E1IJ2[TQG+BF0^H8H+X!+2W0X@3`0H2!E M&A:#C[9#2`GQ>^/>C'9*A`A?!(YO510R9'V?(-,0C(F6<1[WZ'.5 M3>8?P4L>TD1V!?7&X;T/_PI),S5H6Q5WP(ST6Q@;"ADCRADK$MW,B/;[>?JE M58/"\;1A`!PW#Z`UB^)G*%V`Z6SW$4IBD['=0OW+"WNCS,J:NRQN$]\V_UR& ME4,)Z2%VC.;,J8V^2%+&==SMPG+U99 M^W+G1GE1Y\VGE+E37M"2YCRL`%M+N%F)D_=GJ)M+D97*FJ<1K`G)`EOA/:S9 MSA1Z?B0J+FZ4+(\X%\<+ZB1I?9&FGIE!^;CCF]5L-`5.3M!IZRT@CNY4F\+I M/<0YX:Z:EH\5N&X^A)%!^;@\%.AYH2UMMEHGX1B$;K!QI5R:KV(FEQTOTA8[ MY.L*;O@<0,^&]A(YS?"-ZQ'D,LVCT6@TM9JVM$A^!)ZMSN.<0H MCPFT6"PFGQ>IM47R;8#*7G6($9[P$&J'*]8?EDM-2\0NLE9@NG2M"^',JAI5 ML3'P[Z-Z%OJU!P!F]6CE$;J!O[P2#5"U1G.QN/73XO)=C)&4#33)Q_AYQ07W MT(WN?=>][7S-2EA7`/-]K1DZ7B)?M%#);G#>+9Q;R`M(73+< MZ&ZD:X$/],,2UABC*;\D%Z6&V-B3Y4H@'&@(VQ!_.6@V7E&XR(?VEX,`AQG. M5D%.RP6^WQM'LV/]V1'6K73Z0BG+G+]P*5HM_"QZ6"ZFF3IN5$I*$FA[,1/* M9",K8:$TI&=D7`Z8)8SXF-\?#W?-#.A%4;&AA,$';^ M?IW7K3'$-[H[K8`DN4F!!'`63]6VHBS@IN^'N2B:&^P8/0G0S":D$#7DP:2' M(V_M:/-A'^+(#RF:6,8[0QG7`>9\HMKIQ*MJ+MG[<2P4)DJ$FCE]4(L=;J?' M2+U+K$AT=Q]5821G7R=AN1M,;=3+G29DM7J&KE:2Y";82QOK;1_7]+97.PV- MM:1E6>*@>&-M#/8T!?;55)O;:H<+Z[TXN!<'WZ9&0YZIR`M4:6*Y&Q4A;I5S(+6LDA/Y>25%?.WP3<2I+B(FI%U^R^JGE6&&@YDY[FQ*27I;&D60[(RZ*/@&@_D3NVS'E+:Y MR^I=E2EQ,73FH%%PP8^0J,M)I+C[J'*AK@-E*CW5=B=S1:H7!E$,`M+>6$\7 MZ^GN/BDKXV1C57/832LBS,>[]80J,Y`-5LW5@0CLO,MKAYB>4H'80?:\%G7A M4_03^ZE;QEAUJN0<4'/Y@.%`I-INR-ZJ[>Z1EX%?S84&;N6+_EX`']ITN"6/ MT2O;QR+G&%1_$E%BI/KG9<(#R%^ M=*S-QM)4)KM'+<\1%JV?5:0UJJ-O9#4[C]TCE>,'B]-?BGUH7JM6'02\/GBA MZRWS7[A/=&PSE:F0@WWT(1OZG(Y[#K!,DTH4VU M$CE^3(+"H^>OR>=-VQ`_C]WA2,(/)DN;2B)O8BE/,^)FL?,`T7R8*L[J!(TQ>-]4Z&$TO%[3H88#536Z0 MTWNA+.$-D[=J!8PN#$A?@J:P@WP6@2MI%*8FC9-9Z`EYH:H=R^D@MO$>X$_< M#UU-[[:UCDF^M\W1M_(\D(UN&^/_91W_5<_L7FFM7K=E#.:PK_6N?F5<&]W1 MST.MW]&[PQ*WC$O%O(W1GZVC'YI77?/2;.G=D::W6H2&$76GW^N8+=,H$3@G M'NX2;;.QCG:!<*@-C)9AWNH7':-$A)E!M_^K!$7.G` MN3&FXW5,9O>65,/>H,06E!5%-P9TL@[HTOQJM.=%56+E6@FN&X/YN`ZF;5R, MR@,A"JP;XSI=Q]7J75^3+G`XZK7^T$8#TH'H+=HIEEABC)"[,<9/ZQC[`^/2 M&`P(F1',\I`Q`_#&V%)#2L>XTCL$8:]E&&W2G958;L)`O#'*U,`Q,#KZB)1? M7Q^,OFV)9F:$WAAF>H2XN1@:?]Z0;D0S:&=2U6#&'-2.4\.$8%#3#I>?/FRE M6UP+XAOC3HT@RJ#9&&-J1%G%V#9&NMD9[D^8[4^8I9ZS=OF$ M&1EO9N2!_84^!$1A[\CSS(SZ<`< M&BLEZ#+$I!C)M(_X2.:*]!/_/!7;H)(S51OR)/""V7-62U8OF$!\#:P)F9+A MEZ2W7,I$9I6<(MJ0."E?6/15?-"(Z?(59J^X\(WN/BN[!",!7,TN4;>LYUOK_/M=;Z]SK?7^?8ZWU[G4TV&^*%UOBJB6A6O\RD18$VB'+NR-YY'MKF$P038] ML^`'U*7T50B[8,J3VMZ6I:H:7!$%I9RNPP(M$6R<;51%*/@BR$D%'!>5RX]` MI[+BW'8I+T>P8QS2UD,_P`[PT",8DLR+/;_[$F?7)2$2^@P?6%$C:OA+-06XJE,\'-7DLY@UNZG+$0\P< MV!1L6<-P.@71ZP`O'0]XE@-\%4#XN=SER3:=W$?;D,H^CUEP@OWLWG M/2Q>4\(@16BG,!5RV%D$5/3FQ?0!4XYZECK%O7;2=*O*'PT@((:<.M)-`PIL M&RHCS(`8?>JD-S/LP+9=6@U&(/3D)'4`?"TXP;;QKX"F&P;1]8 M@0W$OJ2.C+,#'>PE\;TD_OXE<593NGA)_L(1P/-DH*KQA!/*4RZ34( M0ARMZ,1O[:`_L9YE94Q59DP>O\1JR%:#BJ^&_A3K>*GC[^N10/?JW5Z]>__J MW6(UVWO@"'1K:535X#)=44[-B5%RI9Q4J@H$MNSRS"IPQ06TC8I<6>DL+RTJ M2V-T*Q5]9=/KKE2.")"=N`I)C%7QD0Q8-1\D4_,GW\+.C/`L``00E#@``!#D!``#=??USXS:2]N]OU?T/ M>.?>JTRJ[/%,)MF[F=O)6$)+[[ M\=67Z]/1]7@Z?872+(C#($IB_..K.'GUE__ZE_^#V#]__K^GI^B2X"C\B";) MZG0:KY/_1/-@@S^B3SC&-,@2^I_HYR#*^2?)+^=7,_:?Q<]]1._?O%^ATU.' MQG[&<9C0+U?3NK'[+-M^/#M[?'Q\$R3[]Z^^^[MO[]_]]O##V^>U@SW),C8M_SCL[,/?_KX_7O' M7\F"+$_K7WG[]+;\IU#_G?V MW=NW[\Y^^3R[7MWC37!*8OY"5OA5I<5;4>F]^_#APYGXMA*5))]N:53]QONS M"D[=,ON6&.0;2%+R,17P9LDJR`2?K#^#M!+\OTXKL5/^T>F[[T[?OWOSE(:O MJHD=]ASO]\1W>OZ?-!M*\'Y/NJ'9AAWQ#V?LKQ9P M_)2Q,0B'%73>EL'!B9\2?K=LNVX]6;7:C;BS3*CRB8@FUT%Z*]K-T].[(-B> MB?$(1UE:?7+*/SE]^Z[TCO]:?OS;->L).+U8LB8QI9CUB63U^V>\N<7USPE; M?WSEI''6M83KCFAE3D!7EF=22IRM$C9@;+/3J'CZA?J:)AM'(.7C2YS$?XMN MZ]\HGCB#H3&F)49Q*F8)O5YXTR+W9UMBW$1,A\^[<'SZY?K5?QDT_GRV^XD! M"<8F.'B#XVP2ZAZ!7MXKN6RP6]32"<,AE@6A1"N=/`Q2C9/- M)HGMODHAYY-$6IA-\DA"8$BC0]8E2R&'A"`,?M3TO?@C)]DS`[AER](X2UT< MCUIG$.=C@J]T0"H%,'QR0=GE5B&*=K+H'USZOV'P;!2&A*]B@V@9D'`:CX,M M89-SHT^RZ/CDF1/\)L^,"F!XYH*RR[.=#N)*I],8E6HO91H/')U682/!GOG/ MLU^:SG6>9+_B;)JF.0Z5U'%1\,$;=^"<-';IP1GC#-$TY"&FA9@:*O1@>*8K MG`4DQN%%0&,2WZ5&EZ03]NF+S(";3D@M.3B7G.!U>50)HTH:G:'1:I5O\H@' M(-`$K\F*9$?R02*2I/EPQC-HK#VH;S MYQOVVX95E9.F3T;U,*7)+@9L MU,QRBIF5E^2)_V6>Z9@4?++0#KQ)/KTT&,Y9(7:I5BL(DE4J,&BUR.XQ+9=_ MY)\XU'8H(]=ZM^*3@'N:V&1ESR;`4'4_W%W^SH+;G6L\TOQ\E*<9)0'/7;EF MBX-@FU"\S/`L,X0)[#K>9O*N\.OIO4UA<`KU02E%F"QJ,%P?3QX*\P@OUD7D M]3/.[I-P&C_@--N%;IN?8LPSF4R!]15ULLX> M`XIA$$K,/3X'JWL28_K<;RII5/,^=W0P0IHL&G3`D,T1:)=SM49[S0R#=>Y)A>&@R[K!"[O*H44%,#%JN^R, M`*&3FU!\_&]:>?1KPR;C^AC7Y MYZX-AHV](4OQ-M8`:HBB0AW4AGA M:<,/<,)NER1F\!FU#;ZL(^-UNTH%K[5#U10`PPH5*FD?JI(!Y4E4036C-S$I M^&2*'7B3-GII,!RR0I2.3MP'%-\G40C%MUQAD4NV#&CV?$.#.`U6/-.5C<#- M;PR.IT\#?E,&^QK63B-TU0;#Q=Z0Y73#(JU0R(%R>!-"\8JU;71R72&?9%,# M;!*J+0&&-$I876)40D7(')H'&]\3O+YXPJL\(P]LCKW@KU@+24HO M9C*("9E>YC''XI M.1%0TB$<:.8E(>)K2UD!YPR<$0^1S#Q)5L70SV#%&>1D\NA%5X$:W;+@/ M5IERHNFDYV_JWL.,W43>00G&,-X#J31Q*U71B'=XH8P:VH<<75*\>G.7/)R% MF!0#"_NC.YZPCWXK4%SA.\*1QQE/,.U8K1?S02D;2,X@GF>@%_7%`!O8B@PZ.1"\L("38E:% M."KDQ>[!H,ZAF*S\'4?13W'R&%_C($UB'(KR3]T8E8.\W^FD!79[6JD1!D$B M%X1=)DW3:F$:(*YY^CM7195N4<&+_F4X4OV<1'FC#')^2:2! MV29/1P@0:=3(3&2I-9!0&9`AI3.\PMN$\ESHX@()_?)+(^YY#6L$W5G**F4! ML<<(4$NB;U)4:Y2W?J"RI0'9)-@\9N/H74+U$9".E%_N*"&V*=,2`<04%2Y- MY$.(HDIV.$(L\]N(K"ZC).@&XS4R?LF@@->F0D,`$!%D5!H:%()(2`XXQNPJ MHHIU*D>*:HH3UD M#*Y8V!5AGTOVF6HZ8Y#U'8O3PNW&XR1!$$RRH=/&Y$RK#LX9'`]PX MTY`H,3'!;SD`E"(8:)G32T%'*(EH+HU,48R#UW_BY]9BU_:SG35O$:PT2 M!;A6Y9'&]V#(H0`E1?XK$1@<.,]3$N,T':W^R$DQ`5ZR)W(?I'A)R0J/HJB\ MDKL:_\3`MJ1X&Y#PXFF+XY07=Q)9A40]SAIII$F M>4`NR`I2?V73MKZR"5=JD!8A!?/_BJ/P,J'7082%>YVS-^W@F4QJ_IV5W0C9 M?^EUP+#/$:@49L=9%A5Q]L5M1.[$M*YP=)"89S1Z"!;IN0)QD#..;I!&M1D) M;DG$5@$X91Y4Y#L4M:S2HI2?)9KNKNZU7G!/HUK5@AUUP?BAGH"EP^S3T?ET M-KV97ERCT7R"KF\6XY_^NIA=7%U_@R[^]F5Z\RMZ/;FXG(ZG-]^"XZS;GH]) M82!>.NS^Z*4A\XBKE?9^SZ3;2*H1!<,F,SZWB"JX%>8L M"6*WY:52TN]]6UJH[8NU)#$P%-)CDZ_*8I*PUI/.CF=HG^/F;@;V--:0O;.G M:6].`_0P\=T-IAM>$]P6$56*^O4Q>K!M)R/+`?(R6G"RFXGO3MD2;@./-XHU M@W6CV:(S\!K.O,5L5`##+1>4>I*%C)$@0P4-]MO=\6"CF648`SM^&0Q2'K0M/)R1=14F:4VP9R7JVX?5,SS[F=>Y5<&\`C./:![7BXH6J M#9&CU6H%!GF7K"W,G'&QY?YS$.7=&HA&2<_IR#JHG?3CKA@84NFQ*=*+"TF4 M%M4[@CR[3RCY)_ODW=N3MV_%_U`J:GJ0G-,[':>I M\`TJ[UY^/<%KLB(9D/R;1ED=D]N3Q7P/OBJ0W?&U*0.&-AI@JE%R5Z6HZ>=. MOO_@Y.J^_^[]R???O3WYCQ_>"!'0F-$]':U6^287J^G2&6L>@XNBWVN?70UI7_=LTP+#.V>HBLR*2A"% MA20,[LF3!N?9Q=#3-;=I&JSPB1:?.HKR-VT"!%XEH`E>7@A`2845`)2U_B[1]"#$@E MMQK6C(WC4_:G;F=`)3@(.R2@2H;44O!8TH5F8`H714+62!7U&(7J@R[Z/$0XO*B:/ZHB$4U175AHN2*XS0!\O M[VJ`Z?1.,/51="FZ!)=OXD*:/ERK%(;F61NXC6.%-&A^M2!:N355AA@A\FP9 M4)[=S&,&(C"[Q%08[/1H],K#\<]FD)Z+.DV@O+3`M7*T#IK#H*5TM8%UK#5J M#+0SXS+*&L3!4,V.T77K!BB[C".K5GI05NG'5(TH7#891],VD]2[=>!8U7,< M==(T6"EG,[PZP&F1[O[#2TM,^O*0DI376+8:8BN4VA8!PPDU+D6IQS!?94A(PZ!%Q5(+UX=Q#R:W M`&O;M(-*O3U*"R$8+WZ+6SK=:,GYGLPIX[7EK0P",'U"ADN>BJ;C0 MJJ0#$$?PB29IRAS46IM&UI+PR04%M"83&E^#X8&,JR=-,!SL!5<1LZLE42D*@Y!\8,=I*LX*7&+MXDD6 M\WR_@A)DYTZ%E@P8XFB`2<4%\!U;5W&7U51`7`,&4S[AF`WG$2^R&&Y(3/A0 MSL\GF7V65Z$E:-?6@\$Y:0;I.M,<>-[N-%^' M%?;1P5/'?VKI:C0#XJ1J7,7FQHPM3&WV-B4'(8T,54F;G1A0XD@`N]29XPQ% M/%3`'P1*"KTDAD(=7A:QL('?=N08.+`H>2]1:35`JE2IU0`SMCG![))-*"%2 M['&^+JN0?PLDM/`I(''*>PI.%VSIP'M/3M)[O@N[6/-R9[I1WJ[G=3[E:D9K M1F53`L,[5Z32K(KI\3M`U^RGV%2*WSW*@^2\:!@,^DW+:N?FJ;LDY3QUJ0'D M3#-;,UB7;VXQ M7:R+0P&+77J_B5P]V_!)NKW,:Y*Q5P-@2+H/ZBYYJS904#12%6L#=^9#LDJW M@2[+>4U(T,%LY2%TA;Q2BODFDH3764`STYBI`RFY/WQ'8NXLT6W`OECADY)# M@Q5YV+.6E-^R#JYO08_3X44$&WYI')`.S"TI#J!-I M.*VV)TF[N@`XJC;'@:)M1>@,5:+=@Z!?C1M5)VSMTZUU+0$@KXNISMY6W0QT M8CM@[T?SAO[7XX\/P79C0P#([F"HJ]O^.JENA_X"IG\UCKWX_#*AUY@^D-5^ M\V1%(P`8;C'0V9-++4!GMAEV+U:GI>[7X[M?2&A=&P#X;#;/U5E_=6PVHMZ3 MS(=QS_%#]"0H^O;?2X+.?Y[]\ENG^_';6\MK7HMO.N8[ZO@@8"_XG'!."H,3 MK`]*Y6TW5\O4V3%9](=R4DYFZ1R641D([_HCEDC8 MNBN)#X>T:D4,EJP=%)0-'=NON5AC\'%]U&$Q4N?[W'6_(CZ:?6(O.OITD5/V MDS$_OL7^WLM'VAH8BI)NANE(:=8&24LGR'9BDJJ9.G`_D*/4V./L*2WZP'CI MYBN-RE\3*WMZ2R,I(44?^1F/<1(_8,I/8Q=_93BI>T=0)KKU66PBSC`990\V@[_FU4&N3K/`%YYC9M" M'HQ/=0"IOUB/C6=<"0DM<)7-V4#`T2UI\D!"')X_?TGYD%Z7TACQF]^+FTO- M%-RG(<_GX_8TM#/J]VP%#(GWABZ5D.-L7@LV-\NG,'<:U$T`J6[1F@S9":R2 M'>P,IX6&LB`DIFG1&2:B7/KKF.W[G?LXW#"JAJ>K>@2C;X["_\G3C`^1Z4UR MA?E;(A%N67*3'&9L.LY/>2UN>L2'U2J%>H3?`>.7CFA]TFN;B7)-+/U!AI8CU27 M"]P5W^Z0=26Z+MLENB9@2G1-\):Y+R)8QXNZ;A*:D7^:NK]1P^^FDA5Z>P=) M*P[&&]@Q=@G6U!#E=8.&#@R*-:THNLN$I"L>D5M2O"'Y1C>@V_6\3M)_1?FD_*`#>I9<85'1();$D&:ELMVCE:B M8Z5L?8/)`\^-=GY$*M5A6:HWQLQ/60\P,[5@NYQ\7>E^B\)26Q"TU.>KS+(! MJ.2D.U$(MKLS\+]1,VM1,-,*:Q%@#[.0Y[MELE]>E\DNK@WDYC MC-7A=?0&Y^8>8%W8"6O8=4]O>7%^#-3$I9!=O;L-8ML<[:T&Z-Z8V\2]ZJ`90ECP$-4\;9 M6@4&9]W[Z8L[.E0/_#+/^U5,)O2XK9,)E;\%3=U+$@?QZ@"3"6-#`*CL8*@# MI0VM0)],V*';)A/KJ@6`DXG&@%-5J5NLQZ)&GSJRH-DF`:DF66W":7)([^I#&0(OZXX MEB[6CHPSJ_ADG`OX)N-,\M"6V`Y8N\2[:A9^*PIH`&2<^YSUQ9->J*N1EZU" MOHJ%M1ZW=F&]+9M`M\_*]0<,^HI*8W'(_\4+3#RPV2G/&!#%*;J[:YI'UJ\) MGQ3>Q[@FB?OHPZ+Q'LA51";5)NGK*DOI6QXKXOR&3-\1Z\.4/K/^)HHV]7I& MDN[PA-688V=J1Q'B=8-]@"NC/$&&;NM["-E$H?C=@0X''OG]`2P2U0^X[@WB M.'1[=QZ/!^?;;5&_+8BJ$CG3>)W037%2S5*^R%7;ZP'B?B:U3A2[J8)9Y_;# M*YTYWFG39Q0G\:F8T?$C7E&2YA1,\+C*QEL&)-2F2#5%_&:@R>#:F6:[[\$0 M1P%*Z;1$FG91<+=0@$((7O?A)GCBL4,#)SI2GA,351`[.8A-$4#D4.'J\N.2 MLK7>/6&S9G["CA2E@#*N=*1TZL8V1%U-NEG7O&.-HXZW)&I7^'7^M$UA<+[T M02EYE^;M5(VR%R&8\@D+>A?$YL&#-#QX7SB&-=T^TVS[!+5:%SZXV3Y?9]2_@'8_`:Z. MY8L>V*2>JM[@I^P\TN<1'/YGOIK.9WA(!^N'BM_XW]$E]89U>^?Y:/S3IZO% ME_GD9#3^VY?KZC^03-IG_[,IU,;WZ%T>-FY(^*74X_S:>7T_%H?H-&XS$;=F^X0UPN M9M/Q]`*(Z]L5AK'Y/*6DWZ0<+=1V+HXD!H9/>FQRRDTM"4.# M$+,YZB*[Q[0!N<>T;;^VO,[G7F)N:Z*W3T-@N/L2]-*H7;C#:W1U,;Z8_CPZ MGUT<*2);`$[K9XG2Z0O[C&28GTY8`PP@E+.DV:B$$ MSI?(]VGSD)Z[=^FA[_>*ZIYFF6]"URB#86!?Q%**[>+SY\4<7=\LQC^AFZO1 M_'HTYCE)0.9-2]86IA2'PD[[3%XC[7?2;H375Q>7%VQ MF;=@TU#'#I/-AA3A87X6+Q$)`SCFZ0)N\]E>#<"[JW`_^*K,^[(5$0!HM0-Y MACS#=T'T.<@RY@^[]EMWPMUTO>Y\]S&GM=/MH@C&T?1!VZ7J[.+3:(:65XOQ MQ<5D.O\$9.1J%G:YH4&<\FH726S/\;&I^4WX<3.BG?UCU@%#.D>@W&\E`3/H=ND`M2P8CED`RL4!*G%4R(-S@5V#K%$-O?R0 MI#)'+73"8&EE3=S^5E3WK(8 M7VALG=JX9SN#D_$`X"6>[MI`JG,PU1\P?.%YD))TL6X>9V2+K1>=C7E9DSX] MZB&,;SK=E[0W>%AF%:]U\1S`M^.9 M>GDP1'0`*>DZS;A0Z`L$Q==]*-;FZZP]=C="&@BR(<)O9`JR[A MQ\/E_(^&.@Q"UIFG;AS4BP^2`^S`-)TL&')9`.HRS,',(+^D>+&^2#.R80.Z MKHAW5\@G6]0`FQQI2X!AAA*6-+=*Q74IM1@,4F@3-MW!6Q17=\IWXPCM.]8_R2UYGB\1Y5:Y)Y^)\!T\>. M9UNW,_):Z'4-PHC]0-D!`]$2C+YW$5!>29]?%7%]'U#LUH^L6EXSJ]U,:*5: MFU7`<-4-IU2`+TC)2HP`$Q+E/$Q9M8->SY(T_987WD>B01@DO&0=4EPN#+WC>LZBDYV^C"H M.<>/C?T!FL3LSQ5N&.CF,/LWX_?JK_V,;%\`UJ\-,#3>$[BJE!8_2;S;(=VV MVH)!YRO\@.,<,[#)74S"^> MMCA.L7$%XJ3IUVDYF]+V7E8U,'1SQRJ/D85FL3[>Z:)QDD)Q9V/^CN.,BN#1 M%4E_'U,\D[NC$P7#-CE$^6=C0$)D[0@-Q%1@,6U*2 MT.)Z6#8CB((T%F*DBW_4+NIUK<9O_N;^QG9WN?LUP88 MUNX)7+&L;>D>ZTZS7<[R)7FJHO`WIHKA[FH#9)];C5!DFFMU!N=43Z!2L(_+ MHT(!%1I0O*`F)V#O?`YHF1S[Y7#`6UXX0Y5.+ZSN<9A'N+@&;,=#X`3\1)-4 MEWMF4P)!O)8!3J03&O`)UX2I31)25944BC!H-UJM\DTN3MI.\);B%1%C._L[ MPN7YB-$FH5EY5YCV66B>W>&:]WS+T4$?2N=.I(.T#:9['-@@J=X%3M./J/$C MJ/DK`U7=T1HQQ_W*Z#)YSS5ULB0+HMD^[JZ)M9>[8XI'7RI\2DA\)Q;;-)X' ME*^W'_`$9P&)'%<-;BT,L(#H8YIB+>&B/K@SV1^SG/;(-UQ+750KHU+[2$3\ M>T)_YY"#+6'=:X+9&IDH^:81]$8K(]":/4HI&"0Q09,N;<%WQ.^+KJI"6+N+YOB-"SNU`8G77^L4D'4\OQ*B`I1Q&6//B!6 MN[*[7=[2`]8NT6U8[-/.`(-C?S,50Z1[(X/3\:7(-=>9IFC70C54[@9/&/ZR M3C^X3&B5?"#;KUNE."I[76;V,JBUB'32')RL>\$U9YV$,+-.U#=V+1YC3--[ MLEUBRG"61"0CV@/IAVI\>$>S[P.Q>Z&^+0-W47N:(^W.YC'W6&AQ M&Y$[0*5EU$:/PE#D-;=L[?78-"T,3WRC:79V*]6!4]B$6A0-1 MV93/?*;]@C%.#0R;X[1'^,5!&P;S]H%LS(`"&FEI[K!JG'A;Q.\-:S*X]K5J MN^\'IXT!E'P9WTX$E>GKQT^Q%)>\[>6+S)H#."$74Q3>QZ0V.'_Z8U7?\0C3 MS_"[N])E\,RC?^4B1=-_E))>ST7KH;:./LMB@W/(CDW:-^62J!1%I2P,RES? M)S3C\W[.ZUV\[1RSY2^;#/+!=1IGF#V[["K(=.'6WJUX+8:_GXFM$OG]F@!# MT?UPRR<*"Q'$9=`B1H#YS(L-<8.;G5/S<-2B7J_G,H!MW<:ED`/#,0,XHQ^$ MQ9<7N;^^C0S!L?V=7[\6P/'RB*X/!H6O\#9X%H50%FMNK.9YR&)^#TZK0;9/ M2;=EP%!)`TP^T%>*H<4:<;DCK38_!23FQ<86\<43C[OE)+T7&ZNJU^^DX6UU MZ0:]7E6:Q0?GASM&*:N6*7%WA#XQF22UCVH0*-K`FF1]3+)^22R*`%09,Y?\G$,*6E`1/,^F=O9^_:Q@`^OI]Y"M?NUL#@;'T):OFL8JE<,A*H M^V[;^'/"Y^I7Y.X^TQ<#T"OX/0QD`]X^`Z23'IQTSA!M#"M44*$SV)'EIA&V ME&"]-+RL8`>LMA=TV$'I&/U_GBR#HL2VTU-HB@_7]V70>H[M9('V>PF@*ZF6 M+A7V_?ECM]=1&`J\K[=!NKZ/T88?'#K2S'-!R1V)@ZB^\$-<-]O`7-W?H)K@ M]%#V-M?L;5`]R736'+S#[P57BG"5^FAWU\MBC;HDK)T!.@]2]NDB1J(\GV`G M/^4&8_#9!8FO@P@7H>%=KK9N!FK5\GICF)L)K6O"S"J#\[0?3JF2#M/@?!LG M3)2F)4&/N.\S8C\3W.$Q6[.QZ>\Y"1G35TK'IY/TYN7,4&N7IA8;G!=V;-*A MVD(8E=*(B2,A#\/]J*;TBSQ+LT`DZO=8"+2TAIL):TVP+;H:*H/3K!].VW2L MH0%KX57XQXQ?]*9?6G[9)O'.D>HWR/JWY'DC,L:18\ICG)+@G[H;N)*0'1IN8WY=#- MB':2H5EG<-KU!"H52V9"B$GQ>IM,"B3;YL&&+7Z6$5L-962]=GL`DM*`3-,8 M8.!91P,JR]0PI0&S^AYQ>9`4FP0;MDQ*KY/\[CXSA=\=]`8DFMX,`]=D):AT MTR*5EKTB](LF.4RVC:((%TERN@B;26%`?BF`&XC5D(;**!FB=(X[H3P9`2:1 MKG&61>*RT=$=Q;BX'8%N'%FEUQZ08C:3#'S3J4(EGP6O-%6KQ5$M?YC2*`>J M)I#C2_9FK[`HW[X,**]`-&<$,)[XM6IYK3G@9D*K#(%9!0SWW'#*>PE!W(S@ M#;2US<#?)(OUFJPP31=4A%!XV3WV7X9#VG8M>!O?/3#;WA6L`[`-XCTWLJH- MIQ>-&G[/B%FAMX^+:<7!>`,[1MV)0QAL:AZB_!QD.17E[NI32^9)D(OJ4$=A M;<;H#L#J],`PK@=8I6.;Y!10I<+K_#;%?^3\`MH'IVLS30I>3TE8@;>./VBE MP?#*"E&.>%8*2&B@ALJ1]F(:!Y.*?:8=ANBYV']2;28XJ7G;H>EA1+U9XZ`# M90+6$Z_IU-A`D^3/P>J>Q)@^-V^M^(PWMYBJ^K9!W/.TV-2]75!*!2`KG<[] M5/\H]/Y[H/=3U`(TK%=:`H#>@1J7%',54BC0_+54.6_6]@;YJ%V>\4"/MAE+*6I3*Z>\DM1OWX-Y MT`9PTC2W(?H-*H31*,LHN@*3 M/0_TDJXP6R/E:F=4?0?HH4N0Y./JA;BWP[T^*O`<!05,_N,36ZEJ8`H.>LQB41FTL-[DXXB'D2)^T>::"W60/:6[`# M5;^6IE[M>$K5H7R/TW$<^6#+>S!O1(]-FN\+R1,`F_5SG(V#]%Z<<`AQ>/[\ M)>4U3>M1:;3*R(-VA>NN#:CC[`%:OL,Z0[P-5#6";I_1:]X.(O&WC@K#EZF=#RY$+*,TN6%#^0)$]'*[9>28EN2\E=&]#[W0.TE`1=-B%N-WU= MM8+XH_T650VA1DNP>F]Q['C?WJO0!O1V]P#=L_?630W?>YLU@YM9("[%C[OR M@-ZA$TQM8>24W^-:JB&A9STO[[\+EE<^[MD%%=J`7M\>H'MVP;JIX;L@1SF* M0_XO'MM["").P:(>(YLX4QRD>(*+?ZO>ETU-M3J0VWPB#&=TF?&1.T!'2=%0*N4?GA[O-*`=^FB#5%NQW=< MY:B)+\/WS-Y0U5DO1MTAWMAAJ_F'R?_.C&?N+?5Q]Q/[OECEL]LG_!U!+`P04 M````"`"+@S-!6`,V7`L``00E#@``!#D!``#M75ESXSB2?M^(_0_:FMC8 MZHAU^>ICJJ9[-V0='D7+DD:2:[J?.F@*DK%%$6J0]#&_?@%2DGGAHD@CY7`_ M5+M<2#`S/R2.1&;BY_]]6GNM!T0#3/Q?/IQ_.OO00KY+%MA?_?+A=G;2GG4& M@P^M('3\A>,1'_WRP2KZ9#]-?G?3X]_SP___SEAQ^_?'^I^970":-@_Y6SI[/M M?PGYSQ[VOWWA?]PY`6HQ(/S@RU.`?_F0DNWQ\A.AJ].+L[/ST]]NAC/W'JV= M$^QS0%ST84?%>RFC.__\^?-I_*^[IH663W?4VWWC\G3'SKYG]J]8TC[%28"_ M!#%[0^(Z83R>E)]I"5OPOYWLFIWP7YV<7YQ+_ M9R-D_U4_>L`>1D]L5*Q/^3^>,H"B-?+#MK_H^2$.GSE:=!TSRP2(>[NG:,G& M.!L1)[OQP#_Y%QW:\'G#["/`ZXW'%'):D=^6U$2L87&9=('F&/#S&V(V=\6 M3!OJD:?903W\7A.V2'8(&^N4?^7&\9U5HJ()LP"E1C7):\(\+SES8HJ:.`H"-H^Q[<)]LBK* MF2EK7`\?`_^!C0U"E590:%C/]_OX"2UB^93CI:1I/3QTT9UR$DVWJ>>K';)> M$S^>G.>46:;C:BTU"K)Z>)NPCR-*T2+^CHJE\M;U<#)$*\>;4.(BQ`\/2O6( MVM?#S11Y;+U:L/U'^&P"FHJNIMDXN@O0GQ$STQZW5?4$+&C_"FM#+6M$,VM% M:IJ9\WG?9%[*$M3.3Q>%#O9,&,I1U+]#&3F4[W8?D"9O.K2O,/Y,V:[465-[ ME^UG]I\UW\N(>FA@;V/,K`YQ4Y:ES:4&:7U[$U/F9#2-[EU,&37LIHF]C2G+ M>M3-['U,>=6E;W9O9,JU:3^-[)U,F=8DE_&ZH2A@I+'K:,A^D2%!3R'R%VBQ MZXCS?*!'DOV:]W%V=G;>.FGM*-(_.OZBE9"WTO1;KG=\>\3-L.IQ-RVA*HV- MO@Y_^T/&9_LN""G#?M>1Y]PA+^[^#TZK1WI:A=FM6F/'<8#<3ROR<+I`^#3V MV+,?8D%.SLZW;N._L%_]D?`P12O,/^V'W%4OX+R\:9[3]'!H4[=%Z`)1!M>N M4X>ZF4%0='5O6YQN8F_IB7N/O?WX65*R-M7E5F]$)4E:OXR'5P>APR2ACC=@ M]O+T*WJ6HE!HJPG#.4`\Y*`$"NC:;BOP>E^%(Y;2B\$U$N M8Q\'KN/]CAPJ'_SBYIHP_``*!I7T]I;@?R+/^]4GC_X,.0'QT6(0!!&BTJ58 M2*.)S8^@L-'2@SV`OA(O8BJDSWWL(1I(@2FTU03D)X"`".2VN%E-;'B*-H1R MGV(2W"/?LPI(-&'Y*T!8Y%JPATX\2CIL2EVE+CY+0((_($E+33/L4!U'^)P!:GIQR>"1Z,HS`.VF1&*I^DI(2Z^(`\ M9FNHQ.8I,-D.)F>B/ON=:#&1M->%!^9Q7*@`^ZCP3;H^)JG6NHC`/*`+A"_! MX^?3@GA#]HO&'.6E@:Y[Q_A%ZZ2UCU!D/V];MY+FAPZAI1/&.Q^DQ]0VU__L>=IO.QCG[&$V7@GV\!$N=MH0T'8[LJUL"BTM>I(%^BVH'V!A#!`X/'0(D=6_$]6G>9R M!9(\KY`46XR'&2'AZ"YO:]5?KJUZJ:`PL-B'%8LAR#:QZC#7UGR96#`4?A4% MV$=!T'[)9=A%6TTH=E';\[9Y5CLQ8YDG%&T2`?T=>8L^H3/'0['%CXCO:MB4C,SJ?8&NF:GEAH22%`O;5P2'.0W>RD0W MQ,X=]IC0*&!F7\Q35G@>],GMWC=4!=M4/3"L+\6UG@-)1F#W)L(8@'+P0'N9 M=CZ"B?/,'02*S:&@L=WK"0U5ESA%R@4&`PJ-V%Q>$$R,BZB]+C3-.$R,H9&+ M#0:=]`AB4T,%O/1[T$6P&9_'0<:EHQH8F'8C-">IU",EA#("7<2:\5^8(:86 M'!!`X^42NVSY'=/T8JP!E()0%[!FW!P5`--2!`S@XJ.B]LPH;*T+43-.##.( M%"+#P&5('%]OUU?:4A>/9EP69GA(1`6"A:YY'&`9%\UX,NH]([T9SP;Q5W-$ MUSP57W7\+6VJ"VHS'HN#0)6(#L/:2K8\2A>N@D87KH;\%#*5R_=Z4'VXJ1&H MG@KU]=^,`Z(&!]];F?AX=#0.XWJ#;.;HD+A0#O)YF9PN#ER/!!%%BAG1L`]= M[)OQ<%3%OI*B8-AFM@9*7(98?-E?;*F+5S/^C&IZ)PJ9(,%C?(]2P\W)13.N MC*K&=2QW):E<$ID9%9OIPM*,P\)L0R@2$@8$[<4B'DYL8#EX,?`[S@:'+U6E M\XY;46M=0)IQ3Y@!HA`9!BY37D+)1XN>0WU>O*KMNM$ZBK>NN?+5.8AT"'71 M:L9Y88:6OB)@`%>43GO9,8BK!@",6-!CW\2KCO\5XS'TX3VN.(Q&8+>9"5?^ MOL(^+>Y2EA;7^IBA_NX]3:Y9V>;IVO0B*;:-5.97&,9P;#`O2CH\#P(,S/S0 M@/TH\E:5-80$1V88E2H^Q7AZ%8:@_([G!,%X&<_,[2>LQ*#8_KB@*/*?ON.Q M>9Y-,=8E:[9O%9UH2QI"PD`THC+GVA(9@.`P0Y1M5GI95]4-6M\):W!)*0`@ M(QY9&0N129$.\@7C/4U*B+2C\)Y0_*^7W9K4D5HD`I$`7U@#Q6Y3D=@PCK!E MO,:5VTS@V1%8382OCDU67HBXL',&#W_BCI#8KSA!-&9="R,QL=6L^BIXJ?0` M`[M"V23EG">EL)J`KX>2AL1`H9'.=<+65C/S*T("<99+,6DXQ6E16LV@-X:I MPN3VVIXSQ>.?>[?9]SFWV0M=BRQ;*4J;U3B85&C/F,)))FQM]=KH`?D14A60 M*C:SN8-6J#U[&U0N'XRIBZ<&!UL6QZM;5`,LE"+#0&:&/-;G*GX-G'Y#*8:%SF`Q@=72 M3&J%$STI(,&S+0:&%O'!YLH)T((=@#BCL5+E4.D26ZWC9`2;F3I@0,CG8Q0$ M<4Q='PFW8L5F5BLS&<$B$A$&`-?(9[)X/-]\L<9^_!X=?WA1;CQ**JMEF8S@ MT50`#+0*DNEN$6R7;3ID;_!63C-[P1)E#-EV5`5?NJ7=4DQ5`"S*>?00\OST M1"Q>;D]SOZX@LENJR018+>EAS)37#O8#/O10,&9;'SX<(QS<)P%T/-U3M+*I MZ>S6;-($@1B)!`FY@1\BIM%0O@,IM+);KLD<%8&8YC/DYV2&]-&*[_V!S)&J M_4FVC=U"3>;8E8KX1I`;$9]D%W"Y(:J([)9T,EW=E-(?^PYFA$+E]C/7QFZ- M)P,$2V4[=L!VV6N[^_LK)\"N`#A!6[L5H`P`E,H*8W?R3X17]VRV;C^P66*% M1A$/D1TO"P_:R6`R[,-NP2@#^"KI!D0<2CXQ+9\?N@]%^:$0BO)"VDIH6Q^W MU$`RN"I4-="BA9"_!I/FO(+@Z"DAU23!0TQXB/0B0@&5[YBAU2 ME$2-CQ$>D2SI8I65>G48D_)V=F^-P?MV9JHSF&-6N M$"E=5*-.[<^):@;*M#A&S68$V$4`6IY=A(_.YS=)Q79'D(HHE*ZR`VP3/P3/ MODY#^VZPURB.9#,SL8'B./#P2Z;7;D39\)PDW,6C=H0>XW\2'UOTB(\@M]%, M#S!\G@*>X[2RBM#E:8\@!=)("Z"!2P9;>91H%0L4]70$"9,':`@TQ/&HK`-A M:4=60]H/M]HCQC>=A,U?%D7T`;O5UL^23JS&O-=@N$*]@,8T'I,'0BKJPVJX M_.&6VAB@@A-Z;ACQ9W"VK^`D_R(].53)(GL1; M\P?RU.903F4W_-W8`F2BO\Z8GZ*-\YS<57:."E2@.3\:_HPFY`>R5C MT%**37SD1F+2@]VH]!K1L6$\`_9=GV<1L9^K6H^J#[MAZ)4`TE.+58A,#$C1 MA=V(]#H!JM>$ZME$\\2%#O$?$.6IE0-X954$PQ*/+J1<#Q=5-/DQWF3^<6$[&KSB M929GO);KL)X/(-'F@,M,$P2M>A%*.6\(0IN%"_DVJ>^1QY*ZA3]*ZQ9RPE9" M"2"(-"6(?GAX"8G==8@S-*'D`3,LKYYO`[Z,[M/1VR[;V2:/T<@EK-(1B#KB M$A!S*UM%1<%8_C(KLQK+LK8P`GKT\1++"Q"26O>`S?B7Y"IM+*>0;>WO2(#L M[T#:B_^+@N0Q5_ZPM4M\%WLH(^R=&"_>$HS#K37PKA*Q94C74BZB#'NX@0_?]%>$QKB?\FL7TIA M-:+HM8:'ALY@S`-ISI*!RU]ZYW;+Z9^UT"[`Q@129H;.'/-0$6T[<;C+V"C'N$'2?J\'JG5>*8* MJ$@Q%>L&*IH#_X'IB/"W^[1AS-!8KPI:*X`EZH"*'%L`-@Y>J(K]>--M8FL%4KMQ60V8FT`Y,.#4OVPZ M^#8.3'Q6[?=P!_N+@!0S%$C,]VU!'5>TTHZ`!(,=-C@T5`7#[B=)*';0)Y3) MX"*T"/I,(6R+]X!)%+3=/R,<8(F?T*0#N_%D!T!%JLE;=3:`5G%87W,'SP-@ M`M]JM_\WOCCTL>_X;@V+@[0C(#%UAPT.#54!61Q2$QP/;.9)!DSTEW),HC5! M3:<=5O*:2X$.,,1(3*AHCDB(%!X1<7-=[)KQ9M6/79DRX$&6=@5(+O?E)+K0 M-1;.53-T(J7`@&^?Z1CP-V2UX).3Z,+7C(^K'OATE/)FM\PENCIX=Z0_+!I. M8:Q]5_16MLQQCJ:_X/_C218/CL>'?U(X(^\J%`P'LRYT!P0,!UL5];S-(=%F MED'I,S.".(/0:"P4:'4'`0Q'FI%"WD:QQ<;'@$$6VD7#.9QUCH(WEF48;39> MK"/'V^EHX"\)72<8*=*\=*EUQP$,MYJA4F!L]W>7MKQVN_#J,]U$%Y.&O%F& M.BYY%3$M*10,>&CHW'GB)WH)#+E6VGDJ\)`HE;>A,(Z4;VM?C"1=(4:T6"G) M=/7?4*9?=?WK:@3`^UE7COMM14GD+YR72RJVV`XQ^]LB7C[G^W._^X'DQ7 MCK^-Y.X0/R`>7NSB]RZO>AZZG;XMSXT$2O`R#.1MW5Y[8 M^U__9VQF;=5\#WQ'+^D!,-?\_/, M]7@PNFYUQJ-.;YI,+S?M4?NZ=],;S?]KUIH,VZ/9^SP#=)[9+RCZ\Y=IP4T[:/>6_#EOR;/!]6C0'W3:HWFKW>FP MK<.Q9-*47UE4V5-K2YEI%V(8D#@"84V>!V*0> M/S"?8M-@$:O6ETW3D@"76:L.T1($$PL"%$XBZMZGKY#VUG5>L*[9K#=O36ZG MG;^W9]4,2^!!291(S+>%.H06[2@I'G>#PGM^9\>#'PU/C28=V+08?0#3!F2N M'@!6L\O3+#J&SB_R%C,8?65'L_'4IO=GS^\+9\I,>`F%52]V@2^5_S1K=_CUG,T5)]GX*HPBWPA4S6^^X=\Q4RFO7YO.F5;L]AHWNW$8,^55K5Z>R5H M#=L&%$("&/%#M'*\;4(,]EPE^5:M$-\P[0W;<[;L3-K3^>]0]FHB>917.BHRJREXYK![EZ,' M7S89SU@]``QO%MT%Z,^(==?COL(2@RN&(=Q>S7K_N.V-YJT>]U3;M+,\^\H0 M?U%SJUD+6::4YR)Q>ZMOLBB@R.8D*$2&8!FRX`=AU,Y%(;Q`$;73^KC[Z;LZ M+T=?6-"20^5JJ]J;1;.Z<@(P+JUZ]0X;#FG;K4.O,!)< M,C&(,:_/JA$@)['ZQE*-$.LH!@B$Y?G.>ECJT5I]M:E.4$U4!0/=_?VU'J#B MYE;?3JH10Y5"8,!V&Z#QLA>$>,T.1*)$MGPCJT\AU0A1N?`P@!'>7>O9ESZY MU3>/:@335&$P8+XF9/&(/8\Q/&!*]U?XSD-)?(T>T"8=6'V_J$:HS94&`^S! M>N-@&M<#H$P=&Q(XWG@Y)/YJB!]V854#W_4B?JM1+IKF\MK$EZR^BE3GRMP< M###&6<^A/K\6FR`:/^BG-V:45%8?1:H1?TWUP,"RSX9J7/XEE6DW\)EPT?KE M3"!`5)/6ZC-)->)JI"H8Z([08TI62GSVHXM2[.J9KGDW=I]6JA'TJAJ$@?\4 ML4-BA/@K?TP/^KXM#3J[CR_5B+"VCJ!`NL\.T\523&#W\:5:051I!09Z^\)" MNFXL47.[[S+5ZL>2:P0&;E.F7<8#]YIVV7SAD?CHOWVK3;I)TJ*T^RI3K7:H MK2<8P,;U5/R0QJJ>XN!;AZ(%#OE/XGL?,87=-YCJO?=1Z04&@!.*"4VJVK)% MP'."()8[5OC^I>,N"ER*-^GW8PH.3=-N[+ZH5*MGLYH&`01FI-(%Y_'B7PS" M*&2AIY,&6Q\3LH;B+0KL:<=62"@A7AI4OBX`%Q.AA$SK3@!B$%-*LBX*'>R5 M&$LA`3UK+-W>O#T8-A6=5&2PBKD42*VF/6VK&,PE+\+D&ZGLH#"@7LD%N&9H`#AA:\A@%8=CKH!TN4BIN$N;MVX1]7'($[?\!5MB^4^!%"(9P?&B)),J M_=R=S>K.O"+;C<-D]Q%]3HLFQ4M-=KRHJ67;!>A9QDXHWS4E@?&N8TMD-;!; MO)/56JDRVMTNNDSA=F_DGH-_Y-9X,9]EVTQ"X6 M\2EH"\,]:Z+_M$%)%0#`.2N]Q%$;2*%XFS+3]/5,QDBT>I)/:S:J=V=P#4B^ M^XD!."+?_<2@X7GW$[_[B=_]Q.]^XG<_L;&?^-PR4E<1$YJGI0*9=!+GD9K?=SV\UWKX[ZKAKQ(:AFT74H'@"3Q:7ZT14N^^60#./\"^V9E[CQ:1QZM9E;ZX5_PM M0B-G+7/:'M;E<0!ZD(A`/(0B)J4>7A41!/AJ&-+RIRBS(A\,IV!M;D=L*L>. M3QZ<&3OE.QM"T21$PW`A/4>KR0!@I#?V,EM!I5@P_+KE8V[\R`[^P3W>3!#E MR;?.2K3U,*`_@M.TL39@!*:EGA2+ZSP%@R"(7@X!)0^JE+8^@L!"A:25(]$> M$+TC`EH2N8VPZ$:6QXIP[=KX+L;"\:5V='T'< M8KUZA&'FY3*U%XNX5E!&%*,!(.C!:O';0U"6:N10*`6[GQOBA_?>'Z@-QT M6+ZN=*J`2)A,$Q@^8P-HLB_5%J4%8![Q`[I*NR@\>,;?:'Y->RAC4]L0Y,0V MJV22$`43YYD[$(78 M7I(M=]S^!WZ(F+;#*5LN18Y&TUZ`//)A"F=%;<&`FA?'YKRGQZ0`S_*F0%[U M,`5-)CT_\@!;AX#YVKU=`'#+/AKR5R.R/'&=QY> MR4Y)@K9`GK4P14DJ.8`34\HGG7EB5WF(*CQBVQG?W(Q'K=E\W/DU\VCT:YZL M-,71/FP9]V=VOT MKVCG>=[9MZJ8MVXW5J/$TRQ^)7RIG^+5?2C.XQ03P+!#,_"R`>,J9<#8[V3Y MU+C6EA$`<8S5A=K;O/K.RC@B$R=YY$@+[W1S('ZSNM`N:@*BA>I#9892TXZR MVF92`4"O;HR"A7],\0K[CL?YC'4$F#W2)P`0P-Z($ZSZL@:ZPJ&0;ZX M,V8.CR?E!^V7J`C19D=)!<2O5AU.3;TTY'!K,YMV5JC#I&!;K2N\F+`#CC!; M2M`8B(.M.@9R+<"PG[)-UC@*@]")PUH,]IT9*B!NMWHWGR5Z@0%BAS#+IB%_ MQE:\:;[=$#]I&$B]J.8]`7DZMCK8!^@/@$-FB%:.-Z'$18@/3;43]K+P*L^P M=]T>MB;3<:?7ZPY&UZ_@?,USK7"^B)M;O9X-`NZI9PPAWWT>.H]!A,,^P\=? M=647LBHRFPX7%3#9.U<]!<"8)G/<\F06MLGUV$XIQ,NE'E@%(JMNE@.P$D@/ M$JFNLV;[J&!&HM5]*#MT:]!9=90<@)=8!R`A:WL>2FXM16%9NVANVY[UN:]*>SG]OZLZ]KL"H<9!U)MMG./T;+WA-R(;V3'RR5V MD1P!*<71P"&5`D@=TVZ$^DRTE$#\'0OBN](<0"75$51`,3LGVQ$4 MC&E\+7)//*;$0)ZMJ4-X!-57].4__F@TP:9(DELFI3B"DBD:$L,PPW1VVXT3 M1C2NU;+/HY)[[W1(CZ#RB8D.`'CL9M%=@/Z,6'>]!_:'VE%7>&AO=GLUZ_WC MMC>:MWI?^9^-W\J6\ZSPMJF((#AZCLS7IH?#NZ<-@/,&L*=M6_#+7TF<:;DV M1Z'R',]`/"][KJ3^L$(K`!HO'2>E"@?F[.*16;SV_$L=6QC>K<)Z%;@4;R3IVC("F]%/>CM1M;@-!5:G"TR,#$R,#G#053B]F$SJX;#^.F-M9-LZ'\_-,__J[`OZM_-IO*+<&.W5&ZS&J:=,I^ M5/IH@3O*'::8(X_Q'Y5'Y/ABA'VZ&?7@9RB_H[1/VI;2;%80]HBIS?C#R$R$ MS3UOV5'5Y^?G$\I6Z)GQ+^Z)Q:J)&S.?6SB115?.^E]GW;/3UMGI]^W6[ZOS MD_44].XB#V;%L'IZJ;8N)ZW+SOE%YV.[XBH>\GPW6>5T?1K]"]FO7&N.%T@! MR*E[W=@RZ+E]POA,/3L];:F?[GOC@*X1$G;6#J%?\LA;EY>7:C`;DV8HUT_< MB46W53']A%R<2(994D!/J.LA:NW0VU["L$U\KH:3.Z0DE_0B)"4QJ8U3="ZV M3F9LI<*$*GS1/&TUVZV8W'>;,X26";$2OC*F7890`4Q[.8J%\SD:-=_['U*&*B_(@[!:XCLA1K')]R3#EY@ MZMTRONCB*?(=\,)7'SED2K#=4#S$9]@30>@ND85+I,61C"AE$+%P9T8C8FRY M)!#1,/"W*Q$N'W34II*S+I]B:BMA'*4+4%7:EK$EF#?Q?:`_A1< M+SEV04S`U(.!B#$BD3!9R+%\9S^>C2JY+-%`C/1!V-\@1]RIXSG&7HCUSH@< MVS,`5.Q;.`(W8E,"OMI#.40R%!"(.O(G=\Z[#DGNC=3@5\VQ&&\AY>1R?'_7IQ`B&LYS/4Y%INYIO]R-QH\ M]+O_T?1?'\RQ.3$'?47K=Y6>";^[YN1S+9UQQR"+U!D\Z+@`]QY1-`LC=0B/ MORC\RXCDCO@A[8B[@=F_4_1!7S=&(?[W6E^[,^Z-_N3?8V78T_KC6CIB3&84 M,@4+PFKO4GBJ;K<%M,A%>& M@YZIFT8]\8\0=4?8PF2%GAP<@IXS+D6Z=9I&.D)WK(P,W3`?M9N>44]T71=. MXCZWYD%I(P!V9TB.:2N#Z7AL3)3APTC_KS:N)YPF78$IC$>/RLU/.8QG:1C- M_B/LN8-1/9][MV2-[2`$H\UU>T".8CN-XJWYR>B&(5G/?;.+GZ*L)+B20_1I8?7!_#X?;\62@_Z),1G"B MTG1QW*UG@`XYGF+.L1U@&H*<&I-C>Y'&=C@R;HW1".[Y`-Y:(MK#,^0,.;,P M%N^@HL#-C,I1S:1G/>-.ZP&V`]TPNG`4K6>DCC#HA.TAXMY+=F.0SLIQSF1? M(Z.G32!VA]IH\OE]:QC[3R[^ZH,YACA`Q6E6>E0.<#:S>K@9&[\^P,%*,<3Q MJJ:X%B6J>^2TY;GM62;C*LEME0_Q53V+G%O'W(E(9K.GWVA8#GDF(=L^`RL? M0O[:H]O%'B).%MYX7(YO)E/;Q;=K3#2S5]/PW:Y$]A$7[XA6>`?J0@HYZ)G$ M;K=0^:&OC4;:Q'PTOJNY!PHW['R7[,^*K'<'9G$6%J3?/>1I%*9 M[YH2&JE'VIE$.57)?/>#M+Z9[XE2*KDO,AETIO[Y[HW2JFB^5RI3R[V3R;_E M5=-W-\EJJ?G>*2.2.R63GZJ9BQW,36@1_'TK=>XS[S/V3-?UL7V/%T^8-P)U M=_+K7"+B.*+T>MWPN"\V&]$"VH%-B#![$NR5ML^CCKUP[PR;)SLV6R!"30\O M!!G8"LA4C@3 MFU>![E!30LFO8(K8%$,-!^$.&6FH+<2+J<224K(]#`GGGL)^S^N&Q;$M.NVV M[8/M&K)+_O+ZSAKA)7H1%&%GF6:OA!9NH>/*>-[B;Z%_RWB.UL'BM93.:/376,(K#]LFY%<\>'1L&QK\C9'$ MS8>Q'BT2X$*.(9LSJ699H!L8XF'0W]LNP<:V5R4^W%H;/WU#8[=.[$D,;]^; M.2=[&=W1.A12$>Q.V"VAL!Q!SJ9I.7U,JD)Y=(>D3?6XTC>GF:/AH>Q'#$3F MJT^YT06D?PT#H[<#E2S,T!ZQB47?.\J-K<9U=&;_QO@7H3A:$@\YR=_$"*V3 M398J'19'O3_YD5)Q0ZGNTP/%')V3-Q:5?XTH1V,?WF.&H.@+P`+KJ[$=G>'W MC'ISY^76I^*;"C@\17\(*+FM8U.K$![K8;+HF5/!MY68CLZS&_WSONR36UM, M?71FWB%">\QU!]18BVCTB3L/ZQAAHW1H7BG5T28)&\=4_$A0[MF]!1R=LS>V MI#_+@U4K85"5[^A,'W`R@_3/$76*8)W!=->6(>9!/2.V>1^&ZB>VZ)6!OQ#3 M`?MKO%M:P:-DAG5P$8!U0^PA)U9BB'3VC;5.?X^8#CKY_-$%5_YG8FF#RJB. MSJQ,<6AC@?.R6Q*N1OKG%8*OU/"].5S^`5!+`0(>`Q0````(`(N#,T&"/+^K M,6X``$/1`@`1`!@```````$```"D@0````!N=FQX+3(P,3(P-S,Q+GAM;%54 M!0`#Y2I:4'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`(N#,T'N-!6P:PP` M`"J2```5`!@```````$```"D@7QN``!N=FQX+3(P,3(P-S,Q7V-A;"YX;6Q5 M5`4``^4J6E!U>`L``00E#@``!#D!``!02P$"'@,4````"`"+@S-!P8"&KZ,. M``"'Q0``%0`8```````!````I($V>P``;G9L>"TR,#$R,#&UL M550%``/E*EI0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`BX,S02>U(\3I M+0``JH8"`!4`&````````0```*2!*(H``&YV;'@M,C`Q,C`W,S%?;&%B+GAM M;%54!0`#Y2I:4'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`(N#,T%8`S9= MR1\``$WE`0`5`!@```````$```"D@6"X``!N=FQX+3(P,3(P-S,Q7W!R92YX M;6Q55`4``^4J6E!U>`L``00E#@``!#D!``!02P$"'@,4````"`"+@S-!!,;= M_^L)``"/6@``$0`8```````!````I(%XV```;G9L>"TR,#$R,#`L``00E#@``!#D!``!02P4&``````8`!@`:`@``KN(````` ` end XML 24 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
FIXED ASSETS (DETAILS) (USD $)
Jul. 31, 2012
Apr. 30, 2012
Computer
   
Property Plant and Equipment Gross $ 23,664 $ 23,664
Less: Accumulated Depreciation 23,664 23,664
Property Plant and Equipment Net 0 0
Furniture and Fixtures
   
Property Plant and Equipment Gross 0 0
Less: Accumulated Depreciation 0 0
Property Plant and Equipment Net 0 0
Machinery and Equipment
   
Property Plant and Equipment Gross 0 0
Less: Accumulated Depreciation 0 0
Property Plant and Equipment Net $ 0 $ 0
XML 25 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
SIGNIFICANT ACCOUNTING POLICIES (NARRATIVE) (DETAILS)
3 Months Ended
Jul. 31, 2012
Computer
 
Estimated Useful Life 3 years
Furniture and Fixtures
 
Estimated Useful Life 7 years
Building Improvements
 
Estimated Useful Life 15 years
Building
 
Estimated Useful Life 40 years
Machinery and Equipment
 
Estimated Useful Life 7 years
XML 26 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 27 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
BACKGROUND,ACQUISITION AND LIQUIDITY
3 Months Ended
Jul. 31, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BACKGROUND,ACQUSITION AND LIQUIDITY

NOTE 1 – BACKGROUND, ACQUISITION AND LIQUIDITY

This summary of accounting policies for Nuvilex, Inc. and Subsidiaries is presented to assist in understanding the Company's consolidated financial statements. The accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the consolidated financial statements.

History of the Company

The Company was founded as DJH International, Inc., a Nevada corporation, on October 28, 1996, changing its name to eFoodSafety.com, Inc. following the October 16, 2000 acquisition of Global Procurement Systems, Inc. The Company acquired Ozone Safe Food, Inc. for Common Stock on October 29, 2003. The Company’s early mission provided methods and products to ensure safety of marketed fruits and vegetables worldwide. On February 4, 2004, the Company registered shares with the Securities and Exchange Commission and its Common Stock began publicly trading on the OTC Bulletin Board under the trading symbol EFSF. The Company did not issue shares of Common Stock pursuant to an initial public offering. With less than projected demand for its produce sterilization methods and software tracking products, the Company changed its strategy and acquired Knock-Out Technologies, Ltd. and MedElite, Inc. in May 2004 and August 2005, respectively, of which Knock-Out Technologies, Ltd. was a developer of products using organic, non-toxic, food based substances and MedElite, Inc. was the exclusive U.S. distributor of TalsynTM-CI Scar Cream (“Talsyn”), a topical scar- reducing cream. The Company’s strategy was to bring to market scientifically derived products. The Company sold its Ozone Safe Food, Inc. operations in August 2005. In November 2006, the Company formed Cinnergen, Inc., a wholly-owned subsidiary, to manufacture and market a non-prescription liquid nutritional supplement designed to promote healthy glucose metabolism, and purEffect, Inc., another wholly-owned subsidiary, to manufacture and market purEffectTM, a four-step non-prescription acne treatment. On March 10, 2006, the Company licensed the marketing rights for purEffectTM to Charlston Kentrist 41 Direct, Inc. (“CK41”). In July 2007, I-Boost, Inc., a wholly-owned subsidiary was formed to market products to support the immune system. In March 2008, Cinnechol, Inc. became a wholly-owned subsidiary to promote cardiovascular health. In February 2009, the Company sold the rights to the purEffectTM product to CK41 for an equity position in CK41 and future royalty compensation. In March 2009, Freedom2 Holdings, Inc. was acquired to manufacture and market products including Infinitink®, a permanent tattoo ink designed to be removed more easily using conventional laser light. The Company changed its name to Nuvilex, Inc. on March 18, 2009 as part of the process.

XML 28 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Balance Sheet (Parenthetical) (USD $)
Jul. 31, 2012
Apr. 30, 2012
Common Stock, authorized 1,490,000,000 1,490,000,000
Common Stock, issued and outstanding 423,420,851 416,293,195
Common Stock, par value $ 0.0001 $ 0.0001
SeriesEPreferredStockMember
   
Preferred Stock, authorized 10,000,000 10,000,000
Preferred Stock, Issued and outstanding 8,500 8,500
Preferred Stock, par value $ 0.0001 $ 0.0001
XML 29 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
LEGAL PROCEEDINGS
3 Months Ended
Jul. 31, 2012
Commitments and Contingencies  
LEGAL PROCEEDINGS

NOTE 11 – LEGAL PROCEEDINGS

 

In July 2011 a claim was filed by Cornerstone Bank (“Cornerstone”) against Freedom-2, Inc., a wholly owned subsidiary of the Company, for amounts due under a promissory note (the “Note”), in the original principal amount of $1.6 million (collectively the “Indebtedness”). The bank also sought to foreclose its mortgage on the property securing the Note, which is located in Cherry Hill, New Jersey (the “Property”). Given the passage of time and the Company having made no payments toward the Indebtedness for several years, as of May 2012, the amount due was approximately $2.0 million.

On May 7, 2012, the Company and Cornerstone entered into a comprehensive settlement agreement that resolves all matters related to Cornerstone’s claims (the “Settlement”). Since that time, the Company and Cornerstone have proceeded to carry out the terms of the Settlement Agreement as follows: (i) the parties stipulated to judgment in the amount of the Indebtedness, with a stay of execution for 2 years pending the Company satisfying the Indebtedness in any of several ways, including direct payments of cash and discounts of up to 30% for early payments, or a combination thereof; (ii) the Company has conveyed the Property to Cornerstone, which will sell the Property and apply the net proceeds to reduce the Indebtedness (in the event the Property is not sold and the Indebtedness satisfied as otherwise described herein, the Property will be reconveyed to the Company); and (iii) the Company has transferred 14,605,614 shares of the Company’s common stock as security for payment of the Indebtedness (the “Stock Collateral”), which can be liquidated by Cornerstone from time to time in accordance with an SEC Rule 10b5-1 plan, with the proceeds being applied to reduce the Indebtedness. Any excess Stock Collateral will be returned to the Company upon payment of the Indebtedness in full. When the property is sold and any and all remaining payments, if any, are made by Nuvilex directly or through liquidation of the transferred stock collateral sold over time, the proceeds will be used to eliminate the Indebtedness, which, together with the Stock Collateral will remain on the Company’s financial statements in the then outstanding amount/value until fully satisfied. The building is listed as a Company asset under “Settlement Obligation Asset” and the indebtedness is listed as a Company liability as “Settlement Obligation Liabilities.” All assets and amounts due under the settlement, including the building, principal, interest and any and all applicable fees are therefore fully reported herein.

To date, the Company has completed all paperwork and signed the Deed In Lieu to Cornerstone Bank, provided all necessary paperwork for transfer of the property and the stock issuance and is awaiting delivery of final signed paperwork from Cornerstone Bank. Therefore, we have come to completion of this issue. Nonetheless, until the property is sold, payments made by Nuvilex, or the stock sold over time, any or all of which are expected to eliminate the debt, such amounts will continue to be reported in the financial statements under the headings of “Settlement Obligation Asset” and “Settlement Obligation Liabilities.” All assets and amounts due under the settlement, including the building, principle, interest and all applicable fees have thus been reported.

XML 30 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
3 Months Ended
Jul. 31, 2012
Sep. 10, 2012
Document And Entity Information    
Entity Registrant Name NUVILEX, INC.  
Entity Central Index Key 0001157075  
Document Type 10-Q  
Document Period End Date Jul. 31, 2012  
Amendment Flag false  
Current Fiscal Year End Date --04-30  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? No  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   423,950,851
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2012  
XML 31 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
RELATED PARTY TRANSACTIONS
3 Months Ended
Jul. 31, 2012
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 12 - RELATED PARTY TRANSACTIONS

During the quarter ended July 31, 2012 and the year ended April 30, 2012 a shareholder loaned the Company a total of $360,258 and $337,408, respectively for operating expenses. All loans bear interest at 6% and are due on demand.

As of July 31, 2012 and April 30, 2012, the Company owed a Director and shareholder $22,700; the loan accrues interest at 8% and is due on demand.

As of July 31, 2012, Dr. Robert Ryan, CEO, loaned the Company $202,769, at 8% interest, to provide for payment of operating expenses.

 

During the year ended April 30, 2012 three shareholders advanced $600,000 to the company. These funds were repaid with the issuance of 9,250,000 shares of common stock and an additional 1,650,000 shares as an incentive for making the advances.

XML 32 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Operations (USD $)
3 Months Ended
Jul. 31, 2012
Jul. 31, 2011
Revenues:    
Product Sales $ 6,626 $ 19,762
Total revenue 6,626 19,762
Cost of revenues    15,675
Gross profit 6,626 4,087
Expenses:    
Sales and Marketing 81,982 125,130
Compensation Expense 181,181 305,564
Legal and Professional Fees 52,243 59,954
General and Administrative 230,006 166,039
Total Operating Expenses 545,412 656,687
Net loss from operations (538,786) (652,600)
Other income (expense):    
Gain on forgiveness of debt 71,742   
Interest expense 2,590   
Other expense (46,063) (33,420)
Total Other Income (Expense) 28,269 (33,420)
Net Income (Loss) $ (510,517) $ (686,020)
Basic Income (Loss) per share $ 0.00 $ 0.00
Weighted average shares outstanding 419,566,403 367,294,646
XML 33 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
INVENTORY
3 Months Ended
Jul. 31, 2012
Inventory Disclosure [Abstract]  
INVENTORY

NOTE 6 - INVENTORY

On July 31, 2012 and April 30, 2012, inventory consisted of $9,620 and $6,846, respectively of finished goods inventory for Cinnergen™ products. Inventories are stated at the lower of cost or market. Cost is computed on a weighted-average basis, which approximates the first-in, first-out method; market is based upon estimated replacement costs.

 

XML 34 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
ASSET PURCHASE
3 Months Ended
Jul. 31, 2012
Notes to Financial Statements  
ASSET PURCHASE

 NOTE 5 – ASSET PURCHASE

 

On June 21, 2012, the Registrant, Nuvilex, Inc. (“Nuvilex”), a Nevada corporation, purchased 100% of the shares of Austrianova Singapore Pte. Ltd. (ASPL) in exchange for 100,000,000 shares of restricted Nuvilex common stock. A copy of the final Asset Purchase Agreement, dated May 26, 2011, is attached as Exhibit 2.1 on the Company’s Form 10-K for the fiscal year ended April 30, 2012.

 

Under the terms of the Asset Purchase Agreement, the Nuvilex and ASPL shares are held in escrow until the completion of Nuvilex’s financing obligations. The Asset Purchase Agreement, as amended, provides that Nuvilex will fund future ASPL operations in the amount of $2.5 million with a target date to complete the funding by December 31, 2012. Nuvilex will continue current funding of $60,000 monthly in operating capital until the overall funding is completed.

 

The shares for both ASPL and Nuvilex are being held in escrow and are therefore not reflected in the financial statements. This is due to the potential unwinding of the agreement in the event Nuvilex is unable to satisfy the Asset Purchase Agreement requirements including monthly maintenance payments or the $2.5 million minimum financing requirement.

XML 35 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
GOING CONCERN (NARRATIVE) (DETAILS) (USD $)
Jul. 31, 2012
Going Concern Narrative Details  
Negative Working Capital $ 2,821,368
XML 36 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUBSEQUENT EVENTS
3 Months Ended
Jul. 31, 2012
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 13 - SUBSEQUENT EVENTS

The Company has performed an evaluation of subsequent events in accordance with ASC Topic 855, noting no additional subsequent events other than those noted below.

Subsequent to July 31, 2012, the Company granted 530,000 shares of common stock for services.

 

XML 37 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMON STOCK TRANSACTIONS
3 Months Ended
Jul. 31, 2012
Equity [Abstract]  
COMMON STOCK TRANSACTIONS

NOTE 9 - COMMON STOCK TRANSACTIONS

During the year ended April 30, 2012, 23,575,000 shares of common stock were issued to officers of the Company for compensation. Shares were valued using the closing stock price on the day of issuance for a total expense of $1,160,880.

During the year ended April 30, 2012, 8,550,000 shares of common stock were issued for various services. Shares were valued using the closing stock price on the day of issuance for a total expense of $409,400.

During the year ended April 30, 2012, 9,250,000 shares of common stock were issued in exchange for $600,000 in cash advances to the Company. In addition, another 1,650,000 shares were issued as incentive for providing the cash advances to the Company. These additional shares were value at $101,750 and charged to interest expense

During the year ended April 30, 2012, 1,025,000 shares of common stock were issued to settle various debts. The shares were valued using the closing stock price on the day of issuance for a total expense of $55,725.

During the quarter ended July 31, 2012, 2,400,000 shares of common stock were issued for various services. Shares were valued using the closing stock price on the day of issuance for a total expense of $147,000.

During the quarter ended July 31, 2012, 1,842,656 shares of common stock were issued to settle various debts. The shares were valued using the closing stock price on the day of issuance for a total expense of $98,596.

During the quarter ended July 31, 2012, 2,885,000 shares of common stock were issued to officers of the Company for compensation. Shares were valued using the closing stock price on the day of issuance for a total expense of $172,181.

During the quarter ended July 31, 2012, the Company issued 100,000,000 shares of restricted common stock to Austrianova Singapore Pte. Ltd. (ASPL). Under the terms of the Asset Purchase Agreement, the shares are held in escrow until the completion of Nuvilex’s financing obligations (refer to Note 5). The shares for both ASPL and Nuvilex are being held in escrow and are therefore not reflected in the financial statements. This is due to the potential unwinding of the agreement in shares in the event Nuvilex is unable to satisfy the Asset Purchase Agreement requirements including monthly maintenance payments or the $2.5 million minimum financing requirement.

All shares were issued without registration under the Securities Act of 1933, as amended, in reliance upon the exemption afforded by Section 4(2) of that Act. No underwriters were involved.

 

XML 38 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
FIXED ASSETS
3 Months Ended
Jul. 31, 2012
Property, Plant and Equipment [Abstract]  
FIXED ASSETS

NOTE 7 - FIXED ASSETS

Fixed assets consisted of the following:

   July 31, 2012  April 30, 2012
Computers  $23,664   $23,664 
Furniture and fixtures   —      —   
Lab equipment   —      —   
           
Less: accumulated depreciation   (23,664)   (23,664)
   $—     $—   

 

Depreciation expense for the three months ended July 31, 2012 and fiscal year ended April 30, 2012 was $0 and $24,659, respectively.

 

XML 39 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
DEBT
3 Months Ended
Jul. 31, 2012
Debt Disclosure [Abstract]  
DEBT

NOTE 8 – DEBT

 

As of July 31, 2012 the company owed various individuals a total of $310,000. All notes accrue interest at 10% per annum and are due within one year.

 

As of July 31, 2012 the company owed $20,000 plus accrued interest to an individual. The note accrues interest at 8% per annum and is past due.

 

As of July 31, 2012, the Company had an obligation to pay $400,000 in licensing fees for a licensing agreement that since then has been terminated. The debt is presently under negotiation for settlement.

During the year ended April 30, 2012, the Company settled various debts with a combination of cash payments and the issuance of common stock. In total over $500,000 debt was settled. As a result of those settlements the Company recorded a gain of $370,619.

During the quarter ended July 31, 2012, the Company settled various accounts payable with the issuance of common stock. In total over $132,000 of debt was settled. As a result of those settlements the Company recorded a gain of $71,742.

 

 

XML 40 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
PREFERRED STOCK
3 Months Ended
Jul. 31, 2012
Equity [Abstract]  
PREFERRED STOCK

NOTE 10 - PREFERRED STOCK

Series E Preferred Stock has, among others, the following features:

·Series E Preferred Shares will not bear any dividends.
·Each share of Series E Preferred Stock is entitled to receive its share of assets distributable upon the liquidation, dissolution or winding up of the affairs of the Company. The holders of the Series E Preferred Shares shall be entitled to receive in cash out of the assets of the Company before any amount shall be paid to the holders of any capital stock of the Company of any class junior in rank to the Series E Preferred Shares.
·Each share of Series E Preferred Stock is convertible, at the holder’s option, into shares of Common Stock, at the average Closing Bid Price of the Company’s common stock for five (5) trading days prior to the Conversion Date.
·At every meeting of stockholders, every holder of Series E Preferred Stock is entitled to 50,000 votes for each share of Series E Preferred Stock in his name, with the same and identical voting rights as a holder of a share of Common Stock; therefore, the holder of the preferred stock can effectively increase the Company issued Common Stock shares without a vote of the Common Stock shareholders thus enabling any potential shortfall of authorized common shares outstanding from being covered should the Preferred Stockholders wish to convert.

On March 1, 2011, the Company issued 3,500 shares of preferred stock to a shareholder for an $80,000 loan that was made to the company. Based on prior year issuance of preferred stock, the original valuation was $50.00/share and since the valuation of the preferred stock for this loan was set to $80,000 per 3,500 shares or $22.86/share, the Company has recorded a loss on conversion of debt of $95,000 for year ending April 30, 2011.

The average Closing Bid Price at April 30, 2011 was $0.03. Based on the Series E Preferred Stock provisions, if converted on April 30, 2011, the outstanding 3,500 Series E Preferred Shares would have converted into 2,666,667 shares of the Company’s common stock.

Under the terms of the Series E Stock Certificate, the holders have specific rights to be paid in cash out of the assets of the Company prior to any junior class shares.  As a result of the obligations for Series E preferred shares, the Company has determined these redemption features have the potential to be outside the control of the Company, and accordingly, the Company has classified the Series E shares outside of shareholder’s equity in accordance with ASC 480 regarding instruments with debt and equity features.  Thus, the full value for the convertible Preferred Stock was recorded outside of stockholders’ equity in the accompanying consolidated balance sheet.  

 

XML 41 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
FIXED ASSETS (Tables)
3 Months Ended
Jul. 31, 2012
Fixed Assets Tables  
Schedule of Fixed Assets

Fixed assets consisted of the following:

    July 31, 2012   April 30, 2012
Computers $ 23,664 $ 23,664
Furniture and fixtures   -   -
Lab equipment   -   -
         
Less: accumulated depreciation   (23,664)   (23,664)
  $ - $ -
XML 42 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
ASSET PURCHASE (Details) (Narrative) (USD $)
3 Months Ended
Jul. 31, 2012
Apr. 30, 2012
Jun. 21, 2012
AustrianovaSingaporePteLtdMember
Percentage of holding     100.00%
Common Stock Issued 423,420,851 416,293,195 100,000,000
Funding Obligation     $ 2,500,000
Funding Terms

Purchase Agreement requirements including monthly maintenance payments or the $2.5 million minimum financing requirement.

   
Monthly Operating Capital Funding $ 60,000    
XML 43 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders Equity (Deficit) (USD $)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Common Stock Not Yet Issued
Total
Beginning balance, amount at Apr. 30, 2011 $ 35,714 $ 34,415,655 $ 768,031 $ (37,948,693) $ (2,729,293)
Beginning balance, shares at Apr. 30, 2011 357,137,581        
Issuance of common stock for cash, shares 500,000        
Issuance of common stock for cash, amount 50 20,950     21,000
Issuance of common stock for compensation, shares 23,575,000        
Issuance of common stock for compensation, amount 2,358 1,196,272 (37,750)   1,160,880
Issuance of common stock for services, shares 8,550,000        
Issuance of common stock for services, amount 855 408,545     409,400
Stock issued on stock payable, shares 14,605,614        
Stock issued on stock payable, amount 1,461 728,820 (730,281)    
Shares issued for repayment of cash advances, shares 9,250,000        
Shares issued for repayment of cash advances, amount 925 599,075     600,000
Shares issued for incentive for cash advances, shares 1,650,000        
Shares issued for incentive for cash advances, amount 165 101,585     101,750
Shares issued for settlement of debt, shares 1,025,000        
Shares issued for settlement of debt, amount 103 55,622     55,725
Net Income (Loss)       (1,899,312) (1,899,312)
Ending balance, amount at Apr. 30, 2012 41,631 37,526,524   (39,848,005) (2,279,850)
Ending balance, shares at Apr. 30, 2012 416,293,195        
Issuance of common stock for compensation, shares 2,885,000        
Issuance of common stock for compensation, amount 290 171,891     172,181
Issuance of common stock for services, shares 2,400,000        
Issuance of common stock for services, amount 240 146,760     147,000
Shares issued for settlement of debt, shares 1,842,656        
Shares issued for settlement of debt, amount 184 98,412     98,596
Net Income (Loss)       (510,517) (510,517)
Ending balance, amount at Jul. 31, 2012 $ 42,345 $ 37,943,587   $ (40,358,522) $ (2,372,590)
Ending balance, shares at Jul. 31, 2012 423,420,851        
XML 44 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACCOUNTS RECEIVABLE
3 Months Ended
Jul. 31, 2012
Receivables [Abstract]  
ACCOUNTS RECEIVABLE

NOTE 4 – ACCOUNTS RECEIVABLE

The Company recognizes receivables predominately on sales of its Cinnergen product.  At July 31, 2012 the company recorded an allowance for doubtful accounts of $6,497.

 

XML 45 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
FIXED ASSETS (Details) (Narrative) (USD $)
3 Months Ended 12 Months Ended
Jul. 31, 2012
Apr. 30, 2012
Fixed Assets Details Narrative    
Depreciation Expenses $ 0 $ 24,659
XML 46 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 60 164 1 false 16 0 false 4 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://nuviliex.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - Balance Sheet Sheet http://nuviliex.com/role/BalanceSheet Balance Sheet false false R3.htm 0003 - Statement - Balance Sheet (Parenthetical) Sheet http://nuviliex.com/role/BalanceSheetParenthetical Balance Sheet (Parenthetical) false false R4.htm 0004 - Statement - Statements of Operations Sheet http://nuviliex.com/role/StatementsOfOperations Statements of Operations false false R5.htm 0005 - Statement - Stockholders Equity (Deficit) Sheet http://nuviliex.com/role/StockholdersEquityDeficit Stockholders Equity (Deficit) false false R6.htm 0006 - Statement - Statements of Cash Flows Sheet http://nuviliex.com/role/StatementsOfCashFlows Statements of Cash Flows false false R7.htm 0007 - Disclosure - BACKGROUND,ACQUISITION AND LIQUIDITY Sheet http://nuviliex.com/role/BackgroundacquisitionAndLiquidity BACKGROUND,ACQUISITION AND LIQUIDITY false false R8.htm 0008 - Disclosure - GOING CONCERN AND MANAGEMENT'S PLANS Sheet http://nuviliex.com/role/GoingConcernAndManagementsPlans GOING CONCERN AND MANAGEMENT'S PLANS false false R9.htm 0009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://nuviliex.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES false false R10.htm 0010 - Disclosure - ACCOUNTS RECEIVABLE Sheet http://nuviliex.com/role/AccountsReceivable ACCOUNTS RECEIVABLE false false R11.htm 0011 - Disclosure - ASSET PURCHASE Sheet http://nuviliex.com/role/AssetPurchase ASSET PURCHASE false false R12.htm 0012 - Disclosure - INVENTORY Sheet http://nuviliex.com/role/Inventory INVENTORY false false R13.htm 0013 - Disclosure - FIXED ASSETS Sheet http://nuviliex.com/role/FixedAssets FIXED ASSETS false false R14.htm 0014 - Disclosure - DEBT Sheet http://nuviliex.com/role/Debt DEBT false false R15.htm 0015 - Disclosure - COMMON STOCK TRANSACTIONS Sheet http://nuviliex.com/role/CommonStockTransactions COMMON STOCK TRANSACTIONS false false R16.htm 0016 - Disclosure - PREFERRED STOCK Sheet http://nuviliex.com/role/PreferredStock PREFERRED STOCK false false R17.htm 0017 - Disclosure - LEGAL PROCEEDINGS Sheet http://nuviliex.com/role/LegalProceedings LEGAL PROCEEDINGS false false R18.htm 0018 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://nuviliex.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R19.htm 0019 - Disclosure - SUBSEQUENT EVENTS Sheet http://nuviliex.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R20.htm 0020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (POLICIES) Sheet http://nuviliex.com/role/SignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (POLICIES) false false R21.htm 0021 - Disclosure - FIXED ASSETS (Tables) Sheet http://nuviliex.com/role/FixedAssetsTables FIXED ASSETS (Tables) false false R22.htm 0022 - Disclosure - FIXED ASSETS (DETAILS) Sheet http://nuviliex.com/role/FixedAssetsDetails FIXED ASSETS (DETAILS) false false R23.htm 0023 - Disclosure - GOING CONCERN (NARRATIVE) (DETAILS) Sheet http://nuviliex.com/role/GoingConcernNarrativeDetails GOING CONCERN (NARRATIVE) (DETAILS) false false R24.htm 0024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (NARRATIVE) (DETAILS) Sheet http://nuviliex.com/role/SignificantAccountingPoliciesNarrativeDetails SIGNIFICANT ACCOUNTING POLICIES (NARRATIVE) (DETAILS) false false R25.htm 0025 - Disclosure - ACCOUNTS RECEIVABLE (Details) (Narrative) Sheet http://nuviliex.com/role/AccountsReceivableDetailsNarrative ACCOUNTS RECEIVABLE (Details) (Narrative) false false R26.htm 0026 - Disclosure - ASSET PURCHASE (Details) (Narrative) Sheet http://nuviliex.com/role/AssetPurchaseDetailsNarrative ASSET PURCHASE (Details) (Narrative) false false R27.htm 0027 - Disclosure - FIXED ASSETS (Details) (Narrative) Sheet http://nuviliex.com/role/FixedAssetsDetailsNarrative FIXED ASSETS (Details) (Narrative) false false R28.htm 0028 - Disclosure - DEBT (Details) (Narrative) Sheet http://nuviliex.com/role/DebtDetailsNarrative DEBT (Details) (Narrative) false false R29.htm 0029 - Disclosure - COMMON STOCK TRANSACTIONS (Details) (Narrative) Sheet http://nuviliex.com/role/CommonStockTransactionsDetailsNarrative COMMON STOCK TRANSACTIONS (Details) (Narrative) false false R30.htm 0030 - Disclosure - PREFERRED STOCK (Details) (Narrative) Sheet http://nuviliex.com/role/PreferredStockDetailsNarrative PREFERRED STOCK (Details) (Narrative) false false R31.htm 0031 - Disclosure - LEGAL PROCEEDINGS (Details) (Narrative) Sheet http://nuviliex.com/role/LegalProceedingsDetailsNarrative LEGAL PROCEEDINGS (Details) (Narrative) false false R32.htm 0032 - Disclosure - RELATED PARTY TRANSACTIONS (Details) (Narrative) Sheet http://nuviliex.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details) (Narrative) false false R33.htm 0033 - Disclosure - SUBSEQUENT EVENT (Details) (Narrative) Sheet http://nuviliex.com/role/SubsequentEventDetailsNarrative SUBSEQUENT EVENT (Details) (Narrative) false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - Balance Sheet Process Flow-Through: Removing column 'Mar. 01, 2011' Process Flow-Through: 0003 - Statement - Balance Sheet (Parenthetical) Process Flow-Through: Removing column 'Mar. 01, 2011' Process Flow-Through: 0004 - Statement - Statements of Operations Process Flow-Through: 0006 - Statement - Statements of Cash Flows nvlx-20120731.xml nvlx-20120731.xsd nvlx-20120731_cal.xml nvlx-20120731_def.xml nvlx-20120731_lab.xml nvlx-20120731_pre.xml true true XML 47 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
SIGNIFICANT ACCOUNTING POLICIES (POLICIES)
3 Months Ended
Jul. 31, 2012
Significant Accounting Policies Policies  
Unaudited Financial Statements

Unaudited Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), for interim financial information and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X. While these statements reflect all normal recurring adjustments which are, in the opinion of management, necessary for fair presentation of the results of the interim period, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. The unaudited interim financial statements should be read in conjunction with the Company’s annual report on Form 10-K, which contains the audited financial statements and notes thereto, together with Management’s Discussion and Analysis, for the fiscal year ended April 30, 2012.  The interim results for the three months ended July 31, 2012 are not necessarily indicative of the results for the full fiscal year.

Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud. The Company's system of internal accounting control is designed to assure, among other items, that 1) recorded transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented.

Principles of Consolidation

Principles of Consolidation

The consolidated financial statements include the accounts of Nuvilex, Inc. and its subsidiaries, Knock-Out Technologies, Ltd., MedElite, Inc., Cinnergen, Inc., I-Boost, Inc., Cinnechol Inc., Freedom-2 GmbH, Berlin, Freedom-2 Creditor Partners, Freedom-2 Holdings, Inc, Freedom-2, Inc., Exceptional Equipment and Ink Supply Company, Inc. With respect to the latter three subsidiaries the financials include the profit and loss activity from the date of purchase March 2, 2009 to July 31, 2012 as the acquisition was accounted for under the purchase method of accounting.

All significant intercompany balances and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and Cash Equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes. There were no cash equivalents as of July 31, 2012 or April 30, 2012.

Inventories

Inventories

Inventories are stated at the lower of cost or market. Cost is computed on a weighted-average basis, which approximates the first-in, first-out method; market is based upon estimated replacement costs.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Property and Equipment

Property and Equipment

Property and equipment are recorded at cost. Expenditures that increase the useful lives or capacities of the plant and equipment are capitalized. Expenditures for repairs and maintenance are charged to income as incurred. Depreciation is provided using the straight-line method over the estimated useful lives as follows:

Computer equipment/software - 3 years

Furniture and fixtures - 7 years

Machinery and equipment - 7 years

Building improvements - 15 years

Building - 40 years

Goodwill and other indefinite-lived intangibles

Goodwill and other indefinite-lived intangibles

The Company records the excess of purchase price over the fair value of the identifiable net assets acquired as goodwill and other indefinite-lived intangibles. The FASB standard on goodwill and other intangible assets, prescribes a two-step process for impairment testing of goodwill and indefinite-lived intangibles, which is performed annually, as well as when an event triggering impairment may have occurred. The first step tests for impairment, while the second step, if necessary, measures the impairment. The Company has elected to perform its annual analysis at the end of its reporting year.

Valuation of long-lived assets

Valuation of long-lived assets

The Company accounts for the valuation of long-lived assets under the FASB standard for accounting for the impairment or disposal of Long-Lived Assets. The FASB standard requires that long-lived assets and certain identifiable intangible assets be reviewed for impairment whenever events or circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the long-lived assets is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less cost to sell.  

Basic and Diluted Earnings (Loss) per Share

Basic and Diluted Earnings (Loss) per Share

Basic and diluted earnings per share is calculated using the weighted-average number of common shares outstanding during the period without consideration of the dilutive effect of stock warrants, convertible notes and convertible preferred shares.

Fair value of financial instruments

Fair value of financial instruments

For certain of the Company’s non-derivative financial instruments, including cash and cash equivalents, receivables, accounts payable, and other accrued liabilities, the carrying amount approximates fair value due to the short-term maturities of these instruments. The estimated fair value of long-term debt is based primarily on borrowing rates currently available to the Company for similar debt issues. The fair value approximates the carrying value of long-term debt.

ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, “Financial Instruments,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures.  The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

     
  · Level 1. Observable inputs such as quoted prices in active markets;
  · Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
  · Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The following presents the gross value of assets and liabilities that were measured and recognized at fair value as of July 31, 2012 and April 30, 2012.

     
  · Level 1: none
  · Level 2: none
  · Level 3: none

Effective October 1, 2008, the Company adopted Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures ("ASC 820-10") and Accounting Standards Codification subtopic 825-10, Financial Instruments ("ASC 825-10"), which permits entities to choose to measure many financial instruments and certain other items at fair value. Neither of these statements had an impact on the Company's financial position, results of operations or cash flows. The carrying value of cash, accounts payable and accrued expenses, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments.

As of July 31, 2012 and April 30, 2012 the Company has recorded several of its assets and liabilities at fair value. The building or “asset held for obligation on settlement” (Note 11) was written down in the last quarter of fiscal 2010 to its fair value based upon a pending sale agreement. Although the agreement was not finalized it established the current market value for the property.  In March of 2009 through the acquisition of another company the Company acquired certain debt. As part of the acquisition these liabilities were evaluated by a third party and valued at fair value at which they were recorded. As a result of this the Company is amortizing the associated discount and premium for two of the liabilities

Recent accounting pronouncements

Recent accounting pronouncements

In September 2011 the Accounting Standards Update No. 2011-08, Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for impairment. This ASU's objective is to simplify the process of performing impairment testing for Goodwill. With this update a company is allowed to asses qualitative factors, first, to determine if it is more likely than not (greater than 50%) that the FV is less than the carrying amount. This would be done, prior to performing the two-step goodwill impairment testing, as prescribed by Topic 350.  Prior to this ASU, all entities were required to test, annually, their good will for impairment by Step 1 - comparing the FV to the carrying amount, and if impaired, then step 2 - calculate and recognize the impairment. Therefore, the fair value measurement is not required, until the "more likely than not" reasonableness test is concluded. Effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011.

In May 2011, FASB issued Accounting Standards Update No. 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.    This ASU clarifies the board's intent of current guidance, modifies and changes certain guidance and principles, and adds additional disclosure requirements concerning the 3 levels of fair value measurements. Specific amendments are applied to FASB ASC 820-10-35, Subsequent Measurement and FASB ASC 820-10-50, Disclosures. This ASU is effective for interim and annual periods beginning after December 15, 2011.

In June 2011, FASB issued Accounting Standards Update No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income. - ASU 2011-05. Current US GAAP allows companies to present the components of comprehensive income as a part of the statement of changes in stockholders' equity. This ASU eliminates that option. In this update, an entity has the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In both choices, an entity is required to present each component of net income along with total net income, each component of other comprehensive income along with a total for other comprehensive income, and a total amount for comprehensive income This ASU is effective interim and annual periods beginning after December 15, 2011.  This ASU should be applied retrospectively. There are no specific transition disclosures.

The Company has implemented all new accounting pronouncements that are in effect.  These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Revenue Recognition

Revenue Recognition

Sales of products and related costs of products sold are recognized when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the price is fixed or determinable, and (iv) collectability is reasonably assured. These terms are typically met upon the prepayment or invoicing and shipment of products.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts

The Company provides an allowance for estimated uncollectible accounts receivable balances based on historical experience and the aging of the related accounts receivable.

Income Taxes

Income Taxes

Deferred taxes are calculated using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

In June 2006, the FASB interpreted its standard for accounting for uncertainty in income taxes, an interpretation of accounting for income taxes.  This interpretation clarifies the accounting for uncertainty in income taxes recognized in an entity’s financial statements in accordance the minimum recognition threshold and measurement attributable to a tax position taken on a tax return is required to be met before being recognized in the financial statements.

The FASB’s interpretation had no material impact on the Company’s financial statements for the quarter ended July 31, 2012 or the year ended April 30, 2012. Current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, the amount available to offset future taxable income may be limited. No tax benefit has been reported in the financial statements, because the Company believes the carry forwards may expire unused, although acquisition of sufficient operating capital to complete the acquisition of all of the assets of SG Austria may change this. Accordingly, the potential tax benefits of the loss carry forwards are offset by a valuation allowance of the same amount.

Research and Development Costs

Research and Development Costs

Expenditures for research and development are expensed as incurred. Such costs are required to be expensed until the point that technological feasibility is established.

Concentration of Credit Risk

Concentration of Credit Risk

The Company has no significant off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. The Company maintains the majority of its cash balances with one financial institution in the form of demand deposits.

Reclassifications

Reclassifications

Certain items in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current period’s presentation. These reclassifications have no effect on the previously reported income (loss).